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The important thing is not to stop questioning. Curiosity has its own reason for existing. 
One cannot help but be in awe when he contemplates the mysteries of eternity, of life, of 
the marvelous structure of reality. It is enough if one tries merely to comprehend a little 
of this mystery every day. Never lose a holy curiosity. 
 
-Albert Einstein (1879-1955) 
To Ba and Dada for the heritage, 
Mom and Dad for the opportunities, 
Hemben for my childhood, 
Daxaben for the indomitable support, 
Pritty for the kindred friendship, 
Bhikhu for the humor, and 
Smita and Trisha for the future 
 
 






I have been an inexorable dreamer my entire life, often aspiring for so many different 
ambitions that the immediate goals were frequently lost in thought.  However, with every 
phase of my life, some things never changed.  I always wanted to be just like my two 
older sisters, who could not be more disparate from one another.  One sister wanted to 
be an astronaut, and thus, I, at the ripe age of seven, announced to the entire school 
during the morning announcements that I would one day become an astronaut.  I always 
knew my forte embraced science and mathematics, quite contrary to the study of music, 
art, theatre, writing, and photography I commenced in vain.  I recognized in myself a 
curiosity so reminiscent of scientists, and my perfectionist attitude and attention to detail 
often warranted teachers to suggest engineering as a profession.  Thus, when sprinkled 
into the recipe of my life, these events led me to the Georgia Institute of Technology and 
Emory University in Atlanta, GA to write this dissertation in biomedical engineering.    
 
In the epigraph, I quote the great Albert Einstein’s thoughts on curiosity, a tenet that is 
arguably intrinsic in life.  I wholly believe science requires a balance between the innate 
curiosity to question the reasons why certain entities exist and the acquired prudence to 
accept the things to which we have no answer.  It is with this curiosity that science has 
delved into the puzzle of the human body, ascertaining the causes of pathologies that 
once evaded us and cultivating therapies to mitigate these medical maladies.   
 
In the spirit of Einstein’s words, I have completed my formal education by never losing 
my holy curiosity.  From extensive “To Do” lists to three-week-in-advance experimental 
plans, this dissertation is brought to you after four years of diligence, vigilant thought, 
and an earnest aspiration to help others.   
 
 





I always knew that I enjoyed science and all things scientific in school but 
yearned to attempt my hand at various artistic ventures, which always seemingly failed.  
However, in graduate school, I found a wonderful balance among my many assorted 
interests and even managed to find a home for creativity in science.  Along the way, I 
met a clan of the most eclectic personalities who inspired me scientifically and dazzled 
me personally.  To them, I owe my heartfelt thank you, for this dissertation is the product 
of their indomitable support, charming friendship, constant encouragement, and invasive 
laughter. 
I would like to acknowledge my advisor, Hanjoong Jo, who allowed me to work 
on a project related to microgravity and NASA.  I am truly grateful to have been able to 
travel near and far to present our work at scientific sessions, which facilitated in my 
developing a knack for answering questions on-the-spot.  My earnest admiration goes to 
my dissertation committee formed by Dr. Barbara Boyan and Dr. Robert Guldberg of 
Georgia Tech, Dr. Diana Risin of NASA, Dr. Clint Rubin of the SUNY Stony Brook, and 
Dr. Janet Rubin of the UNC.  When we formed this committee, I was unaware that there 
were existing friendships among this group, making my committee meetings a joy...a 
sincere joy.  After comments about my project had been laid on the table, the 
culmination of the meeting was more of a reunion of old friends.  In turn, I benefited from 
a relaxed atmosphere of scientific discussion among mentors whose advice to me 
sincerely had my best interests at heart.  To Dr. Boyan, thank you for taking me under 
your wing and leading by example in being an amazingly interesting and capturing 
lecturer.  I am forever thankful to have had the opportunity to lecture to a room full of 
young undergraduates because when I first received an email saying “You make science 
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fun.”, I knew teaching was in my future.  To Dr. Guldberg, thank you for taking an 
interest in me as a person, inviting Srin and me to spend time with your beautiful (ideal) 
family, and for being a fantastic teacher.  To Dr. Clint Rubin, your down-to-earth attitude 
and honest criticism have made our e-mentorship so rewarding, and to Dr. Janet Rubin, 
thank you for your appreciation of the details.  Dr. Diana Risin, my genuine gratitude 
goes to you for always having my interests at the forefront of your actions.  You were a 
wonderful mentor when I worked at NASA with the perfect balance of guidance and 
freedom.   
To the Jo lab, transitioning from the start of this uphill climb to finally reaching the 
summit was indeed a hike that I could not have made without the resolute support I 
found in your presence.  You, as a whole, are an amazingly talented group of fun, 
intelligent, and stylish people.  Waking up and coming to work for what would surely 
have been a dreadful balance between classes and research ended up being one of my 
favorite things to do because of your shining personalities.  Of course, all sorts of mad 
love and thank yous go to Tress, Ames, and Rando for being three of the coolest people 
I have ever met!    
Tress, I can still remember meeting you at recruiting weekend and thinking you 
were such a sweet person.  It was a most pleasant surprise to find that you had joined 
the same lab as I, and it was instantly apparent that we would share this frustrating, 
undulating, and exhilarating journey with persistent support and unwavering friendship.  
During these past four and a half years, we have laughed, shared, shopped, failed, 
succeeded, and persevered together.  I am truly most fortunate to have had you along 
the way.  Your sense of humor, innate quality for baking desserts, and enviable “nice” 
attribute make you a marvelous friend.  We have often remarked that you and Pritty are 
identical, and as such, I often feel like you are my own sister.   
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Ames, my wonderful, beautiful, words-do-not-do-justice-to-you Ames.  It often 
feels like speaking to you is like looking in a mirror.  You read my mind with uncanny 
accuracy, and together we have celebrated our ups and commiserated our downs.  I 
secretly hoped you would join our lab when you rotated that summer, but I never 
imagined we would form a friendship that is without a doubt centered about a sincere 
appreciation for each other.  I have lived and learned vicariously through your beautiful 
marriage, and I am eternally thankful to have had a friend who just “got it”.  Thank you 
for the laughter, the tears, the successes, and the lessons.  You truly are a remarkable 
person.  I actually cannot wait to share our future with each other.    
Rando, you quickly became one of my favorite friends for your ability to listen and 
sincere love of music.  Thank you for keeping me hip enough to listen to music outside 
of my country-filled iTunes.  My many thanks go to you for sharing in my joy of college 
football, and Thanksgiving day games with you were one of the highlights of my years 
here in ATL (sorry I missed this year).  I do not know if I will ever hear the words South 
Dakota without thinking of my farm friend Randy!  For you, I would actually go to 
Yankton. 
Maria, thank you for your no-holds-barred attitude and for being an awesome lab 
manager!  Michelle, thank you for always being an open ear for my venting, sharing your 
drama-filled personal life with me ☺, for changing my media from those annoying 
Opticells, for not making me feel bad when I asked you to change my media, and for 
taking the time to listen to me no matter how busy you were.  Dr. Hannah Song, thank 
you for always bringing a smile to work and being a wealth of information on those darn 
BMPs.  Chih-Wen, you are without a doubt one of the most selfless and intelligent 
people with whom I have had the honor of working.  Dr. Kyung-Hwa Chang, your 
laughter rings through the lab daily, and your perky personality makes me smile.  I am so 
proud of how far you have come from when you joined the lab.  You have opened up 
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and allowed your sarcastic, funny personality to shine, and your English is so much 
better.  My appreciation also goes to Dr. Seth Brodie (thanks for sharing in my love of 
fine dining), Dr. Doug Nam, Dr. Kwon, and Dr. Won Jong Rhee.   
I owe a particular bout of thanks to my two wonderfully intelligent mentees, Sauja 
Vadoothker and Christine Hartzell.  Sauja, you are indeed fantastic.  You are a 
fantastically exuberant student and a fantastic younger sister☺!  I love that you called 
me for advice about your graduate lab, and I look forward to the indubitable things you 
accomplish.  Little bits of Sauja are sprinkled in this dissertation because she joined me 
as I was barely figuring out why there was no Eastern blot and what it meant to “vortex” 
something.  In particular, I owe a big shout out to her for the fluid shear stress data in 
Chapter 7.  Christine, you are wise beyond your years, and your honest interest in 
science is palpable.  I have no doubt that with the way you assert yourself, you will 
compile an impressive repertoire of academic achievements.   
To the many Jo lab members who have come and gone during my tenure at 
Emory, thank you.  Steve Pardo, without the fantastic platform you created for me, this 
dissertation would have been quite painful and certainly not as successful.  Thank you 
for your patience in dealing with my anal tendencies and inquisitive nature.  I am so 
grateful that you have kept in touch, and I look forward to seeing Matthew Javier grow 
up!  Deb Smith, what do I say about one of the funniest, most organized, and most 
caring people I have had the pleasure of knowing?  My many thanks go to you for often 
holding my hand as I ventured into this unknown territory of research and for being a 
solid sounding board early on as I searched and found my own role in science.  To Dr. 
Manu Platt, let me just say that anyone who has not had the pleasure of hearing the 
most joyous, infectious laughs from Manu is missing out on one of the definite wonders 
of the world.  It is impossible to resist being caught up in Manu’s energy.  Thank you for 
teaching me to pipette (what’s a pipette?), inaugurating me into the wonderful world of 
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Western goodness, for being my partner in singing out loud in lab, for loving the 
soundtrack to Rent, and for sharing in my love for all things space-related.   
To the other former Jo lab members, I thank Sarah Coleman for gracing us with 
the drama of her life, as I am certain no one’s Wednesday night is as exciting as hers.  
To Dr. Cass Reyes, despite a brief stint in the lab, your sweet smile and notable 
organization were a pleasant addition to daily life in science.  To Dr. Nolan Boyd, my 
gratitude goes to you for teaching me the despicable art of real time PCR, an assay that 
became the pillar of my dissertation.  To Dr. George Sorescu, thank you for being willing 
to answer any pesky questions during my early years in graduate school. 
 There are many scientists and engineers spanning the globe to whom I owe my 
acknowledgement.  From the European Space Agency, I thank Dr. Jack van Loon, Ron 
Huijser, J. Frans Hommes, and Luc van den Berg for their assistance with the RPM.  
Thank you for being available and for promptly responding to my many fear-filled emails 
of RPM parts frayed or missing.  At NASA, I would like to thank Dr. Nancy Ward for 
teaching me about the world of the RWV and to Dr. Kamal Emami for cell suspension 
culture.  From Juvent, I thank Roger Talish and Tommy Wilson for their assistance in 
preparing a platform for our lab, directly resulting in a large portion of my dissertation.  
From Emory University, I graciously offer my gratitude to Linda Gilbert, who answered 
my many random calls for cells and media. To Leita Young, thank you for your 
administrative support.  Finally, to the Division of Cardiology and its many members, 
thank you for accepting me into the world of hearts, arteries, smooth muscle cells, and 
endothelial goodness despite that my research related to systems almost completely 
unrelated to yours.  Initially, I often felt out of place and left out of the group, but as my 
tenure progressed, I found comfort in the Division and realized my insecurities were only 
in my head.  In particular, I would like to thank the Taylor lab for a rather big whooping in 
softball and more seriously for the daily camaraderie.    
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assistance and Steven Marzec for his computer support throughout my tenure here.  I 
must also thank a few folks from Wing 2D (i.e. the infamous Lair).  Although not often, 
many of the members of the orthopaedic wing had to endure a myriad of questions from 
yours truly.  It was an odd situation to get used to, that is being at Emory in Cardiology 
but performing osteoblast research.  I am not one to inconvenience others so when I had 
to ask someone in Wing 2D a question, I often felt distressed and nervous.  However, I 
quickly learned that Wing 2D was full of energetic, intelligent, and supportive students, 
most of whom would venture an answer for some random first year student.  Four years 
down the road, I am even happier to say that some of them have become friends, the 
likes of whom I do not plan on losing!  My heartfelt thanks, first and foremost, goes to Dr. 
Blaise Porter for honest to goodness saving me from the peril of graduate school 
disaster.  P-town heard me present my woes of trying in vain for six months just to get 
osteoblasts to mineralize in vitro, and afterwards, he asked me if I knew that this process 
was FBS-lot dependent.  I, of course being in a different world at Emory, had no clue 
about this little tidbit of critical information.  From then on, I knew I had a friend in Blaise.  
P-town, I thank you in the strongest way I can for sharing Jenny with me from the 
beginning, telling me I was pretty, and for being downright silly.  To Dr. Andres Garcia, 
Dr. Charles Gersbach, and Dr. Ben Keselowsky, thank you for answering my pesky 
questions about mineralization and FTIR when I had no one else to ask.  To Dr. Jenn 
Phillips, you are a breath of fresh air with a wonderful sense of beauty.  Thank you for 
our walks during the summer of 2006.  I will never forget our trip to Chicago in 2005 with 
Sarah West.  Restroom break, anyone? ☺ My many thanks go to Dr. Hiroumi Kitajima, 
Dr. Bryan Marshall, and Dr. Craig Duvall for being top-notch people.  Thank you, 
Hiroumi, for grilling me crazy on fluids during my quals preparation.  Thank you, 
Marshall, for your idiosyncratic personality that always manages to bring a broad smile 
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to my face!  And on top of that, you can move faster than lightning on the dance floor! 
Duvall, I will always remember your ravenous need for Krystal’s and the “That just 
happened” moment during the Days of Blaise.  I still smile at the memory! To ‘Gela Lin, 
you are one of the most sincere girls with a fabulous sense of self who I have had the 
pleasure of getting to know.  You never seem too busy to help anyone, and the word fun 
seems to follow you around!  Dr. Catherine Reyes, although we never hung out when 
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someone.  Your emails make me happy, and I am pretty certain I made it through the 
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I am quite a privileged person who rarely is happy without a multitude of 
simultaneous obligations.  As such, my four short years in Atlanta were packed with 
socials, community service, and education outreach, which inevitably balanced my 
insatiable need to be the best graduate student ever.  During my first year, I suffered 
from a bite of the athletic bug, causing me to crazily sign up to run a marathon when 
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Musculoskeletal pathologies associated with decreased bone mass, including 
osteopenia, osteoporosis, disuse-induced bone loss, and microgravity-induced bone 
loss, affect millions of Americans annually.  According to the National Osteoporosis 
Foundation, 10 million Americans currently suffer from osteoporotic bone loss while 34 
million more are estimated to have osteopenia, or low bone mass, a strong risk factor for 
osteoporosis.  Bone loss is particularly dangerous since it is typically asymptomatic and 
can lead to fractures of any bone, most usually those in the hip, spine and wrist.  These 
fractures can greatly decrease the quality of life and often cause hospitalization.  While 
osteoporosis usually affects the elderly, it can afflict both men and women of any age.  
Additionally, bone loss occurs in spaceflight, rendering astronauts at-risk for fractures 
during long term space travel.  Despite health implications, it is still a national and 
international interest to continue and to expand human-based space exploration.  As 
such, it is imperative to develop countermeasures for bone loss in space.  On average, 
astronauts lose 1-2% of bone mass per month during spaceflight, losing 6-12% in a 
typical six month International Space Station (ISS) mission.   
While many pharmaceutical treatments have slowed osteoporosis, there is still 
no countermeasure that can effectively mitigate bone loss observed in astronauts.  The 
inadequacy of current countermeasures is at least partially due to a lack of 
understanding of the cellular and molecular mechanisms underlying bone loss caused 
by osteoporosis and microgravity.  In recent years, investigators have begun addressing 
these issues by studying changes in gene expression induced by disuse, spaceflight, 
and ground-based simulated microgravity. The assumption is that the knowledge of 
changes in key gene expression may provide means for new, target-specific therapies to 
adequately counteract bone loss due to osteoporosis, disuse, or microgravity.   
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Additionally, it has long been regarded that mechanical stimuli are anabolic to 
bone.  High magnitude, low frequency impact has been recognized to increase bone and 
muscle mass under normal but not microgravity conditions.  However, the opposite 
stimulus, a low magnitude and high frequency (LMHF) mechanical load experienced in 
activities as low impact as standing, has also been shown to be anabolic to bone and 
has never been used in spaceflight.  LMHF mechanical loading has been shown to be 
effective in treating musculoskeletal pathologies in a number of subjects during research 
and clinical trials, including animals, children with musculoskeletal diseases such as 
cerebral palsy or muscular dystrophy, young women with low bone mass, and post-
menopausal osteoporotic women.  While several preclinical and clinical trials have 
demonstrated that LMHF mechanical loading affects bone formation in vivo, the target 
tissues of the mechanical load and underlying mechanisms mediating the responses are 
not known.    
 As such, this research project focuses on understanding how a LMHF 
mechanical load mediates prevention of bone loss in vivo and developing a 
countermeasure for microgravity-induced bone loss.  The objectives of the project are 
to analyze the cellular and molecular changes induced in osteoblasts by 
simulated microgravity or disuse and LMHF loading to identify potential targets 
for therapeutic interventions and to investigate the utility of a LMHF mechanical 
load in mitigating microgravity-induced bone loss.  The central hypothesis of the 
project is that simulated microgravity or disuse conditions induce bone loss by 
inhibiting expression of genes critical in regulating bone formation, osteoblast 
differentiation, and subsequent mineralization while a LMHF mechanical load 
prevents these effects.   
In these studies, we developed an in vitro system that simulates microgravity or 
disuse conditions using the Random Positioning Machine (RPM) to study the effects of 
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disuse on 2T3 preosteoblast cells grown in gas-permeable culture disks.  Exposure of 
2T3 cells to the RPM for up to nine days significantly inhibited alkaline phosphatase 
activity (ALP), recapitulating a bone loss response as seen in spaceflight without altering 
cell morphology or proliferation.  Next, we carried out gene expression analysis using 
DNA microarrays to determine gene expression profiles of 2T3 cells exposed to the 
RPM for three days.  Among 10,000 genes examined with the microarray, 88 were 
downregulated while 52 were upregulated statistically significantly by disuse by more 
than two-fold in comparison to the static 1g control conditions.  We then verified the 
microarray data for select genes relevant in bone biology by using real time PCR assays 
and immunoblotting.   We confirmed that disuse downregulated levels of ALP, runt-
related transcription factor 2 (runx2), osteomodulin (OMD), and parathyroid hormone 
receptor 1 (PTHR1) mRNA, upregulated cathepsin K (ctsk) mRNA, and did not 
significantly affect bone morphogenic protein 4 (BMP4) and cystatin C protein levels.   
The Rotating Wall Vessel (RWV) and the RPM are the two most commonly used 
simulators of microgravity, but these simulators have not been systematically compared 
to each other or to mechanical stimulating models.  These comparisons are vital to 
validate their use in modeling a disuse phenotype.  In the ensuing studies, we 
hypothesized that exposure to RWV inhibits differentiation and alters gene expression 
profiles of 2T3 cells, and a subset of these mechanosensitive genes behaves in a 
manner consistent to the RPM and opposite to the trends incurred by mechanical 
stimulation of mouse tibiae. Exposure of 2T3 preosteoblast cells to the RWV for three 
days inhibited ALP activity, a marker of differentiation, and downregulated 61 and 
upregulated 45 genes by more than two-fold compared to static 1g controls, as shown 
by microarray analysis.  The microarray results were confirmed by real time RTPCR 
and/or immunoblots for seven distinct genes and proteins including OMD, runx2, and 
osteoglycin (OGN).  Comparison of the RWV data to the RPM microarray study that we 
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previously published showed 17 mechanosensitive genes that changed in the same 
direction.  Further comparison of the RWV and RPM results to independently published 
microarray data from mechanically loaded mouse tibiae revealed three genes including 
osteoglycin that were upregulated by mechanical loading and downregulated by disuse.   
Finally, in subsequent studies, we hypothesized that direct application of LMHF 
mechanical loading to osteoblasts alters their cell responses, preventing decreased 
bone formation induced by disuse or microgravity conditions.  To test our hypothesis, 
preosteoblast 2T3 cells were exposed to a disuse condition using the RPM and 
intervened with a LMHF mechanical load (0.1-0.4g at 30Hz for 10-60 min/day).  
Exposure of 2T3 cells to the RPM decreased bone formation responses as determined 
by ALP activity and mineralization even in the presence of a submaximal dose of BMP4 
(20ng/ml). However, LMHF mechanical loading prevented the RPM-induced decrease in 
ALP activity and mineralization. Mineralization induced by LMHF mechanical loading 
was enhanced by treatment with BMP4 and blocked by the BMP antagonist noggin, 
suggesting a role for BMPs in this response.  In addition, LMHF mechanical loading 
rescued the RPM-induced decrease in gene expression of ALP, runx2, OMD, PTHR1, 
and OGN.  These findings show that osteoblasts directly respond to LMHF mechanical 
loading to induce bone formation responses, potentially leading to normalization or 
prevention of bone loss caused by disuse or microgravity conditions. The 
mechanosensitive genes identified in this project may provide potential targets for 
pharmaceutical treatments that could be used in combination with low level mechanical 
loading to better treat osteoporosis, disuse-induced bone loss, or microgravity-induced 
bone loss.   
 
 




 The average, mature adult skeleton is comprised of 206 bones, forming the 
framework of the human body.  The skeleton serves four primary functions: 1) 
mechanical support and locomotion, 2) vital organ protection, 3) blood cell production, 
and 4) mineral storage (40).  Mechanical support includes supplying a shape and frame 
while providing attachment points for muscles at joints, allowing locomotion.  Vital 
organs are protected by the strength and rigidity of specific bones, including the cranium 
covering the brain, the ribs and sternum cosseting the heart and lungs, and the vertebral 
column sheltering the spinal cord.  The marrow cavities of certain bones serve as 
housing for the body’s immune cells, hematopoietic stem cells, and mesenchymal stem 
cells.  These stem cells differentiate into a multitude of critical cells for the body, 
including red blood cells responsible for oxygen delivery and osteoblasts responsible for 
bone formation.  Lastly, bone acts as a reservoir for minerals such as calcium, sodium, 
magnesium, and phosphate ions.  Bone stores 99% of the body’s calcium and regulates 
its release to tissues that need it.  These minerals are needed for various processes, 
including blood clotting, cell signaling, and neural messaging (53).   
Bone Structure and Composition 
There are four types of bone including long, short, flat, and irregular.  Long bones, 
such as the tibia and femur, are longer than they are wide.  They are characterized by a 
central cylindrical shaft called a diaphysis flanked by two extremities composed of an 
epiphysis and metaphysis (Figure 1.1).  Carpals and tarsals are types of short bones, 
which are characterized as having approximately the same dimensions in all directions.  
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Figure 1.1 Anatomy of a long bone showing various characteristic components 
of bone, including the two epiphyses flanking the long cylindrical diaphysis   
(Ref: Image adapted from www.web-books.com) 
Flat bones, such as the cranium, have one dimension distinct from the other two and are 
thin, flattened, and usually curved.  Irregular bones comprise any bones that do 
correspond to the aforementioned categories, such as the vertebrae (53).    
 Morphologically, there are two types of bone called cortical (compact) and 
trabecular (cancellous) bone as shown in Figure 1.2 (40, 53).  Each type is distinguished 
macroscopically by its location in the whole bone tissue and microscopically by the 
orientation of mineral and collagen fibers.  Cortical bone primarily comprises the 
diaphysis of long bones and forms a thin outer wall of other bones. It is a dense, 
compact material, and at the microstructural level, it is organized with parallel structural 
units called osteons.  An osteon is a set of concentric lamellae formed from packed 
collagen fibrils, resembling the rings of a tree (Figure 1.3).  Cortical bone is 
predominantly accountable for the supportive and protective functions of the skeleton.   
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Figure 1.2 Architecture of bone showing near-solid cortical bone and porous 
trabecular bone (27)   
Figure 1.3 Microstructural features of cortical and trabecular bone showing the 
osteon, the building unit of cortical bone, and a rod and plate comprising the 
trabecula, the building unit of trabecular bone (27)  
(Portion of figure also from T. Eienhorn, 1994) 
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Its structure is designed to provide a high moment of inertia to resist bending and remain 
relatively lightweight.  In contrast, trabecular bone encompasses the metaphysis and 
epiphysis of long bones, interior of short bones, and the areas between the outer 
surfaces of flat bones.  It is a loosely organized, porous solid characterized by 
interconnecting units called trabeculae, which are composed of rods and plates of bones.  
These trabeculae form a lattice-like structure with a large surface area, allowing 
absorption and dissipation of energy when joints are loaded and serving as the principal 
site of bone’s metabolic functions (53).  Bones are equipped with the appropriate 
structural integrity, strength, stiffness, and fracture resistance properties, enabling the 
human body to withstand diverse physiologic loads and changes to those loads.   
 Bone is a composite material containing three main constituents:  mineral matrix 
(inorganic phase), organic matrix, and water.  The mineral phase comprises 65% of the 
bone tissue and encompasses calcium phosphate and calcium carbonate in the form of 
hydroxyapatite mineral.  The mineral in bone gives it strength and stiffness, primarily 
resisting compressive forces.  The organic matrix makes up 30% of the bone tissue and 
contains 95% collagen fibers, primarily type I collagen, and 5% of proteoglycans and 
non-collagenous proteins such as osteocalcin (OCN), osteopontin (OPN), bone 
sialoprotein (BSP), and osteonectin (12, 40).  Collagen fibers in the organic matrix act as 
reinforcement and provide ductility, fracture toughness, and tensile strength to bone 
tissue (48).  Water constitutes the remainder of bone at approximately 5% weight and is 
located within the collagen fibers, in the pores, and bound to the mineral phase.  
Although seemingly inert, water plays a role in defining the mechanical properties of 
bone.  Dehydrated bone samples have been shown to display increased strength and 
stiffness and decreased ductility (29, 41).   
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Bone Cell Types 
 There are four main cell types in bone:  osteoblasts, bone lining cells, osteocytes, 
and osteoclasts (Figure 1.4)  (2).  Together, these cells form and maintain bone so that it 
can maintain its properties and perform its functions as previously discussed.  
Osteoblasts, osteocytes, and bone lining cells originate from local osteoprogenitor cells 
while osteoclasts differentiate from hematopoietic stem cell lineage. Osteoblasts are 
differentiated cells accountable for deposition and mineralization of the bone matrix, and 
bone lining cells are flat, elongated, and inactive while covering the bone surface.  
Osteocytes are mature osteoblasts that have become embedded into the mineralized 
matrix and are responsible for tissue maintenance.  The cytoplasmic processes of 
osteoblasts propagate through the unmineralized matrix, called the osteoid, to the 
mineralized matrix and interact with osteocytes.  A single osteocyte occupies a small  







Figure 1.4 Bone is composed of multiple cell types to maintain skeletal 
homeostasis (2).  
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space called a lacuna and forms long, branching processes through the canaliculus, or a 
small channel, to contact another cell, such as an osteoblast.  In this way, cell-to-cell 
communication occurs, potentially creating a diverse and intricate network that is 
hypothesized to sense deformation and instigate bone remodeling.  Osteoclasts are 
large, multi-nucleated cells that resorb bone through dissolving the inorganic mineral 
matrix and enzymatically digesting the organic matrix.  An activated osteoclast rests 
directly on the cell surface and has two distinct plasma membrane characteristics:  a 
ruffled border and a clear zone.  The ruffled border is where the bone resorption takes 
place while the clear zone is a microfilament-rich, organelle-free area that serves as a 
point of attachment to the bone matrix (2).    
Bone Remodeling  
Bone is a live, dynamic tissue undergoing constant remodeling, and 
perturbations to this process lead to bone loss. Bone remodeling occurs throughout life 
in a series of steps known as:  1) Quiescence, 2) Activation, 3) Bone Resorption, 4) 
Reversal, and 5) Bone Formation (Figure 1.5) (2, 40).  During the quiescent phase, bone 
lining cells reside in the bone in an inactive state, and when bone remodeling begins, 
these cells secrete factors to recruit preosteoclasts to begin the activation phase.  The 
activated preosteoclasts then differentiate into osteoclasts, signifying the beginning of 
the bone resorption phase.  During this phase, osteoclasts close off portions of the old 
bone into areas called the Howship’s lacunae.  The large, multinucleated osteoclasts 
pump hydrogen ions into these areas to create an acidic environment for the lysozomal 
matrix metalloproteinases (MMPs) and cathepsins. These proteins first dissolve the 
hydroxyapatite mineral in the bone and then the organic matrix (2, 40).  Once the bone is 
resorbed, the osteoclasts migrate out, and osteoblasts enter the region to begin laying 
down the extracellular matrix with type I collagen and numerous noncollagenous  
 6












Figure 1.5 Bone remodeling occurs through a series of five steps to adapt to 
changes in environment. 
(Ref: Image adapted from International Osteoporosis Foundation) 
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proteins such as OPN, osteomodulin (OMD), and osteonectin.  The osteoid is eventually 
mineralized by deposition of calcium salts in the form of hydroxyapatite to provide bone 
with rigidity (2). The cycle returns to the quiescent phase and repeats throughout life as 
needed.  As such, the new bone is called woven bone and is replaced by mature, 
lamellar bone by the process of remodeling (53).  Woven bone is characterized by 
randomly deposited collagen fibers, which become organized in lamellar bone, giving it a 
directed mineral phase and anisotropic properties (53).  The tightly coupled processes of 
bone formation and bone resorption in skeletal remodeling ultimately make bones 
structurally stronger (2, 40).   
The process of bone formation can occur in a number of contexts, including new 
bone on existing bone (appositional bone formation), within cartilage (endochondral 
ossification), and within an organic matrix (intramembranous ossification) (53).  
Appositional bone formation ensues during enlargement of bones during remodeling and 
growth.  In this type of formation, osteoblasts align on the existing bone surface, 
synthesizing osteoid in resultant layers forming bone lamellae.  Endochondral 
ossification occurs during embryonic formation of long bones and weight-bearing bones 
through pre-existing cartilage.  The cartilage cells called chondrocytes become 
hypertrophic and cause a cascade to resorb portions of the cartilage, creating marrow 
cavities.  Preosteoblast cells invade these cavities, differentiate, and form bone matrix 
on the mineralized cartilage.  Osteoclasts resorb the calcified cartilage, and bone 
remodeling replaces the immature bone with lamellar bone.  Intramembranous 
ossification occurs in the development of flat bones without a cartilage template.  This 
bone is formed directly from mesenchymal tissue, synthesizing an organic matrix that 
contains blood vessels, fibroblasts, and preosteoblasts.  The osteoprogenitor cells 
differentiate and form an osteoid layer, and trabecular bone structures form within the 
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tissue.  As the rods fuse, forming continuous plates, the woven bone is replaced with 
lamellar bone (53).   
Bone Loss Pathologies 
Bone loss occurs when there is an imbalance in the rate of bone formation and 
bone resorption, favoring the latter (Figure 1.6).  Many different perturbations can cause 
bone loss, including alterations in hormonal balance, microgravity exposure, prolonged 
bed rest, malnutrition, or old age.  Bone loss predominantly affects post-menopausal 
women because of sharp decreases in estrogen, which plays a role in inhibiting 
osteoclast function, and progesterone, which plays a role in stimulating osteoblast 
function.  This pathology can, however, affect women and men of any age as well.  The 
onset of bone loss is regarded as a condition called osteopenia, and when the bone loss 
reaches the point of fracture vulnerability, the condition is called osteoporosis.  
Osteoporosis is defined as a disease characterized by low bone mass and structural 
deterioration of bone tissue, eventually leading to bone fragility and an increased 
susceptibility to fractures.  Osteoporotic fractures usually affect load-bearing bones such 
as those in the hip, spine, and wrist.  According to the National Osteoporosis Foundation, 
an estimated 44 million Americans, or 55 percent of the people 50 years of age and 
older, have been diagnosed with osteopenia. Currently, there are approximately 10 
million individuals in the United States already diagnosed with osteoporosis, and of 
these, eight million are women and two million are men.  Bone loss leading to hip 
fractures or collapsed vertebrae severely lower the quality of life.  Moreover, about 20% 
of those who have hip fractures die from complications incurred after the reconstructive 
surgery, such as blood clot impediments and pneumonia.  Lastly, in many aspects, bone 
loss in spaceflight has been compared to age-related osteoporosis; however, the extent 














Figure 1.6 Normal bone (A) is composed of many connections between thick 
and healthy trabeculae while osteoporotic bone (B) is characterized by fewer 
connections of thinning trabeculae.  
(Ref: Physicians Desktop Reference: PDR Health) 
 
 
one loss where astronauts lose as much bone mass in one month as post-menopausal 
omen lose in one year (6).   
Further progress in multidisciplinary studies on bone composition, structure, 
unction, and diseases has significantly changed views on bone physiology (9). It is now 
nderstood that mechanical loading is not alone in altering the skeleton.  In addition to 
echanics, the skeleton is influenced by hormones, cytokines, nutrition, and genetic 
actors.  The current observations continually trigger research to answer the questions of 
hy and how bones adapt to their mechanical environment or how they change their 
tructure to meet the demands of increased loading such as in exercise or decreased 
oading such as in spaceflight.  Despite almost 50 years of human spaceflight and 
ountermeasure efforts, researchers are still deliberating why bone loss occurs in 
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spaceflight and how to best counteract it.  To date, there are no clear answers to these 
questions, and to continue and to expand development of countermeasures, scientists 
have ventured into studying these effects in ground-based systems.  Research in this 
field could also benefit other bone pathologies such as osteoporosis.   
Cellular Sense of Gravity 
In order to develop countermeasures against bone loss in spaceflight, it is 
important to understand how a cell actually senses gravity, which is not certain and 
poses a challenge to understanding the role microgravity plays in pathology.  Much of 
what is known regarding sensing gravity is in the plant cell.  Weight causes differential 
mass displacement, due to differences in masses among disparate organelles.  The 
cytoskeleton has traditionally been regarded as a mediator in the perception of gravity 
both in animals and plants (5, 18, 19, 31, 47).  In plants, the mechanism used to sense 
gravity is most likely through the movement of statoliths, which are the suspected 
gravitropic organelle in Lepidium roots, in specialized cells when an organelle is 
displaced from its natural orientation (15).  The concept of perception time is the 
minimum duration of the stimulation interval necessary to induce gravitropic bending of 
the plant root.  Hejnowicz, et al. stated that the shortest stimulation time was one second, 
and therefore, they assumed that the perception time was less than second (15).  The 
notion of perception time is important because it implies that the perception of gravity 
involves not only the magnitude of the gravity vector but also the constant alignment of 
the gravity vector for some minimal time.   
Spaceflight is a constant state of freefall about the Earth, thereby eliminating the 
effects of gravity.  Therefore, in spaceflight, cell signaling by gravitropic organelles is 
altered because there is no force displacing them to a specific gravity-dependent target 
for gravity-sensing signaling.  Thus, a method of continually changing the direction of the 
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gravity vector faster than the cell’s perception time may inhibit gravitropic responses.  As 
such, simulating microgravity or disuse under normal ground conditions by using devices 
such as the Random Positioning Machine (RPM) that rotate and move the gravity vector 
continuously are based on the hypothesis that sensing no weight would have similar 
effects as being weightless.  These devices, described in more detail below, are known 
as gravity vector-averaging systems. 
Ground-based Simulators of Microgravity or Disuse 
Many of the known space-inflicted pathologies have been the subject of research, 
and unfortunately, to date, they have not been adequately counteracted with dietary 
supplements (3, 14, 45) or rigorous exercise (22).  Accordingly, scientists have tried to 
simulate microgravity using Earth-based models to study the mechanisms that might be 
responsible for causing pathologies such as bone loss in astronauts (1, 23, 28, 38).   
Clinostats 
A clinostat is a device that rotates around at least one axis with a platform that 
has a small enough radial distance to minimize centrifugal forces.  Gravity still exists 
around the clinostat, but the gravity vector relative to the biological species on the 
clinostat continuously changes directions with the rotation.  Over time, the gravity vector 
averages to a net zero force relative to the specimen because it does hot have enough 
time to sense it.  The 2D clinostat, RPM, and the Rotating Wall Vessel (RWV) simulate 
microgravity or disuse by continuously moving the gravity vector, a method called 
gravity-vector averaging (Figure 1.7).  The pertinent variable in the system is the speed 
of the rotation, for the gravity vector must move before the cell gravireceptors have time 
to sense it (17, 39).  The dynamic stimulation of the gravity vector seems to displace the 
statoliths in the plant cells.  Cytoskeletal elements, especially microfilaments, seem to be 
key players in the gravity-dependent change of statoliths.  As the statoliths are displaced, 
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the cytoskeletal tension is disrupted, which alters the chain of cellular events leading to 
gravity-dependent responses (19, 47).   
Hindlimb Unloading (HLU) 
 
The animal hindlimb unloading (HLU) model has been used to partially mimic 
aspects of microgravity exposure such as removal of skeletal weight-bearing loads and 
the cephalic fluid shift (Figure 1.8).  The hindlimbs are unloaded while the forelimbs 
remain loaded and used as internal controls.  The head-down tilt from raising the 
hindlimbs provides the cephalic fluid shift seen in spaceflight.  The HLU system applies 
minimal stress on the animal as noted by normal weight gain and eating habits of 
acclimated animals compared to controls (26).  In comparison to spaceflight, the HLU 
model causes skeletal changes similar to spaceflight, with a few differences.  Muscle 
atrophy occurs in both spaceflight and HLU in only load-bearing muscles, and the HLU 
model is most accurate and useful in studying the response of the skeleton to short 
duration spaceflight.  Bone formation in rats seems to correct itself back to the level of 
control during long term HLU exposure, but in spaceflight, bone formation seems to 
remain suppressed until weeks to months upon return to Earth.  It is also important to 
note that the entire body is unloaded in spaceflight whereas only the hindlimbs are 
unloaded in this model (25, 26).     
Bed Rest 
The bed rest studies are currently the only human-based ground analog to 
microgravity or disuse (Figure 1.9).  Subjects are required to remain in bed at a 6-degree 
head-down tilt from weeks to months in time.  Subjects perform all daily functions 
including eating and sleeping in bed, and cameras are placed in discreet places to 
ensure that subjects do not deviate from the protocol.  In comparison to spaceflight, 





Figure 1.7 Clinostats that simulate microgravity or disuse conditions shown 
here are the Rotating Wall Vessel (A) and Random Positioning Machine (B) (30) 
 
Figure 1.8 Animal hindlimb unloading (HLU) model showing a rat in a cage 
equipped with a rotary clip such that the hindlimbs are raised and forelimbs 
allow ambulation 
(Ref: www.scielo.br)  14
bone is lost, there is a risk of kidney stones from increased urinary calcium excretion.  
Furthermore, muscles in the calf shrink up to 30% within a few months accompanied by 
a 50% decrease in strength.  The headward shift of blood and other fluids mimics the 
cephalic fluid shift observed in spaceflight, and after approximately one day, the body 
adapts to the increased volume by increased urination, as also detected in spaceflight.  
Additionally, bed rest subjects develop a mild vertigo, causing nausea and dizziness.  
Microgravity is known to alter the neurovestibular system, where sensors in the ears and 
nerves in the soles of the feet are unbalanced, causing nausea and dizziness (20).    
Figure 1.9 Human bed rest with head-down tilt showing 6 degree downward 
inclination 
(Ref: Cleveland Clinic Lerner Research Institute, P. Cavanagh)  
 15
Countermeasures for Bone Loss: Current Status and Prospective 
Exercise 
Exercise has been the primary countermeasure to combat many of the 
pathologies induced by microgravity, including musculoskeletal alterations.  It has long 
been recognized that exercise is beneficial to both muscles and bones, increasing their 
strength and size (11, 43, 46).  When a clinical study of young, college-aged women was 
performed evaluating the effects of exercise, it was found that bone mineral density 
(BMD) of the spine increased in women who performed aerobic activity and in those who 
lifted weights.  Additionally, improvements were seen in their back and leg muscles (43).   
Exercise in spaceflight is not identical as on Earth since the loss of the force due 
to gravity yields no reaction force during movement.  Therefore, exercise in spaceflight 
has been centered mainly on elastic-type machinery to load the muscles and bones of 
the body using devices such as bungee cords as early as the Gemini flights of the 1960s.  
Exercise machinery progressed to an adapted treadmill and bicycle as early as the 
Skylab missions of the 1970s, and updated machinery is still used today on the 
International Space Station (ISS).  However, exercise has not been an adequate 
countermeasure for bone and muscle loss since astronauts continue to lose skeletal 
mass (6).  Therefore, to defy the pathological changes induced by microgravity on the 
skeleton, distinct countermeasures must be developed targeting specific changes in 
bone cell adaptation.    
Nutrition and Supplementation 
 Nutritional countermeasures have been integrated into crew meals, but the 
supplementations have not mitigated bone loss.  Despite vitamin D and multivitamin 
intake, post-flight serum levels of 25-hydroxycholecalciferol (25(OH)-D3) were lower 
than pre-flight values for astronauts from the Skylab missions (24, 42).  In another study, 
astronauts from the ISS consumed a vitamin D supplement for an average of five times 
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per week and a multivitamin for approximately three per week.  These 11 astronauts had 
approximately 25% less serum vitamin D post-flight compared to pre-flight (42).  The 
combination of calcium and vitamin D did not mitigate bone loss in astronauts because 
neither compound countered the increase in bone resorption or decrease in bone 
formation (4, 16, 54).  Another vitamin that plays a role in bone health is vitamin K, which 
is involved in forming γ-carboxyglutamic acid (GLA) proteins such as osteocalcin (OCN) 
in the extracellular matrix of bone.  An independent study showed that vitamin K 
supplementation during spaceflight increased urinary GLA excretion and lowered the 
secretion rate of undercarboxylated OCN.  These data suggest that vitamin K is altered 
by spaceflight and that supplementation with vitamin K may be useful for astronauts 
since it counteracts the decrease in bone formation marked by decreased 
undercarboxylated OCN and bone specific alkaline phosphatase (ALP) (4, 45).  However, 
vitamin K did not counteract the increased bone resorption as marked by the absence of 
an effect on type 1 collagen C-terminal telopeptide (44, 45). Although there seems to be 
promising benefits of vitamin K on bone health, there are limitations to supplementation 
of vitamin K because of its classical role in coagulation (50, 51).   
 In summary, the limited data available on nutrition show that the nutritional status 
of the astronauts changes in spaceflight.  The dietary intake of specific vitamins or a 
multivitamin alone or in combination with an exercise regime is currently unable to 
mitigate bone loss.   
Low magnitude and High Frequency (LMHF) Mechanical Loading  
Julius Wolff (1892) was the first to suggest that stress imparted to bone impacted 
its architecture (52), and Harold Frost (1987) elucidated the role of a mechanical 
stimulus to bone (10).  Frost defined a minimum effective strain that was required from a 
mechanical stimulus in order to stimulate bone adaptation, and he defined the 
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Figure 1.10 A low magnitude and high frequency (LMHF) platform (A) applies 
tiny vertical oscillations, where the magnitude of the load is characterized from 
the peak-to-peak value of each waveform (B). 
mechanostat as the biological machinery that determines bone strength (7-9).  Therefore, 
it has long been regarded that mechanical stimuli are anabolic to bone.  High magnitude, 
low frequency impact such as running has been recognized to increase bone and 
muscle mass (11, 43, 46).  However, the opposite stimulus at a low magnitude (0.3g 
where 1g is Earth’s gravitational field) and high frequency (30-90 Hz) (LMHF) is 
experienced in activities as low impact as standing (33).  Figure 1.10 shows the platform 
(A) that applies these frequent oscillating acceleration and deceleration signals (B) to the 
subject upon it.  The notion of stimulating bone formation or inhibiting bone resorption in 
patients with musculoskeletal diseases such as cerebral palsy and muscular dystrophy 
(13, 49), osteopenia (37), and post-menopausal osteoporosis (32) with a LMHF 
mechanical signal is a new, non-invasive treatment.  It has been shown through animal 
and clinical trials that a LMHF mechanical stimulation is anabolic to bone (21, 32, 34-36, 
49).  Although not yet experimented in spaceflight, this potential osteoporosis 
countermeasure may provide benefit to the musculoskeletal system in a non-invasive 




1. Al Ajmi N, Braidman I, and Moore D. Effect of clinostat rotation on 
differentiation of embryonic bone in vitro. Adv Space Res 17: 189-192, 1996. 
2. Bilezikian JP, Raisz LG, and Rodan GA. Principles of bone biology. San Diego: 
Academic Press, 1996. 
3. Caillot-Augusseau A, Vico L, Heer M, Voroviev D, Souberbielle J-C, 
Zitterman A, Alexandre C, and Lafage-Proust M-H. Space Flight Is Associated with 
Rapid Decreases of Undercarboxylated Osteocalcin and Increases of Markers of Bone 
Resorption without Changes in Their Circadian Variation: Observations in Two 
Cosmonauts. Clin Chem 46: 1136-1143, 2000. 
4. Caillot-Augusseau A, Vico L, Heer M, Voroviev D, Souberbielle JC, 
Zitterman A, Alexandre C, and Lafage-Proust MH. Space flight is associated with 
rapid decreases of undercarboxylated osteocalcin and increases of markers of bone 
resorption without changes in their circadian variation: observations in two cosmonauts. 
Clin Chem 46: 1136-1143, 2000. 
5. Carmeliet G and Bouillon R. The effect of microgravity on morphology and 
gene expression of osteoblasts in vitro. FASEB J 13: 129-134, 1999. 
6. Cavanagh PR, Licata AA, and Rice AJ. Exercise and pharmacological 
countermeasures for bone loss during long-duration space flight. Gravit Space Biol Bull 
18: 39-58, 2005. 
7. Frost HM. A 2003 update of bone physiology and Wolff's Law for clinicians. 
Angle Orthod 74: 3-15, 2004. 
8. Frost HM. Bone "mass" and the "mechanostat": a proposal. Anat Rec 219: 1-9, 
1987. 
9. Frost HM. From Wolff's law to the mechanostat: a new "face" of physiology. J 
Orthop Sci 3: 282-286, 1998. 
10. Frost HM. The Laws of Bone Structure. Springfield, IL: Thomas, 1964. 
11. Galloway MT and Jokl P. Aging successfully: the importance of physical activity 
in maintaining health and function. J Am Acad Orthop Surg 8: 37-44, 2000. 
 19
12. Gorski JP. Is all bone the same? Distinctive distributions and properties of non-
collagenous matrix proteins in lamellar vs. woven bone imply the existence of different 
underlying osteogenic mechanisms. Crit Rev Oral Biol Med 9: 201-223, 1998. 
13. Gray B, Hsu JD, and Furumasu J. Fractures caused by falling from a 
wheelchair in patients with neuromuscular disease. Dev Med Child Neurol 34: 589-592, 
1992. 
14. Heer M, Kamps N, Biener C, Korr C, Boerger A, Zittermann A, Stehle P, and 
Drummer C. Calcium metabolism in microgravity. Eur J Med Res 4: 657-660, 1999. 
15. Hejnowicz Z, Sondag C, Alt W, and Sievers A. Temporal course of 
graviperception in intermittently stimulated cress roots. Plant Cell Environ 21: 1293-1300, 
1998. 
16. Holick MF. Perspective on the impact of weightlessness on calcium and bone 
metabolism. Bone 22: 105S-111S, 1998. 
17. Hoson T. Evaluation of the three-dimensional clinostat as a simulator of 
weightlessness. Planta 203: S187-197, 1997. 
18. Hou G, Mohamalawari DR, and Blancaflor EB. Enhanced gravitropism of roots 
with a disrupted cap actin cytoskeleton. Plant Physiol 131: 1360-1373, 2003. 
19. Ingber D. How cells (might) sense microgravity. Faseb J 13 Suppl: S3-15, 1999. 
20. Jones N. Space physiology: lie back and think of science. Nature 435: 730-731, 
2005. 
21. Judex S, Zhong N, Squire ME, Ye K, Donahue LR, Hadjiargyrou M, and 
Rubin CT. Mechanical modulation of molecular signals which regulate anabolic and 
catabolic activity in bone tissue. J Cell Biochem 94: 982-994, 2005. 
22. Katkovsky BS PY. Cardiac output during physical exercises following real and 
simulated space flight. Life Sci Space Res 14, 1976. 
23. Kobayashi K, Kambe F, Kurokouchi K, Sakai T, Ishiguro N, Iwata H, Koga K, 
Gruener R, and Seo H. TNF-[alpha]-Dependent Activation of NF-[kappa]B in Human 
Osteoblastic HOS-TE85 Cells Is Repressed in Vector-Averaged Gravity Using Clinostat 
Rotation. Biochemical and Biophysical Research Communications 279: 258-264, 2000. 
 20
24. Michel EL, Johnston RS, and Dietlein LF. Biomedical results of the Skylab 
Program. Life Sci Space Res 14: 3-18, 1976. 
25. Morey-Holton ER and Globus RK. Hindlimb unloading of growing rats: a model 
for predicting skeletal changes during space flight. Bone 22: 83S-88S, 1998. 
26. Morey-Holton ER and Globus RK. Hindlimb unloading rodent model: technical 
aspects. J Appl Physiol 92: 1367-1377, 2002. 
27. Nagaraja S. Microstructural stresses and strains associated with trabecular bone 
microdamage, 2006. 
28. Nakamura H, Kumei Y, Morita S, Shimokawa H, Ohya K, and Shinomiya K. 
Suppression of osteoblastic phenotypes and modulation of pro- and anti-apoptotic 
features in normal human osteoblastic cells under a vector-averaged gravity condition. J 
Med Dent Sci 50, 2003. 
29. Nyman JS, Roy A, Shen X, Acuna RL, Tyler JH, and Wang X. The influence of 
water removal on the strength and toughness of cortical bone. J Biomech 39: 931-938, 
2006. 
30. Patel MJ. Identification of Mechanosensitive Genes in Osteoblasts by 
Comparative Microarray Studies Using the Rotating Wall Vessel and the Random 
Positioning Machine. Journal of Cellular Biochemistry 101: 587-599, 2007. 
31. Ross MD. The influence of gravity on structure and function of animals. Adv 
Space Res 4: 305-314, 1984. 
32. Rubin C, Recker R, Cullen D, Ryaby J, McCabe J, and McLeod K. Prevention 
of postmenopausal bone loss by a low-magnitude, high-frequency mechanical stimuli: a 
clinical trial assessing compliance, efficacy, and safety. J Bone Miner Res 19: 343-351, 
2004. 
33. Rubin C, Turner AS, Bain S, Mallinckrodt C, and McLeod K. Anabolism. Low 
mechanical signals strengthen long bones. Nature 412: 603-604, 2001. 
34. Rubin C, Turner AS, Mallinckrodt C, Jerome C, McLeod K, and Bain S. 
Mechanical strain, induced noninvasively in the high-frequency domain, is anabolic to 
cancellous bone, but not cortical bone. Bone 30: 445-452, 2002. 
 21
35. Rubin C, Turner AS, Muller R, Mittra E, McLeod K, Lin W, and Qin YX. 
Quantity and quality of trabecular bone in the femur are enhanced by a strongly anabolic, 
noninvasive mechanical intervention. J Bone Miner Res 17: 349-357, 2002. 
36. Rubin C, Xu G, and Judex S. The anabolic activity of bone tissue, suppressed 
by disuse, is normalized by brief exposure to extremely low-magnitude mechanical 
stimuli. Faseb J 15: 2225-2229, 2001. 
37. Rubin CT, Sommerfeldt DW, Judex S, and Qin Y. Inhibition of osteopenia by 
low magnitude, high-frequency mechanical stimuli. Drug Discov Today 6: 848-858, 2001. 
38. Sarkar D, Nagaya T, Koga K, Nomura Y, Gruener R, and Seo H. Culture in 
vector-averaged gravity under clinostat rotation results in apoptosis of osteoblastic ROS 
17/2.8 cells. Journal of Bone and Mineral Research 15: 489-498, 2000. 
39. Sievers A and Hejnowicz Z. How well does the clinostat mimic the effect of 
microgravity on plant cells and organs? ASGSB Bull 5: 69-75, 1992. 
40. Sikavitsas VI, Temenoff JS, and Mikos AG. Biomaterials and bone 
mechanotransduction. Biomaterials 22: 2581-2593, 2001. 
41. Smith JW and Walmsley R. Factors affecting the elasticity of bone. J Anat 93: 
503-523, 1959. 
42. Smith SM, Zwart SR, Block G, Rice BL, and Davis-Street JE. The nutritional 
status of astronauts is altered after long-term space flight aboard the International Space 
Station. J Nutr 135: 437-443, 2005. 
43. Snow-Harter C, Bouxsein ML, Lewis BT, Carter DR, and Marcus R. Effects of 
resistance and endurance exercise on bone mineral status of young women: a 
randomized exercise intervention trial. J Bone Miner Res 7: 761-769, 1992. 
44. Vergnaud P, Garnero P, Meunier PJ, Breart G, Kamihagi K, and Delmas PD. 
Undercarboxylated osteocalcin measured with a specific immunoassay predicts hip 
fracture in elderly women: the EPIDOS Study. J Clin Endocrinol Metab 82: 719-724, 
1997. 
45. Vermeer C, Wolf J, Craciun A, and Knapen M. Bone markers during a 6-month 
space flight: effects of vitamin K supplementation. J Gravit Physiol 5: 65-69, 1998. 
 22
 23
46. Vuori I. Exercise and physical health: musculoskeletal health and functional 
capabilities. Res Q Exerc Sport 66: 276-285, 1995. 
47. Wang N, Naruse K, Stamenovic D, Fredberg JJ, Mijailovich SM, Tolic-
Norrelykke IM, Polte T, Mannix R, and Ingber DE. Mechanical behavior in living cells 
consistent with the tensegrity model. Proc Natl Acad Sci U S A 98: 7765-7770, 2001. 
48. Wang X, Bank RA, TeKoppele JM, and Agrawal CM. The role of collagen in 
determining bone mechanical properties. J Orthop Res 19: 1021-1026, 2001. 
49. Ward K, Alsop C, Caulton J, Rubin C, Adams J, and Mughal Z. Low 
magnitude mechanical loading is osteogenic in children with disabling conditions. J Bone 
Miner Res 19: 360-369, 2004. 
50. Weber P. Management of osteoporosis: is there a role for vitamin K? Int J Vitam 
Nutr Res 67: 350-356, 1997. 
51. Weber P. Vitamin K and bone health. Nutrition 17: 880-887, 2001. 
52. Wolff J. Das Gesetz der Transformation der Knochen. Berlin, Hirschwald: 
Stuttgart : Schattauer, 1892. 
53. Yaszemski MJ, Payne RG, Hayes WC, Langer R, and Mikos AG. Evolution of 
bone transplantation: molecular, cellular and tissue strategies to engineer human bone. 
Biomaterials 17: 175-185, 1996. 
54. Zittermann A, Heer M, Caillot-Augusso A, Rettberg P, Scheld K, Drummer C, 
Alexandre C, Horneck G, Vorobiev D, and Stehle P. Microgravity inhibits intestinal 








Musculoskeletal pathologies associated with decreased bone mass, including 
osteopenia, osteoporosis, disuse-induced bone loss, and microgravity-induced bone loss, 
affect millions of Americans annually.  According to the National Osteoporosis 
Foundation, 10 million Americans currently suffer from osteoporotic bone loss while 34 
million more are estimated to have osteopenia, or low bone mass, a strong risk factor for 
osteoporosis.  Bone loss is particularly dangerous since it is typically asymptomatic and 
can lead to fractures of any bone, most usually those in the hip, spine and wrist (2).  In 
the US alone, there are approximately 1.5 million fractures annually due to osteoporosis 
(www.nof.org).  Additionally, bone loss occurs in spaceflight, rendering astronauts at-risk 
for fractures during long term space travel.  Despite health implications, it is still a 
national and international interest to continue and to expand human-based space 
exploration.  As such, it is imperative to develop countermeasures for bone loss in space.  
On average, astronauts lose 1-2% of bone mass per month during space missions (6), 
losing 6-12% in a typical six month International Space Station (ISS) mission.  While 
many pharmaceutical treatments have slowed osteoporosis, there is still no 
countermeasure that can effectively mitigate bone loss observed in astronauts.   
It has long been regarded that mechanical stimuli are among the many factors 
that are anabolic to bone as shown in Figure 2.1.  High magnitude, low frequency impact 
has been recognized to increase bone and muscle mass (1, 9, 10) under normal but not 
microgravity conditions.  However, the opposite stimulus, a low magnitude and high 
frequency (LMHF) mechanical load experienced in activities as low impact as standing, 
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has also been shown to be anabolic to bone but has never been used in spaceflight.  
The LMHF mechanical load has been shown to be effective in treating musculoskeletal 
pathologies in a number of subjects during research and clinical trials, including animals 
(8), children with musculoskeletal diseases such as cerebral palsy or muscular 
dystrophy (4, 11), young women with low bone mass (3), and post-menopausal 
osteoporotic women (7).  While several preclinical and clinical trials have demonstrated 
that the LMHF mechanical loading normalizes bone loss in vivo, the target tissues of the 
mechanical load and underlying mechanisms mediating the response are not known.    
 




Figure 2.1 The determinants of skeletal homeostasis include many different 
factors, including physiologic aspects such as mechanical loads that instigate
bone formation while ageing and disuse promote bone resorption (5). 
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Project Objectives and Hypothesis 
This research project focuses on understanding how a LMHF mechanical load 
mediates prevention of bone loss in vivo and developing a countermeasure for 
microgravity-induced bone loss.  The objectives of the project are to analyze the 
cellular and molecular changes induced in osteoblasts by simulated microgravity 
or disuse and LMHF loading to identify potential targets for therapeutic 
interventions and to investigate the utility of a LMHF mechanical load in mitigating 
microgravity-induced bone loss.  The central hypothesis of the project is that 
simulated microgravity or disuse conditions induce bone loss by inhibiting 
expression of genes critical in regulating bone formation, osteoblast 
differentiation, and subsequent mineralization while a LMHF mechanical load 
prevents these effects.  A LMHF mechanical loading platform has counteracted bone 
loss in both animal and human clinical trials.  However, the mechanisms by which the 
low magnitude loading instigate an osteogenic response or whether it promotes an 









Figure 2.2 Project hypothesis conjecturing that microgravity or disuse causes 
bone loss through molecular alterations of osteoblasts while a low magnitude 
and high frequency (LMHF) mechanical loading intervention prevents bone loss
through promoting osteoblast function  
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Specific Aims 
The central hypothesis of this project will be tested with three specific aims, as 
follows:     
Specific Aim 1: To determine the effect of simulated microgravity or disuse on cell 
differentiation and mineralization of mouse calvarial 2T3 preosteoblasts 
Working Hypothesis: Microgravity or disuse inhibits genes necessary for preosteoblast 
cell differentiation and subsequent mineralization.     






Figure 2.3 General experimental layout for specific aim 1  
(Ref: Picture of Opticell from Opticell, Inc) 
 
As shown in Figure 2.3, preosteoblast cells plated in Opticells will be exposed to 
simulated microgravity or disuse conditions using the Japanese-designed and 
European-manufactured Random Positioning Machine (RPM) and assessed for markers 
of bone formation.  Alkaline phosphatase (ALP) is an enzyme that is expressed early in 
osteoblast differentiation while mineralization is a late in vitro marker of bone formation.  
Several genes also are expressed during osteoblast differentiation, including parathyroid 
hormone receptor 1 (PTHR1), osteomodulin (OMD), and runt homology domain 
transcription factor 2 (runx2).  In this aim, various markers will be evaluated to determine 
if the decreased bone formation observed in spaceflight can be recapitulated using the 
RPM system.  Most importantly, a high throughput DNA microarray will be performed to 
evaluate alterations in gene expression in 2T3 cells due to RPM exposure, providing the 
first systemic gene expression study performed under disuse conditions.    
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Specific Aim 2:  To compile a list of selected genes that change upon exposure to 
simulated microgravity or disuse conditions 
Working Hypothesis:  Microgravity or disuse alters gene expression profiles of 2T3 
preosteoblasts consisting of critical genes regulating osteoblast differentiation and 

























2.4 General experimental layout for specific aim 2  
ure of cells on microcarriers from Solohill Engineering) 
There are many simulators of microgravity used in the field, although the validity 
obtained from them is often rigorously questioned.  The most substantial criticism 
er the simulators accurately replicate changes observed in spaceflight or disuse.  
 is difficult to currently perform scientific experiments in actual spaceflight, it is 
 to compare the various ground-based simulators to each other and to the small 
 of gene expression available from past spaceflight experiments.  The NASA-
d simulator of microgravity called the Rotating Wall Vessel (RWV) is employed 
ntly in the United States in studying various pathologies and tissue engineering.  
icted in Figure 2.4, 2T3 preosteoblast cells plated on microcarriers will be 
d to RWV simulated microgravity, and the results will be compared to those of the 
The critical information gained here will be a confined list of genes that change 
two models of simulated microgravity or disuse conditions.  This confined list of 
will provide a group of target genes from which to continue molecular-based 
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Specific Aim 3:  To determine whether LMHF mechanical loading prevents 
microgravity- or disuse-induced decrease in bone formation 
Working Hypothesis: LMHF mechanical loading prevents decreased bone formation 
responses caused by the RPM.   
Specific Aim 3 
2T3 
Preosteoblasts ALP 
± Mineralization Gene Expression
Figure 2.5 General experimental layout for specific aim 3  
(Ref: Picture of Opticell from Opticell, Inc) 
It is classically recognized that high magnitude and low frequency signals such 
as in exercise benefit the musculoskeletal system by maintaining bone density.  
However, a LMHF mechanical loading, which characterizes the load that muscles apply 
to the skeleton during activities such as standing, has also been shown to slow bone 
loss in post-menopausal women, young women with low bone mass, and various animal 
models.  However, the mechanism by which LMHF mechanical loading elicits an 
anabolic response is not known because cellular and molecular studies have not been 
performed.  As illustrated in Figure 2.5, 2T3 cells plated in Opticells will be exposed to 
the RPM and intervened with a daily LMHF loading treatment.  Markers of bone 
formation such as ALP, mineralization, and gene expression will be evaluated to assess 
the utility of the LMHF platform in alleviating microgravity-induced bone loss.  More 
importantly, in vitro experiments will provide the means to begin studying molecular 
changes induced by a LMHF mechanical loading, and future therapies may be 
developed by combining the platform with pharmaceutical treatments based on 
molecular targets from this research to better treat bone loss due to osteoporosis, disuse, 
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Chapter 3 
Evidence of Bone Loss and Alterations in Gene 
Expression in Spaceflight and Disuse 
 
Summary 
Significant evidence of bone loss in microgravity is available from early 
spaceflight experiments and from observations on current astronauts and cosmonauts. 
However, spaceflight is infrequent and expensive to study the biomedical effects of 
microgravity on the human body. Thus, it is critical to have adequate in vitro and in vivo 
ground-based models to simulate the effects of microgravity or disuse environments.  
Currently, the most commonly used in vitro simulators of microgravity or disuse are 
clinostats while in vivo simulators include the human-based bed rest studies and animal-
based hindlimb unloading experiments.  Despite the numerous studies that have marked 
a bone loss phenotype in wide ranges of multiple crew members, this pathology remains 
in astronauts without any effective countermeasures.  Development and implementation 
of adequate countermeasures is hampered because little is known regarding the 
molecular changes regulating bone loss in microgravity.   Recently, researchers have 
begun to investigate the molecular alterations in response to both spaceflight, simulated 
microgravity, and disuse, and it is believed that future prophylactic and therapeutic 
approaches may be directed towards specific molecular targets.  In this chapter, we 
review data showing a bone loss phenotype in spaceflight, bed rest, hindlimb unloading, 
and clinostats.  Additionally, we review the limited data on gene expression changes in 
each of these environments.   
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Bone Loss Response in Microgravity or Disuse 
Spaceflight  
It is well documented that spaceflight induces a decrease in bone mass in 
animals and humans after prolonged stay in space.  In rodent animal studies, it has been 
shown that 17 days of spaceflight altered the biomechanics of femur bones, mostly 
concentrated on tissue properties rather than bone structure (47).  Spaceflight did not 
affect maximum stress capability of the femur but did decrease the flexural rigidity 
compared to ground controls (47).  There was no change in cortical bone mass, but 
endocortical bone resorption was decreased along with a trend towards decreased bone 
formation (47).   To test whether changes in bone due to spaceflight exposure could 
impact ossification of new bone, growing rats were exposed to 11 days of spaceflight.  
There was no change in the width or longitudinal growth rate of the tibial growth plate 
(43).  Other studies have shown that 16 days of spaceflight decreased mineral content in 
the distal section of the femur diaphysis, which correlated to reduced type I collagen (1).  
In some of the earliest observations of spaceflight, it was found that after nearly 20 days 
in space, rats suffered a drastic decrease in periosteal bone formation with no change in 
bone resorption (36).  After 26 days of post-flight, the loss of bone mass was regained 
(36).  This phenomenon was observed in another flight where rats exposed to nearly 19 
days of spaceflight experienced an inhibition of periosteal bone formation in the tibial 
and humeral diaphyses and subsequent correction post-flight (53).  These results 
suggest that spaceflight alters bone remodeling in animal models.   
There is a vast amount of individual variation among the data available in human 
studies because of a relatively small sample size, leaving it difficult to draw definitive 
conclusions.  However, a few patterns remain fairly consistent through the years of 
human-based spaceflight, namely an increase in bone resorption and decrease in bone 
formation.  In the Mir missions, one cosmonaut experienced a 7.74% decrease in bone 
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mass of the calcaneus by one month as well as 2.27% in the tibial trabecular bone, as 
measured by broadband ultrasound attenuation (BUA) (14). After six months exposure 
to microgravity, another cosmonaut lost 4.5% of trabecular bone and 2.9% of cortical 
bone in the tibia compared to measurements before launch (14).  After six months of 
return to Earth’s gravitational field, there was no difference between pre-flight and post-
flight bone mass in the cortical bone and still a 2.55% decrease in the trabecular bone 
mass, suggesting a site-specific partial recovery (14).  Both cosmonauts showed a trend 
toward decreased bone formation markers, including osteocalcin (OCN), bone alkaline 
phosphatase (ALP), and the C-terminal peptide of pro-collagen type 1 (PICP) during 
spaceflight.  There was an increase in PICP and a decrease in OCN post-flight (14).  
Additionally, there was a trend towards an increase in two bone resorption markers 
during flight (14). One of the Mir missions consisting of four European astronauts 
showed no change before, during, and after launch in stress-related hormones insulin 
growth factor 1 (IGF-1) and cortisol in three astronauts while one experienced an 
increase in cortisol before launch (11).  Figure 3.1 shows a summary of bone mineral 
density (BMD) data for over 17 astronauts in various locations of the skeleton (27).  In 
another study, parathyroid hormone (PTH) decreased during flight compared to pre-flight 
levels in one astronaut (Figure 3.2). Initially during post-flight, PTH remained within the 
normal range and then sharply increased for a short time, eventually returning to normal 
levels.  In another astronaut, PTH did not change during flight but increased above 
normal range after flight and returned to normal levels after one week (11).  Additionally, 
bone resorption can be marked by the breakdown of collagen, including the products N-
telopeptide (NTX), pyridinium (PYD), and deoxypyridinoline (DPD).  In these astronauts, 
bone resorption markers were increased, with the exception of pyridinium, during flight 
compared to pre-flight.  These markers decreased post-flight, with the exception of one 
astronaut who experienced a sharp, unexplainable increase in pyridinium (11).  In more 
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Figure 3.1 Average BMD and lean muscle data for over 16 astronauts for 




























































































































Figure 3.2 Spaceflight decreased various bone formation markers in two 
astronauts (45).   
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 recent spaceflight missions aboard the International Space Station (ISS), seven of eight 
cosmonauts experienced decreased BMD in the range of 2.5-10.6% in the lumbar 
vertebrae.  All eight cosmonauts experienced a loss of total BMD in the range of 3-10% 
in the femur and four of the eight had 1.7-10% loss in the femoral neck (26).  In another 
study on astronauts from the Skylab missions, there was an increase in bone resorption 
markers due to exposure to spaceflight for 28-84 days.  As shown in Figure 3.3, there 
was a steady increase in urinary excretion of collagen breakdown products during 
spaceflight and a recovery after landing (45).   
N-telopeptide cross-links Pyridinium (PYD) cross-links 
Deoxypyridinoline (DPD) cross links 
Figure 3.3 Spaceflight increased various bone resorption markers during long 
term spaceflight missions (45).   
While long term spaceflight poses the most imminent danger to astronauts, some 
short term spaceflight missions have also induced changes in skeletal remodeling.  A 
mission of 8-15 days induced a 3% decrease in the lumbar vertebrae BMD while the 
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BMD increased in the calvarius post-flight compared to pre-flight (32).  Both astronauts 
experienced urinary calcium excretion after flight compared to pre-flight, which 
eventually corrected itself, but calcium regulators such as PTH, calcitriol, and calcitonin 
did not change (32).  Elevated bone resorption markers were observed in the urine, and 
bone formation, as marked by total and bone-specific ALP, decreased in both astronauts 
one week after flight (32).  There was no significant change in total BMD over the whole 
body by x-ray measurements in both astronauts, but a trend towards a decrease in 
lumbar spine and increase in the calvarius BMD were observed (32).  Perhaps, these 
observations could be due to redistribution of bone formation due to microgravity and 
may be related to the cephalic fluid shift associated with spaceflight.    
These reported results suggest that regardless of significant individual variability 
in the astronauts’ physiological response to microgravity, there is a pattern of an 
increase in bone resorption and a decrease in bone formation, leading to site-specific 
loss of bone mineral density.   
Bed Rest Studies 
Bed rest studies are currently the only human-based ground analog to 
microgravity.  Subjects are required to remain in bed at a 6-degree head-down tilt from 
weeks to months in time.  Subjects perform all daily functions including eating and 
sleeping in bed, and cameras are placed in discreet places to ensure that subjects do 
not deviate from the protocol.   
A potential countermeasure for microgravity-induced alterations in the 
cardiovascular system consists of treadmill exercise in a lower body negative pressure 
(LBNP) chamber.  A LBNP environment creates a hypergravity load on the lower body, 
causing both mechanical and cardiovascular adaptation, and it is used to simulate 
orthostatic stress by unloading of the arterial and cardiopulmonary baroreceptors (9).  
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This countermeasure has recently been evaluated on bone response in identical twins.  
In one study using male identical twins, collagen cross-links and serum and urinary 
calcium concentrations, both measurements marking bone resorption, increased during 
30 days of bed rest in non-exercise control subjects compared to the LBNP group as 
shown in Figure 3.4 (44).  There was a smaller increase in pyridinium collagen cross-
links above pre-bed rest levels in the LBNP group compared to the increase in the 
control group.  In this study, there was no change in the markers of bone formation in 
both groups (44).  They concluded that LBNP exercise partially mitigated bone loss as 
marked by decreased bone resorption (44).  In a follow up study, female identical twins 
were subjected to similar conditions.  Bone resorption markers were excreted in both 
control and LBNP groups throughout the 30 days of bed rest, and bone formation 
markers showed either no significant change or a tendency towards decreased 
expression (60).  The exercise group showed less urinary calcium and helical peptide 
excretion than the control group, and the BMD in the femoral shaft and total hip was not 
different in the exercise group after bed rest compared to their pre-bed rest values while 
the control group had decreased BMD (60).  Therefore, LBNP had a smaller protective 
effect on bone mass loss in women than men, signifying that the impact of disuse may 
be gender-specific.  In another study, ten healthy males were exposed to 35 days of bed 
rest and five additional males were control subjects.  In this study, subjects experienced 
decreased muscle strength in the knee and hip, and bed rest caused atrophy in the 
extensor muscles of the gluteus, thigh, calf, and knee.  Bone density was decreased in 
the proximal tibia and was not recaptured after four weeks of recovery time that included 
exercise.  However, muscle mass and strength was partially recovered by exercise after 
four weeks (4).   
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Figure 3.4 Effects of bed rest and LBNP on urinary excretion of bone resorption 
markers after 30 days exposure.    Bed rest control (square) group showed higher 
levels of excretion than LBNP (triangle) group (44).   
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          In comparison to spaceflight, mineral loss and regional bone loss is similar in both 
environments.  As bone is lost, there is a risk of kidney stones from the increased urinary 
calcium excretion in both bed rest and spaceflight (23).  The headward shift of blood and 
other fluids mimics the puffy faces seen in spaceflight, and after approximately one day, 
the body adapts to the increased volume by increased urination, as also observed in 
spaceflight.  Additionally, bed rest subjects develop a mild vertigo, causing nausea and 
dizziness.  Spaceflight microgravity is known to alter the neurovestibular system, where 
sensors in the ears and nerves in the soles of the feet are unbalanced, causing nausea 
and dizziness (23).    
Hindlimb Unloading (HLU) 
The rodent hindlimb unloading (HLU) animal model has been used to partially 
mimic aspects of microgravity exposure such as removal of skeletal weight-bearing 
loads and cephalic fluid shift.  The hindlimbs are unloaded while the forelimbs remain 
physiologically loaded and used as internal controls.  The head-down tilt from raising the 
hindlimbs provides the cephalic fluid shift, mimicking the situation observed in 
spaceflight.  The HLU system applies minimal stress on the animal as noted by normal 
weight gain and eating habits of acclimated animals compared to controls (34).   
One HLU study showed a small increase in serum calcium and a decrease in 
1,25-dihydroxyvitamin D, and the levels returned to control after 5-15 days of unloading 
(19).   There was no change in PTH in the serum in response to unloading (17, 19).  The 
changes in fat-free bone mass depended on the type of bone, where unloading reduced 
the weights of both the tibia and vertebrae in the lumbar spine but not the humerus or 
vertebrae of the cervical spine (18).  These findings suggest a decrease in calcium 
content of the bone (18, 49), and the mineralized matrix of the unloaded bones appeared 
to be more immature than control bones based on density-gradient fractionation studies 
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(5). The decrease in bone mass was most likely due to a combination of changes in both 
bone formation and bone resorption.  An indicator of bone formation is the radius of the 
periosteum, and this marker decreased with HLU.  However, in these HLU studies, the 
radius of the endosteum did not change, marking the absence of a change in bone 
resorption (17, 48).  HLU decreased the number of osteoblasts in the metaphysis of the 
tibia after five days, but this change was normalized by 14 days (19, 29, 52).  
Subsequently, there was a decrease in trabecular bone volume by 14 days of HLU in 
multiple independent studies as represented in Figure 3.5 (8, 19, 30, 50, 52).  These 
data suggest that HLU-related changes in rodents are partially due to changes in 
osteoblast function.  However, after 14 days of unloading, there was no change in ALP 
activity (29), but the mRNA levels for transforming growth factor β-2 (TGFβ2), insulin-like 
growth factor 2 (IGF2), and osteopontin (OPN), all markers of bone formation, 
decreased in an independent study (58).  There have been conflicting reports regarding 
HLU effects on osteoclast regulation and activity, depending on animal weight changes.  
If there was no difference between control and HLU animal weight, there was no change 
in bone resorption (19, 28, 30).  However, if there was a change in weight, osteoclast 
activity increased (49, 50, 52).   
Taken together, despite the variability among independent studies, these data 
show a pattern of bone loss induced by animal HLU.  Comparison with spaceflight data 
shows that the HLU model causes skeletal changes similar to spaceflight, with few 
differences (6, 7, 50).  The model is most accurate and useful in studying the response 
of bone in short duration spaceflight.  Spaceflight and HLU both decrease bone strength 
(31, 46), and reloading triggers bone formation rates to return to control both after 
stimulus exposure.  Additionally, the model induces a similar cephalic fluid shift as 
observed in spaceflight.  Although there is a significant similarity in the functional and 
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structural changes in spaceflight and in HLU, it is important to note that spaceflight 
unloads the entire body whereas this model only unloads the hindlimbs (34, 35).     
Figure 3.5 Effects of HLU on BMD in the cortical and trabecular (cancellous) 
bone in the tibia (A), humerus (B), and femoral neck (C).  *HLU (gray bar) 
significant compared to 0 day control (black bar), +HLU (gray bar) significant 
compared to 28 day control (black bar) (8) 
Clinostats 
A clinostat is a device that rotates around at least one axis with a platform that 
has a small enough radial distance to minimize centrifugal forces.  Gravity still exists 
around the clinostat, but the gravity vector relative to the biological specimen on the 
clinostat is changing directions with the rotation.  Over time, the gravity vector averages 
to a net zero force (20, 22), a method called gravity-vector averaging.   The Random 
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Positioning Machine (RPM) and the Rotating Wall Vessel (RWV) are the two most 
commonly utilized clinostats for ground-based studies.   
Both the RWV (38, 40, 51, 57) and the RPM (37, 39, 40) have been previously 
used by various groups to assess the effects of microgravity or disuse on bone cells as 
well as on other cells and tissue constructs.  Various markers of bone formation have 
been assessed using the two simulators, including ALP, osteocalcin (OCN), matrix 
mineralization, and runt homology domain transcription factor (runx2).  ALP, OCN, and 
matrix mineralization have been shown to decrease after exposure to the RWV in 
primary mouse calvariae (57), and ALP, runx2, and OCN decreased in human 
mesenchymal stem cells (hMSC), MC3T3 mouse pre-osteoblasts, and 2T3 mouse pre-
osteoblasts compared to static controls (38, 40, 57).  In contrast, in ROS.SMER #14 rat 
osteoblast cells, RWV induced an increase in ALP and OCN expression (41), signifying 
the dependence of clinostat results on species and cell type.  Many of these results are 
comparable to findings obtained with the three dimensional (3D) clinostat.  For example, 
ALP, runx2, and mineralization have been shown to decrease with exposure to the 3D 
clinostat compared to static controls as represented in Figure 3.6 (37, 39, 56).   There 
are a limited number of studies on bone resorption and clinostats.  One study exposed 
preosteoclasts to the RPM and found an increase in apoptosis and differentiation into 
osteoclast-like cells due to RPM exposure compared to static control (33).  Using 
reverse transcriptase polymerase chain reaction (RTPCR), they found elevated 
expression of osteoclast markers, including receptor activator of the nuclear factor κB 
(RANK) and its ligand (RANKL) (33).   
Despite conflicting results, these studies show that the ground-based simulators 
closely mimic changes observed in astronauts after spaceflight by showing an inhibition 
of osteoblast differentiation and matrix mineralization and increased differentiation into 
osteoclast-like cells.  These investigations partially validate the use of the clinostat 
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experimental systems for studying changes associated with the exposure to microgravity. 
In general, accumulated knowledge from spaceflights and experiments on Earth 
demonstrate certain patterns of skeletal tissue response to real and modeled 
microgravity that constitute a specific bone loss phenotype, implying possible changes at 
the genomic level.   
Figure 3.6 The 3D clinostat (Group CL) decreased ALP and mineralized nodules 
compared to control (Group C) in human osteoblasts.  Cells were enlarged and 
bulged in the clinostat group (E vs A) on day 1, and bone nodules formed by day 12 
in the control (C and D) but not clinostat group (G and H).  ALP activity was detected 
by day 7 in control (B) but not in the clinostat group (F) until day 20 (H) (56). 
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Alterations in Gene Expression in Microgravity or Disuse 
Spaceflight 
Although it is extremely difficult to design and conduct gene expression studies 
on humans and animals in space, there is some evidence of gene alterations in animal 
and cell culture after spaceflight.  However, there has been no large-scale gene 
expression study performed on samples from spaceflight exposure.   
In animal studies, after 11 days of spaceflight, there was a significant reduction in 
the mRNA levels for aggrecan and a trend towards reduced type II collagen, both 
members of the skeletal extracellular matrix, in rat tibia (43).  Additionally, spaceflight 
transiently increased mRNA expression of IGF-1, insulin-like growth factor receptor 1 
(IGF-1R), ALP, and decreased OCN (7).  The rise in ALP countered with the decrease in 
OCN may suggest decreased bone maturation over time.  The changes in IGF-1 and its 
receptor may indicate compensation by the animal to decreased bone formation.  Here, 
the authors concluded that spaceflight altered the pattern of gene expression in rat, 
resulting in a less mature genomic profile (7).  In an independent spaceflight study, after 
ten days of exposure, there was no change in ribosomal RNA or glyceraldehyde-3-
phosphate dehydrogenase (GAPDH), and after four days, there was decreased actin in 
the muscles of growing rats (2).  In the long bone and calvarial periosteum, both four day 
and ten day spaceflight decreased OCN and type I pro-collagen (2).  In another 
spaceflight study for 14 days, there was a decrease in mRNA levels for GAPDH and 
OCN in the proximal metaphysis and in osteonectin and type I collagen in the distal and 
proximal metaphysis compared to ground controls (16).  There was no change in any of 
these proteins in the diaphysis or distal epiphyses (16).  This study shows that 
spaceflight induces a decrease in bone formation markers in a site-specific manner.   
In cellular studies, MC3T3 preosteoblast cells were exposed to spaceflight for 
nine days and examined for the effects of microgravity with or without a centrifugal 1g 
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field on the expression of 24 genes (21).  In this study, there was a significant reduction 
in expression of genes such as cyclooxygenase 2 (cox-2), TGFβ1, fibroblast growth 
factor 2 (fgf-2), apoptosis regulators bcl2 and bax, proliferating cell nuclear antigen 
(PCNA), OCN, cpla2, and c-myc compared to ground controls (21).  An in-flight control 
was used to investigate the ability of a 1g field to normalize the changes in gene 
expression, and c-myc, cox-2, TGFβ1, bcl2, bax, and fgf-2 were normalized after 1g 
exposure (21).  Spaceflight did not alter cyclin A, cyclin E, actin, 18s, or fibronectin (21). 
In another study, MG-63 osteosarcoma cells flown for nine days showed no change in 
total protein or DNA content in ground unit-gravity, in-flight 1g gravity, or microgravity 
groups.  With vitamin D and TGFβ2 treatment, cells showed a reduced response to in 
ALP activity increase in microgravity compared to ground controls, and microgravity did 
not affect the response of type I collagen protein production to vitamin D and TGFβ2 
treatments.  However, there was decreased gene expression of type 1 collagen, ALP, 
and OCN genes with the largest change in the OCN gene (13).  Perhaps most 
interesting, this study showed the time-dependent sequence of protein expression, 
where type I collagen production occurred before ALP activity and then was trailed by 
moderate OCN expression.  Additionally, the study found that gene expression for ALP 
and OCN preceded protein changes; however, conflicting results were found for type I 
collagen message and protein levels (12, 13).  These data suggest that differentiation is 
thwarted by microgravity as matrix maturation leads into matrix mineralization.   
These investigations highlight the vast number of changes induced by spaceflight 
in the genetic profiles of the skeleton and bone cells.  Perhaps, it would be useful to 
further explore these changes to advance our knowledge of the mechanisms underlying 
bone loss in spaceflight microgravity.   
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Hindlimb Unloading (HLU) and Mechanical Loading 
The HLU system is a widely accepted model of animal-based simulated 
microgravity. To date, there has not been a large scale gene expression study 
performed from bones of animals exposed to HLU.  However, there have been a limited 
number of small scale studies investigating specific gene expression.  After four days of 
HLU of BALB mice, two independent studies found decreased expression of type I 
collagen, osteonectin, osterix, and matrix metalloproteinase 2 (MMP-2) (24, 59).  In the 
Judex, et al. study, each of these genes was corrected to the level of control by day 21 
of HLU, and there was no change observed in cathepsin K (ctsk) and runx2 expression 
(24).  Moreover, Zhong, et al. showed that ALP expression decreased in BALB mice 
after four days of HLU exposure (59).   
Mechanical loading to the skeleton is beneficial to maintain musculoskeletal 
health.  Various types of loading have been applied to animal models, and gene 
expression was evaluated.  In the Judex, et al. study, HLU-exposed mice were treated 
with a low magnitude and high frequency (LMHF) mechanical load.  LMHF mechanical 
loading increased gene expression of inducible nitric oxide synthase (iNOS), MMP-2, 
and RANKL after 21 days of treatment (24).  These evaluated genes are involved in 
bone remodeling.  For example, RANKL is expressed by osteoblasts and is essential for 
osteoclastogenesis.  RANKL attaches to the RANK receptor expressed on osteoclasts to 
stimulate cell proliferation and differentiation to begin bone resorption (3).  In another 
study, mechanical loading by four-point bending was applied in the tibia of mice at 9 
Newtons and 2 Hz, simulating loading incurred during exercise.  After four days of 
exposure to mechanical loading, RNA was extracted from the loaded region, and DNA 
microarrays were used to evaluate gene expression (55).  Many osteogenic genes were 
increased in expression due to mechanical loading, such as pleiotrophin, osteoglycin 
(OGN), and legumain.   
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Although no systemic gene evaluation data is available, smaller scale studies 
provide evidence that there are molecular alterations in vivo caused by simulated 
microgravity or disuse.  Additionally, mechanical loading ranging from low impact to high 
impact has also been shown to alter gene expression.  These studies suggest that 
molecular changes may be pertinent in the development of adequate countermeasures 
for bone loss due to disuse, microgravity, or osteoporosis.     
Clinostats 
The RPM and RWV have been used for small scale studies evaluating 
alterations in gene expression of bone cells.  There are conflicting data regarding RWV 
effects on ALP mRNA and activity.  Rucci, et al. found that ALP mRNA and activity 
expression increased when exposed to the RWV for two days using a rat osteoblast-like 
cell line that was grown in aggregate suspension (41).  In contrast, Klement, et al. 
showed that exposure to the RWV for up to 14 days blunted ALP activity and bone 
matrix mineralization of mouse embryonic pre-metatarsal tissue explants (25).  Similarly, 
Patel, et al. showed a decrease in ALP mRNA and activity after three days of exposure 
to the RWV (40).  Additionally, an independent study using MC3T3-E1 preosteoblasts 
found that expression of runx2 and downstream target genes OCN and type I collagen 
did not change while ALP was decreased in cells exposed to simulated microgravity for 
five days (10).  In another study, the RWV had no effect on ALP, runx2, OCN, OPN, or 
type 1collagen mRNA expression (42).  In human osteoblasts, exposure to the 3D 
clinostat blunted expression of both cbfa1/runx2 (Figure 3.7) and OCN (56).   
Additionally, it is known that the mitogen activated protein kinase (MAPK) 
pathway regulates runx2 and the expression of its target genes type I collagen and OCN 
(54).   A limited number of studies that have examined the effects of the simulators on 
MAPK, but the data are conflicting.  The 3D clinostat and the RWV both did not alter c-
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jun N-terminal kinase (JNK) phosphorylation (42, 56, 57), and the 3D clinostat inhibited 
p38 phosphorylation (Figure 3.8) (56) while the RWV enhanced it (57) or did not alter it 
(42).  The RWV has been shown to enhance extracellular signaling-regulated kinase 
(ERK) activity (42) and to repress it (57) while the 3D clinostat did not alter it (56).  As 
well, TGFβ1 expression was downregulated by the RWV, comparable to spaceflight data, 
but it was upregulated by the RPM.  Prostaglandin E1 (EP1) was not altered in 
spaceflight, corroborating with the RPM data, but the RWV upregulated its expression 
(21, 39, 40).  In another study, AKT and ERK 1/2 were decreased after three days of 
clinostat exposure (15).  Additionally, growth factors, including IGF1 and basic 
fibroblastic growth factor (bFGF), stimulated bone marrow stem cell proliferation in 
control conditions but only had a moderate effect under simulated microgravity (15).  
These data suggest that there is likely an inhibitory effect induced by the clinostat 
simulators of microgravity or disuse on osteoblast function depending on culture 
conditions, recapitulating a bone loss phenotype similar to spaceflight.  Despite apparent 
differences among experiments due to distinct simulators, cell type, or culture conditions 
used, these ground-based systems allow for molecular studies utilizing gene 
manipulation.    
 
Conclusion and Future Directions: Possible Impact of Gene Expression 
Studies on Countermeasure Development 
In general, the reviewed studies from spaceflight, HLU studies, and clinostat 
investigations confirmed that there is a certain pattern of genomic response to 
microgravity or disuse that could create a foundation for development of molecular-
based countermeasures.  Studies in animal and cellular models indicate the significance  
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Figure 3.7 The 3D clinostat (Group CL) decreased cbfa1/runx2 compared to 
control (Group C) in human osteoblasts (56). 
Figure 3.8 The 3D clinostat (Group CL) decreased p38 compared to control 
(Group C) in human osteoblasts (56). 
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of the gravitational vector and gravity sensing for cellular regulatory processes involving 
the genomic level. This is likely due to specific conditions of the evolution of life on Earth.   
It is perhaps these gravity-sensitive regulatory processes and genes that should be used 
as potential molecular targets for future therapeutic interventions to mitigate bone loss in 
astronauts.  Although data from the different astronauts are not completely consistent, 
patterns have emerged depicting an obvious bone loss phenotype.  Despite almost 50 
years of human-based spaceflight, there is still no effective countermeasure available, 
hindering the possibility of pursuing longer term spaceflight mission such as those to 
Mars. It seems convincing that current studies investigating the molecular changes 
induced by spaceflight and ground-based simulators will provide targets for therapeutic 
interventions to mitigate bone loss in spaceflight, disuse, and osteoporosis.  In the next 
decade, targeting molecular changes induced by microgravity or disuse could provide 
new, exciting, and feasible molecular countermeasures for bone loss.  
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Chapter 4  
 
The Effects of Disuse on Osteoblast Gene Expression*  
 
Summary 
The goals of specific aim 1 are to determine the effects of simulated microgravity 
or disuse using the Random Positioning Machine (RPM) on 2T3 pre-osteoblast function, 
creating an in vitro system that can recapitulate the effects of spaceflight microgravity on 
bone formation.  An in vitro system would provide the means to study the cellular and 
molecular alterations caused by disuse, potentially yielding molecular targets for 
pharmaceutical treatments for bone loss.  To achieve this aim, we investigated the 
effects of disuse on preosteoblast cells by evaluating various bone formation markers 
and, for the first time, systemic gene expression through microarrays.   
Exposure to microgravity causes bone loss in humans, and the underlying 
mechanism is believed to be at least partially due to a decrease in bone formation by 
osteoblasts.  Here, we examined the hypothesis that microgravity alters osteoblast gene 
expression profiles, resulting in decreased bone formation.  For this study, we developed 
an in vitro system that simulates microgravity or disuse conditions using the RPM to 
study the effects of disuse on 2T3 preosteoblast cells grown in gas-permeable culture 
disks.  Exposure of 2T3 cells to the RPM for up to nine days significantly inhibited 
alkaline phosphatase activity (ALP) and up to 15 days blunted mineralization, 
recapitulating a bone loss response as seen in spaceflight.  Next, we carried out gene 
expression analysis using DNA microarrays to determine gene expression profiles of  
 
 
*Adapted and printed with permission from Pardo, SJ and Patel, MJ, et al., Simulated 
Microgravity Using the Random Positioning Machine Inhibits Differentiation and Alters Gene 
Expression Profiles of 2T3 Pre-osteoblasts, American J Physio Cell Physiology, 2005, 
288(6):C1211-21 
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2T3 cells exposed to the RPM for three days.  Among 10,000 genes examined with the 
microarray, 88 were downregulated while 52 were upregulated significantly by disuse by 
more than two-fold in comparison to the static 1g control conditions.  We then verified 
the microarray data for select genes relevant in bone biology by using real time RTPCR 
assays and immunoblotting.   We confirmed that microgravity downregulated levels of 
ALP, runt-related transcription factor 2 (runx2), osteomodulin (OMD), and parathyroid 
hormone receptor 1 (PTHR1) mRNA, upregulated cathepsin K (ctsk)  mRNA, and did not 
significantly affect bone morphogenic protein 4 (BMP4) and cystatin C protein levels.  
The identification of these mechanosensitive genes provides useful insight in generating 
further hypotheses regarding their roles not only in microgravity-induced bone loss but 
also in the general population of patients with similar pathologic conditions such as 
osteoporosis.   
 
Introduction 
 Musculoskeletal pathologies such as osteoporosis and muscular dystrophy affect 
millions of Americans.  Bone loss incurred by osteoporosis, disuse, or microgravity 
renders the skeleton at risk for bone fractures.  The underlying mechanisms regulating 
bone formation are still largely unknown.  Additionally, there is an increasing interest for 
manned space exploration, including extensive trips to deep space planets such as 
Mars.  Microgravity conditions in space have been shown to cause decreased bone 
mass (6, 7, 10, 16), bone demineralization (8, 35, 38), skeletal muscle atrophy (20, 25), 
cardiovascular deconditioning (2, 39), and immune dysfunction (32).  Many of these 
pathological changes cannot yet be counteracted adequately by physical exercise (20) 
or nutritional supplementation alone (7, 13, 36).  Therefore, it is imperative to understand 
the mechanisms of microgravity-induced pathologies so that manned space exploration 
can continue with minimal negative effects on astronauts.  Furthermore, the knowledge 
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of the mechanisms inducing spaceflight-dependent bone loss may also provide insight 
into the understanding of pathologies occurring in the general population, including 
osteoporosis and muscle atrophy.   
Unfortunately, it is difficult and impractical to conduct well controlled and large 
numbers of in vitro studies in a microgravity environment due to the limited and 
expensive nature of spaceflight missions.  Thus, to investigate pathologies that occur 
during spaceflight, several ground-based systems, including the 2D and 3D clinostats 
and the Rotating Wall Vessel (RWV), have been developed to simulate microgravity or 
disuse using cultured cells and tissues (1, 21, 26, 31).  The RPM is a 3D clinostat that 
simulates disuse by continuously moving the gravity vector relative to the cells in three 
dimensions before the cells have enough time to sense it, which is a method called 
gravity-vector averaging (14, 15).     
Previous studies have indicated that spaceflight-induced bone loss may be due 
in part to decreased osteoblastic function with or without enhancing osteoclastic bone 
resorption (9).  Simulated microgravity has been shown to inhibit markers of bone 
formation such as ALP activity and runx2 expression (26, 43).  While these studies 
examined only a few candidate genes that are likely to be involved in bone mass 
regulation, systematic and unbiased characterization of gene expression profiles 
scanning the majority of genes has not been carried out.  Here, we hypothesized that 
bone loss due to simulated microgravity or disuse is due to an inhibition of preosteoblast 
differentiation and alterations of gene expression critical in maintaining bone formation.     
To test this hypothesis, we have 1) developed and characterized an in vitro cell 
culture system using 2T3 preosteoblast cells exposed to simulated microgravity or 
disuse conditions produced by the RPM, 2) examined cell proliferation, ALP activity, and 
mineralization of 2T3 cells, 3) performed gene expression analysis using DNA 
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Cell culture–2T3 murine osteoblast precursor cells were kindly provided to us by Dr. Xu 
Cao at the University of Birmingham in Alabama (41).  The cells were cultured in growth 
medium (α-minimal essential medium) containing 10% fetal bovine serum (Atlanta 
Biologicals) with 100 units/ml of penicillin and 100µg/ml of streptomycin in a standard 
humidified incubator (37°C, 5% CO2).  For mineralization experiments, the growth 
medium was supplemented with ascorbic acid (50 µg/ml) and β-glycerolphosphate (5 
mM) with or without BMP2 or BMP4 (0-50 ng/ml) 
 
Seeding cells in OptiCells–Confluent 2T3 cells grown in T-75 flasks were trypsinized 
using 0.05% Trypsin/EDTA (Sigma), and two million cells were seeded into a gas-
permeable cell culture disk (OptiCell) according to the manufacturer’s instructions.  As 
shown in Figure 1A, an OptiCell disk is a sealed cell culture disk encapsulated by two 
optically clear and gas-permeable polystyrene membranes containing two ports, which 
allow access to the contents of the disk.  The internal disk dimensions are 74.8 x 65 x 
2.06 mm, and it can be filled with 10 to 14 ml of medium. To seed cells on each 
membrane of the Opticell, the disks were turned over every five minutes for one hour 
after seeding.  Cells were allowed to grow for three days to confluency in 14 ml of growth 
medium before exposure to the stimulus, and the day on which the OptiCells were 
mounted on the RPM was referred to as Day 0.  On Day 0, the medium was changed 
with 14 ml of fresh growth medium, and air bubbles were removed to prevent potentially 
uncharacterized mechanical perturbation during RPM exposure.   
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Random Positioning Machine–A desktop RPM described by Huijser (17) and 
manufactured by Fokker Space was used to simulate microgravity or disuse conditions. 
As shown in Figure 1B, the dimensions of the entire RPM are 30x30x30 cm with an inner 
and outer frame creating a cargo volume of 150 mm3.  The OptiCell disks were mounted 
on the center of the platform located on the inner frame, and a maximum of eight disks 
were used in each experiment.  The RPM was operated in random modes of speed and 
direction (0.1-2 radians/second) via a computer user interface with dedicated control 
software inside a humidified incubator (5% CO2 at 37oC).  Under this experimental 
condition, the cells were exposed to the RPM with a range of 0 to 0.01g centrifugal 
forces (17).   For static 1g controls, OptiCell disks seeded concurrently with the RPM 
group were placed in the same incubator as the RPM.  Samples were harvested at Days 
0, 1, 3, 5, 7 and 9.  For a three day experiment, the Opticells were exposed to the RPM 
without interruption as there was no media change necessary over this period.  
However, for experiments longer than three days, the medium was changed every three 
days (Days 3 and 6) by stopping the RPM for approximately 20 minutes before restarting 
it.   
 
Cell proliferation assay–To determine cell proliferation, attached cells were collected by 
trypsinization after experimental treatments.  Cell number was determined using an 
aliquot of cell suspension and a Coulter counter.     
 
Whole cell lysate and alkaline phosphatase (ALP) enzyme activity–After collecting the 
culture medium following the experiment, cells were scraped in 500 µl of lysis buffer 
containing 0.2% NP-40 in 1 mM MgCl2 and stored at -80ºC until needed. ALP activity 
was determined using a Diagnostics ALP assay kit (Sigma) according to the 
manufacturer’s instructions (28).  Aliquots of lysate (20 µl) and p-nitrophenol standard 
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(Sigma) were used for the assay.  ALP enzyme activity was normalized to total protein 
content as determined by a Biorad-DC protein assay and expressed in international 































Figure 4.1  In vitro simulated microgravity or disuse conditions using 2T3 cells 
cultured in OptiCell disks and the RPM   
 
Alizarin Red Stain—Following the experiment, cells were washed with ice-cold PBS two 
times and fixed in 70% ethanol for 15 minutes.  Cultures were stained for two minutes 
with a 1% Alizarin red solution for calcium detection.  Following the stain, cultures were 
rinsed with a 0.01%HCl-ethanol solution and dH20.  The plates were dried overnight 
before being scored for percent mineralization using ImageJ analysis software.  
Quantification graphs express mineralization as a percent of the experimental control.   
 
Codelink Gene Microarrays–Total RNA was isolated from 2T3 cells exposed to RPM or 
static 1g control conditions for three days using the RNeasy kit (Qiagen), and 
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experiments were performed in triplicate.  The total RNA was reverse transcribed, and 
the second strand was synthesized using T7 RNA polymerase and biotinylated dNTPs 
according to Amersham Biosciences instructions (29).  Each cRNA preparation was then 
hybridized to individual Uniset Mouse 1 microarrays (CodeLink) containing synthetic 
oligonucleotide probes corresponding to 10,000 unique mouse genes in the Amersham 
Biosciences facility (Piscataway, NJ) (29).  The gene expression intensity was 
determined by using streptavidin-Cy5 conjugated to the biotin.  The processed slides 
were scanned using an Axon GenePix Scanner with CodeLink Expression Scanning 
Software (29). The fluorescence intensities of individual probes that were above the 
threshold levels determined by internal controls were considered to be genes expressed 
by the cells and were further analyzed by the CodeLink Software (Amersham).  Using 
this software, the median intensity of all discovery probes in each microarray was used 
to normalize the fluorescence intensity of individual gene probes (normalized 
fluorescence intensity) in order to minimize inter-array variations.  The filtered and 
normalized data were statistically analyzed by the Student’s t-test, and the genes that 
changed in response to the RPM by more than two-fold above or below the static 1g 
controls with p-values of less than 0.05 were deemed considerable and significant. 
GoMiner software (http://www.miblab.gatech.edu/gominer) was used to sort the genes 
by biological processes and to assign some of the functions of each known gene (44).  
The entire RPM microarray can be accessed from Gene Expression Omnibus (GEO) 
with accession numbers GDS928 or GSE1367. 
 
Reverse Transcriptase and Real-Time Polymerase Chain Reaction (RTPCR)—Total 
RNA was prepared by using the RNeasy Mini Kit (Qiagen) and reverse transcribed by 
using random primers and a Superscript-II kit (Life Technology) (33).  The synthesized 
and purified cDNA was amplified using a LightCycler (Roche Applied Science), and the 
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size of each PCR product was verified by agarose gel electrophoresis as described by 
us (33). The mRNA copy numbers were determined based on standard curves 
generated with the genes of interest and 18S templates. The 18S primers (50 nM at 
61ºC annealing temperature; Ambion) were used as an internal control for real time 
RTPCR using capillaries (Roche Applied Science), recombinant Taq polymerase 
(Invitrogen), and Taq start antibody (Clontech).  The primer pairs for the quantitative real 
time RTPCR are listed in Table 1 along with their annealing temperatures, extension 
times, and base pair yields.  Real-time RTPCR for the listed genes were carried out in 
PCR buffer (20mM Tris-Cl, pH 8.4, at 25°C, 4mM MgCl2, 250µg/ml bovine serum 
albumin, and 200µM deoxynucleotides) containing SYBR green (1:84,000 dilution), 
0.05unit/µl Taq DNA polymerase, and Taq Start antibody (1:100 dilution) as described 
previously by us (33). 
 
Table 4.1 List of mouse primers used for quantitative real time RTPCR 
Accession # Gene Primers (5’-3’) bp Conditions for LightCycler 
NM_007431 ALP Fw CAGTATGAATTGAATCGGAACAACC 107 7 sec at 62ºC 
  Rv CAGCAAGAAGAAGCCTTTGAGG  6 sec at 72ºC 
NM_009820 runx2 Fw GACAGAAGCTTGATGACTCTAAACC 171 7 sec at 62ºC 
  Rv TCTGTAATCTGACTCTGTCCTTGT  9 sec at 72ºC 
NM_011199 PTHR1 Fw GCACACAGCAGCCAACATAA 531 7 sec at 63ºC 
  Rv CGCAGCCTAAACGACAGGAA  22 sec at 72ºC 
NM_012050 OMD Fw GACGGGCTGGTGAATGTGACTATGCTTGA 147 7 sec at 63ºC 
  Rv CCAAGGGGCATTGATTCTAATCTGTTATT  10 sec at 72ºC 
NM_007802 ctsk Fw AAGTGGTTCAGAAGATGACGGGAC 342 5 sec at 55ºC 
  Rv TCTTCAGAGTCAATGCCTCCGTTC  13 sec at 72ºC 
 
Immunoblot (Western blot)—Aliquots of cell lysate were resolved on a SDS-PAGE gel 
and transferred to a polyvinylidene difluoride membrane (Millipore) (4).  The membrane 
was incubated with a primary antibody overnight at 4°C and then incubated with a 
secondary antibody conjugated with alkaline phosphatase for one hour at room 
temperature.  Expression was detected by a chemiluminescence method and the 
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intensities of the immunoreactive bands were determined by densitometry (4).  
Antibodies specific for BMP4 and cystatin C (Santa Cruz Biotechnologies) were used.  
 
Statistical Analysis–Statistical analysis was performed by using the Student’s t-test for all 
experiments.  A significance of p<0.05 from three or more independent experiments was 
considered statistically significant.  
 
Results 
Exposure of 2T3 cells to the RPM did not alter cell morphology or proliferation. 
To examine the effects of simulated microgravity or disuse on osteoblasts, we 
developed an in vitro system to expose 2T3 cells grown in gas-permeable culture disks 
(OptiCell) to the RPM.  The morphology of 2T3 cells grown in standard tissue culture 
dishes and OptiCells were indistinguishable (data not shown).  When cells grown in 
OptiCells were exposed to RPM or static 1g conditions, the pH of the medium remained 
neutral at or near pH 7.4 (data not shown).  As shown in Figure 2A, the morphology of 
2T3 cells exposed to static 1g control and RPM conditions were not significantly different 
from each other.  
Next, we examined whether RPM exposure induced any changes in 2T3 cell 
proliferation by using cell count as a marker.  For this study, OptiCells were seeded with 
2T3 cells, and three days later (Day 0 of the experiment), the cell number reached 
approximately three million cells per disk (Figure 2B).  The cells were fed with fresh 
medium every three days during the experiment, and they continued to proliferate to a 
maximum of 13 ± 1.1 million cells (static 1g on Day 7) and 10.8 ± 0.3 million cells (RPM 
on Day 7), showing no statistical difference between the two groups (p=0.10, n=6 to 7).  
The cell number in both groups reached maximum by Day 5 and remained unchanged 
until Day 7.  The static 1g control group showed a decrease in cell number at Day 9, and 
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to determine whether this decrease was due to increased cell detachment, we counted 
the number of dead cells in the media on Day 9 by trypan blue assay.  Although the total 
number of detached cells tended to be higher in the RPM group (194,250 ± 6,475) than 
the static group (103,600 ± 33,645), there was no statistically significant difference 
(p>0.05, n=6).  These results suggest that simulated microgravity or disuse does not 

















































Figure 4.2 Simulated microgravity (µg) or disuse had no significant effect on 
2T3 cell morphology and cell number.   At Day 0, 2T3 cells grown in OptiCells 
were placed on the RPM or exposed to the static 1g condition for 1, 3, 5, 7 or  9 days. 
A phase contrast microscope was used to image cells after the experiment (A), and 
cell proliferation was assessed by cell number using a Coulter counter.  Data are 
represented as mean ± SEM (n=6, *p<0.05). 
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2T3 cells experienced low shear stress and strain due to fluid movement caused 
by the RPM rotation.   
The attached cells grown on the OptiCell membranes could be exposed to 
mechanical forces such as fluid shear stress and strain in addition to disuse during RPM 
rotation.  In order to visualize the dynamics of the fluid within the OptiCell, we marked a 
disk with a calibrated grid and filled it with water and colored bead markers 
(density=1.018g/ml, Amersham Biosciences).  The beads had a density close to that of 
water, allowing visualization of potential fluid movement.  Short movies were recorded 
using a digital camera mounted on the RPM to track bead movement over the calibrated 
grid, and flow velocities, v, were estimated from the recordings.  The shear stress, τ, was 










where, µ is the viscosity of water or growth medium at 37°C (6.92 x 10-4 and 7.8 
kg· m-1 · s-1, respectively) and h is half the height of the fluid within the Op
(1.028mm).  These calculations suggested that the magnitude of shear stress caus
movement of the growth medium experienced at the membrane was close to 0 dy
for 43 seconds, 0.09-0.22 dyn/cm2 for 13 seconds, and 0.22-0.44 dyn/cm2 for 4 sec
during a one minute period of random rotation by the RPM.  The maximum shear s
intensity was present at the larger radius of the OptiCell close to the rigid frame whi
center portions of the membranes experienced minimum shear stresses.   
Due to forces generated during the RPM rotation, cells in this experimental 
may experience mechanical strain.  As such, mechanical strain, ε, was calculated 









the 1D wave equation with fixed boundary conditions at both ends of the OptiCell frame.  
We assumed that the maximum height of the stretched membrane, h, was located at half  
the membrane length, L.  The static solution to this wave equation for the first harmonic 











   
where f(x) is the assumed shape the membrane takes when filled with 14 ml of m
h is the differential gap height between the stretched membrane at the center
filled with medium) and the unstretched membrane (when unfilled), and L is e
Lshort, half the length of the membrane’s short side, and Llong, half the length
membrane’s long side.  To determine the length of these arcs, we used the i





   
We calculated the arc for the filled OptiCell when the RPM is not rotating, wh
height is equal to h (arch), and then we calculated the arc at h+∆h (arch+∆h), wher
the change in gap height due to additional membrane stretch occurring during 
directional changes by the RPM rotation.  The strain, ε, of the membrane along th





   
This calculation suggests that the maximum microstrain occurs at the center












 of the 
ugh we 
have not determined the time-dependent changes in the strain history, we assume that 
the maximum strain occurs only briefly during sudden directional changes of the RPM.  
 
Exposure of 2T3 cells to the RPM inhibited ALP activity and mineralization. 
Since ALP activity and mineralization are established indicators of osteoblast 
differentiation and bone mass formation (40), we determined whether exposing 2T3 cells 
to disuse using the RPM inhibited these markers.  As shown in Figure 4.3A, ALP activity 
increased during culture as expected.  ALP activity of static 1g control cells dramatically 
increased by more than eight-fold within two days of culture (Day 1 to 3).  By Day 5, ALP 
activity in control cells reached maximum (24 ± 1 µmol/min/mg protein), which remained 
maximum at Day 7.   In contrast, exposure of 2T3 cells to the RPM significantly blunted 
the culture time-dependent increase in ALP activity (Figure 4.3).  Unlike the static 1g 
control group, ALP enzyme activity of the RPM group at Day 3 did not increase 
significantly above the Day 1 level.  By Day 9, ALP activity increased by four-fold above 
the Day 1 level.   As shown in Figure 4.3, ALP enzyme activity of the static 1g group was 
2.7 times higher than that of the RPM group at Day 9.  An additional group of cells was 
exposed to the RPM for three days and restored to static 1g conditions for the remainder 
of the experiment.  As expected, the ALP activity of the restored group continued to 
increase to levels between the static 1g and RPM groups.  Additionally, as depicted in 
Figure 4.3B and D, the RPM inhibited mineralization after 15-16 days of exposure even 
in the presence of BMP4 or BMP2.  This finding that simulated microgravity or disuse 
significantly decreases ALP activity and mineralization is consistent with the inhibitory 





























































































































































































































































































































Figure 4.3 The RPM inhibited ALP activity and mineralization of 2T3 cells.  Three 
days after seeding (on Day 0), 2T3 cells were exposed to the RPM or static 1g 
conditions for 1, 3 , 5 and 9 days.  ALP activity in the cell lysate was determined by a 
colorimetric Sigma assay and graphed as averaged ALP activity normalized to total 
protein.  For mineralization studies, cells were exposed to the RPM for 15-16 days 
and treated with BMP4 or BMP2 to support mineralization.  Cultures were stained 
with Alizarin Red for calcium detection.  Data are shown as mean ± SEM (n=6-10, * 
p<0.05 between Static and RPM groups). 
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The RPM altered gene expression profiles of 2T3 cells as determined by 
microarray studies. 
By performing microarray studies, we analyzed the global changes in gene 
expression profiles of 2T3 cells when exposed to simulated microgravity or disuse 
conditions.  Among 10,000 genes examined with the microarray, only 88 were 
downregulated and 52 upregulated to statistically significant levels (p<0.05) by more 
than two-fold in comparison to the static 1g control level.  Figure 4.4 shows a scatter plot 
of the averaged microarrays for both the RPM (µg) and static 1g control groups where 
each dot represents one gene.  The diagonal line represents no change in expression 
due to RPM exposure (fold change=1), and genes upregulated by the RPM are above 
the diagonal while genes downregulated by the RPM are below the diagonal line.  A heat 
map was generated (Figure 4.5) representing the data as low gene intensity (green) to 
high gene intensity (red).  The genes are identified by their accession number (accn #) 
and sorted based on fold changes induced by the RPM (µg 1-3) when compared to static 
1g conditions (st 1-3). Table 2 categorizes genes with known functions from the 
microarray study that were upregulated or downregulated by the RPM significantly 
(p<0.05) by more than two-fold above the static 1g control.  Since these genes are 
sorted based on typical cell function using the GoMiner program, genes with unknown 
functions were not included in this analysis.  Table 3 shows genes that have potential 
involvement in osteoblast differentiation and matrix mineralization regardless of the two-
fold change threshold.   
 Many osteoblast genes that have been shown to be relevant in bone formation 
were influenced by simulated microgravity or disuse.  ALP, a known marker for bone 
formation, was downregulated by the RPM by five-fold below the static 1g control.  
Runx2, a master transcription factor regulating osteocalcin levels, was downregulated by 
1.88-fold by the RPM when compared to static 1g.  PTHR1, which acts directly on the  
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Upregulated = 52 genes





















































































Figure 4.4 Scatter plot of gene expression profiles of 2T3 cells after exposure to 
RPM or static 1g control conditions.  Total RNA was isolated from 2T3 cells 
exposed to the RPM or static 1g conditions for three days.  For each group (n=3 RPM 
and static 1g), the RNA was reverse transcribed and hybridized to probes on 
Codelink microarrays corresponding to 10,000 mouse genes.  Gene expression was 
determined by fluorescence intensity, and the scatter plot shows mean values of each 
gene as a single dot.  Genes changed by the RPM are shown in black relative to the 
diagonal line and unchanged genes in gray.keleton to promote Ca2+ release from bone and on the kidney to enhance calcium 
absorption, was downregulated by five-fold by the RPM.  In contrast, inducers of 
steolytic activity were also upregulated by the RPM.  For example, ctsk was 
pregulated by 1.66-fold above the static 1g control.   
Although the fold changes for runx2 and ctsk fall slightly below the two-fold 
hange threshold for significance, these genes were included in the analysis because of 
eir established relevance in bone formation and resorption.   These results are 
onsistent with the notion that disuse decreases the expression of genes necessary for 
ifferentiation, matrix formation, and subsequent mineralization while increasing the 
xpression of genes that trigger osteoclast activity. 
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accn # st1 st2 st3 µg1 µg2 µg3 fold ∆ 
NM_009115       0.09 
NM_012050       0.18 
NM_011606       0.19 
NM_011199       0.20 
AK014166       0.20 
NM_007431       0.21 
AF064749       0.21 
NM_030127       0.22 
NM_053078       0.24 
NM_008604       0.24 
NM_008524       0.26 
NM_010753       0.26 
NM_007884       0.27 
NM_011253       0.27 
NM_008196       0.28 
NM_025711       0.28 
NM_011338       0.29 
NM_007729       0.29 
NM_020568       0.31 
NM_013456       0.31 
AK017110       0.31 
M58755       0.32 
AF309508       0.33 
NM_008185       0.34 
NM_013641       0.34 
NM_009128       0.35 
NM_007934       0.35 
NM_009964       0.35 
AK005141       0.35 
NM_010941       0.37 
NM_010357       0.37 
AK010249       0.37 
NM_013584       0.37 
NM_015744       0.38 
AB040819       0.38 
NM_009155       0.38 
NM_011058       0.38 
NM_016911       0.38 
NM_010354       0.38 
NM_008760       0.38 
NM_016867       0.38 
AK017798       0.38 
NM_009921       0.39 
NM_019521       0.39 
NM_009073       0.39 
AK002518       0.39 
NM_010315       0.40 
AK018128       0.40 
NM_010255       0.41 
AK004002       0.41 
NM_009144       0.41 
NM_010497       0.41 
AF422245       0.41 
AK008108       0.41 
NM_016894       0.42 
NM_007763       0.42 
NM_012043       0.42 
AK018504       0.43 
NM_008599       0.43 
AK004556       0.43 
NM_018887       0.43 
NM_009923       0.44 
NM_016757       0.44 
NM_008492       0.44 
NM_021472       0.45 
NM_008976       0.45 
AK004179       0.45 
NM_054077       0.45 
BC005529       0.45 
NM_026428       0.46 
accn # st1 st2 st3 µg1 µg2 µg3 fold ∆ 
NM_010551       0.46 
NM_026131       0.46 
AK013035       0.47 
AK003918       0.47 
W53823       0.47 
NM_026486       0.47 
NM_013888       0.48 
NM_010358       0.48 
NM_011817       0.48 
NM_010222       0.49 
NM_020010       0.49 
NM_010846       0.49 
AK017193       0.49 
AK013793       0.49 
NM_021515       0.49 
NM_010368       0.49 
NM_011985       0.49 
NM_019517       0.50 
AF321817       2.00 
NM_008654       2.00 
NM_019553       2.01 
NM_008723       2.01 
NM_025640       2.01 
AK011383       2.01 
AK010437       2.02 
NM_009138       2.04 
NM_019425       2.04 
NM_026631       2.04 
AK018113       2.08 
NM_011710       2.08 
NM_008361       2.10 
AJ002730       2.11 
AK009010       2.14 
NM_012006       2.17 
NM_011361       2.17 
AK013772       2.18 
NM_033320       2.18 
NM_008987       2.20 
NM_008462       2.21 
NM_013525       2.20 
NM_020562       2.20 
NM_009052       2.25 
NM_008519       2.28 
NM_010415       2.28 
AK011873       2.30 
NM_015774       2.30 
NM_010235       2.33 
AK008546       2.33 
NM_011670       2.35 
NM_030556       2.35 
NM_011433       2.36 
AK010138       2.37 
NM_007703       2.38 
NM_007836       2.40 
NM_029292       2.44 
NM_026633       2.44 
AK002480       2.49 
NM_009635       2.59 
NM_013490       2.60 
NM_009943       2.67 
NM_026626       2.77 
AB059565       2.80 
AK007530       2.86 
AK006554       2.89 
NM_016660       3.06 
AK011900       3.18 
NM_020013       3.22 
NM_007823       3.93 
NM_009731       4.41 
NM_009802       5.57 
Figure 4.5 The effects of the RPM on gene expression profiles of 2T3 cells.  The 
heat map was generated by converting the fluorescent intensities of the 140 
significantly changed genes to corresponding pseudo-colors.  The pseudo-color bar 
represents data as low gene intensity (green), no change (yellow), and high gene 
intensity (red).  The genes are identified by their accession number (accn #) and
sorted based on fold changes induced by the RPM (µg 1-3) when compared to static 
1g conditions (st 1-3). 
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Table 4.2 A list of selected mechanosensitive genes in 2T3 cells.  Genes are 
sorted based on typical cell functions.  
 
 
 Accession # Gene Name Fold ∆ SEM 
p-
value Molecular Function 
 
Cell Adhesion 
 NM_012050 osteomodulin 0.184 ± 0.031 <0.01 aka osteoadherin, may mediate 
cell attachment 
 AF064749 collagen, type VI, alpha 3 0.213 ± 0.012 <0.05 extracellular matrix structural 
constituent 
 NM_007729 procollagen, type XI, alpha 1 0.292 ± 0.013 <0.025 extracellular matrix structural 
constituent 
 NM_008462 killer cell lectin-like receptor, subfamily A, 
member 2 




 NM_011817 growth arrest and DNA damage inducible, 
gamma (GADD45G) 
0.485 ± 0.081 <0.025 structural constituent of 
ribosome 
 NM_021515 adenylate kinase 1 0.490 ± 0.042 <0.025 nucleobase, nucleoside, 
nucleotide kinase activity 
 NM_008654 myeloid differentiation primary respose gene 116 
(MYD116) 
2.004 ± 0.187 <0.025 myeloid differentiation primary 
response gene induced by IL6 
 NM_007836 growth arrest and DNA damage inducible 45 
alpha (GADD45A) 




 NM_009964 crystalline, alpha B 0.351 ± 0.061 <0.05 chaperone and heat shock 
protein activity 
 NM_009144 secreted frizzled-related sequence protein 2 0.409 ± 0.009 <0.005 transmembrane receptor and 
signal transduction activity 
 
Metabolism 
 NM_007431 alkaline phosphatase 2, liver 0.210 ± 0.017 <0.01 essential for hydroxyapatite 
formation and matrix 
mineralization 
 NM_008196 granzyme K 0.279 ± 0.014 <0.025 hydrolase and peptidase activity 
 M58755 glucokinase 0.318 ± 0.017 <0.01 hexokinase activity 
 NM_009128 stearoyl-coenzyme A desaturase 2 0.347 ± 0.050 <0.01 metal_ion_binding and 
oxidoreductase activity 
 NM_007934 glutamyl aminopeptidase 0.350 ± 0.042 <0.005 metalloexopeptidase activity 
 NM_010941 NAD(P) dependent steroid dehydrogenase-like 0.367 ± 0.021 <0.025 oxidoreductase activity, acting 
on CH-OH group of donors 
 NM_015744 ectonucleotide 
pyrophosphatase/phosphodiesterase 2 
0.376 ± 0.087 <0.025 hydrolase activity 
 NM_010255 guanidinoacetate methyl transferase 0.406 ± 0.069 <0.05 methyltransferase activity 
 NM_018887 cytochrome p450, 39A1 0.435 ± 0.051 <0.05 oxidoreductase activity 
 NM_008976 protein tyrosine phosphatase, non-receptor type 
14 
0.451 ± 0.034 <0.01 phosphoric monoester hydrolase 
activity 
 NM_020010 cytochrome p450, 51 0.486 ± 0.011 <0.025 oxidoreductase activity 
 NM_019425 glucosamine-phosphate N-acetyltransferase 1 2.041 ± 0.077 <0.01 transferase activity 
 NM_012006 cytosolic acyl-coA thioesterase 1 2.165 ± 0.175 <0.025 CoA hydrolase activity 
 NM_033320 glucuronyl c5 epimerase 2.184 ± 0.105 <0.025 racemase and epimerase 
activity, acting on carbohydrates 
 NM_007703 cig30 or (FEN1/ELO2, SUR4/ELO3, yeast)-like 3 
(ELOVL3) 
2.377 ± 0.157 <0.025 involved in a pathway connected 
with brown fat hyperplasia 
 NM_009943 cytochrome C oxidase, subunit VI A, polypeptide 
2 
2.669 ± 0.199 <0.01 oxidoreductase activity, acting 
on heme group of donors 
 NM_007823 cytochrome P450, subfamily IV B, polypeptide 1 3.925 ± 0.241 <0.005 oxidoreductase activity 











value Molecular Function 
 
Protein Metabolism 
 NM_010222 FK506 binding protein 7 0.485 0.073 <0.05 peptidyl-prolyl cis-trans 
isomerase activity 
 NM_011985 matrix metalloproteinase 23 0.493 0.009 <0.025 metalloendopeptidase activity 
 NM_011710 tryptophanyl-TRNA synthetase 2.080 0.085 <0.025 ligase activity, forming 
phosphoric ester & carbon-
oxygen bonds 
 NM_011361 serum/glucocorticoid regulated kinase 2.169 0.014 <0.005 serine/threonine kinase activity 
 NM_015774 ERO1-LIKE 2.305 0.108 <0.01 unknown 
 NM_011670 ubiquitin carboxy-terminal hydrolase L1 2.354 0.423 <0.05 thiolester hydrolase activity 
 
Stress or Immune Response 
 NM_010357 glutathione S-transferase, α4 0.368 0.046 <0.05 transferase activity, transferring 
alkyl or aryl groups 
 NM_008599 small inducible cytokine B subfamily, member 9 0.430 0.069 <0.025 G-protein-coupled receptor 
binding activity 
 NM_010358 glutathione S-transferase, µ1 0.482 0.085 <0.05 transferase activity, transferring 
alkyl or aryl groups 
 AF321817 LPTS1 2.001 0.293 <0.05 nucleic acid binding activity 








 NM_011338 small inducible cytokine A9 0.287 0.046 <0.005 G-protein-coupled receptor 
binding activity 
 NM_013641 prostaglandin E receptor 1 0.338 0.026 <0.005 transmembrane and G-protein-
coupled receptor activity 
 AB040819 RAC3 0.377 0.012 <0.05 GTPase activity 
 NM_011058 platelet derived growth factor receptor, alpha 
polypeptide 
0.378 0.025 <0.025 transmembrane receptor protein 
tyrosine kinase activity 
 NM_010315 guanine-nucleotide binding protein, gamma 2 
subunite 
0.404 0.041 <0.05 heterotrimeric G-protein 
GTPase activity 
 NM_016894 RAMP1 0.418 0.047 <0.025 coreceptor, soluble ligand 
activity 
 NM_009138 small inducible cytokine A25 2.038 0.117 <0.01 G-protein-coupled receptor 
binding activity 




 NM_011199 parathyroid hormone receptor 0.198 0.010 <0.005 transmembrane receptor activity 
 NM_011606 tetranectin 0.187 0.027 <0.025 binds to plasminogen, may 
regulate matrix mineralization 




 NM_010753 max dimerization protein 4 (MAD4) 0.261 0.058 <0.025 transcription regulator activity 
 NM_010497 isocitrate dehydrogenase 1 (NAP+), soluble 0.409 0.094 <0.025 oxidoreductase activity, acting 
on CH-OH group of donors 
 NM_010235 FOS-like antigen 1 2.328 0.199 <0.025 DNA binding activity 
 NM_016660 high mobility group protein I 3.060 0.442 <0.025 DNA binding activity 
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Table 4.3 The effect of the RPM on selected genes that may be involved in 
osteoblast differentiation and matrix mineralization. Genes are sorted based on 
fold changes. 
 
Accession # Gene Name Fold ∆ SEM 
p-
value. Molecular Function 
 
 
NM_012050 Osteomodulin 0.184 ± 0.031 <0.01 aka osteoadherin, may mediate cell attachment 
NM_011606 Tetranectin 0.187 ± 0.027 <0.025 binds to plasminogen, may regulate matrix mineralization 
NM_011199 pararthyroid hormone receptor 0.198 ± 0.010 <0.005 transmembrane receptor activity 
NM_007431 alkaline phosphatase 2, liver 0.210 ± 0.017 <0.01 essential for hydroxyapatite formation and matrix mineralization 
NM_008524 Lumican 0.259 ± 0.030 <0.005 regulates collagen fibril formation in different extracellular matrices 
NM_007729 procollagen, type XI, alpha 1 0.292 ± 0.013 <0.025 present in cartilage 
NM_007559 bone morphogenetic protein 8B 0.337 ± 0.071 <0.1 growth factor and cytokine activity 
NM_008760 Osteoglycin 0.380 ± 0.003 <0.025 binds to TGF-beta, no GAG in bone, keratan sulfate in other tissues 
NM_016894 RAMP1 0.418 ± 0.047 <0.025 calcitonin signal transducer activity 
NM_007743 procollagen, type I, alpha 2 0.431 ± 0.091 <0.1 the major constituent of bone matrix 
NM_021355 Fibromodulin 0.450 ± 0.103 <0.1 binds to collagen, may regulate fibril formation, binds to TGF-beta 
NM_019444 RAMP2 0.500 ± 0.027 <0.005 calcitonin signal transducer activity 
AF053954 cbfa1/runx2 (osf2) 0.533 ± 0.058 <0.1 essential transcription factor for osteoblast differentiation and bone formation 
NM_007833 Decorin 0.562 ± 0.003 <0.005 binds to collagen and may regulate fibril diameter 
NM_013691 thrombospondin 3 0.581 ± 0.034 <0.01 involved in cell attachment 
NM_011607 tenascin C 0.589 ± 0.024 <0.025 noncollagenous macromolecule of cartilage matrix 
NM_011693 vascular cell adhesion molecule 1 0.633 ± 0.075 <0.05 cell adhesion molecule activity 
NM_008970 parathyroid hormone-like peptide 0.655 ± 0.233 >0.1 signal transduction and hormone activity 
NM_007553 bone morphogenetic protein 2 0.704 ± 0.065 <0.05 growth factor and cytokine activity 
NM_016919 procollagen, type V, alpha 3 0.716 ± 0.024 <0.1 present where there is collagen type I 
NM_011581 thrombospondin 2 0.724 ± 0.298 >0.1 involved in cell attachment 
NM_013605 mucin 1 0.733 ± 0.047 <0.05 cell adhesion receptor 
NM_011146 peroxisome proliferator activated receptor γ 0.734 ± 0.016 <0.1 RNA polymerase II transcription factor 
NM_007433 alkaline phosphatase 5 0.736 ± 0.108 >0.1 hydrolase activity, acting on ester bonds 
NM_010514 insulin-like growth factor 2 0.752 ± 0.077 <0.1 signal transduction and hormone activity 
NM_007737 procollagen, type V, alpha 2 0.767 ± 0.026 <0.1 present where there is collagen type I 
NM_022415 prostaglandin E synthase 0.778 ± 0.041 <0.05 intramolecular isomerase activity, other intramolecular oxidoreductases 
NM_010512 insulin-like growth factor 1 0.785 ± 0.190 >0.1 signal transduction and hormone activity 
NM_007644 CD36 antigen-like 2 0.833 ± 0.013 <0.025 signal transducer activity 
NM_010181 fibrillin 2 0.842 ± 0.172 >0.1 may regulate elastic fiber formation (calcium ion binding activity) 
NM_013731 serum/glucocorticoid regulated kinase 2 0.848 ± 0.348 >0.1 
phosphotransferase activity, alcohol group 
as acceptor 
NM_009262 osteonectin (SPOCK1) 0.853 ± 0.210 >0.1 may mediate deposition of hydroxyapatite, binds to growth factors 
NM_011707 Vitronectin 0.861 ± 0.297 >0.1 binds to collagen, plasminogen and heparin 
NM_008712 nitric oxide synthase 1 0.861 ± 0.025 <0.1 nitric oxide synthase activity 
L27439 protein S 0.864 ± 0.170 >0.1 calcium ion binding activity 
NM_008689 NFκB 1 0.875 ± 0.027 <0.05 transcription factor activity 
NM_011808 ETS 1 0.883 ± 0.199 >0.1 transcription factor expressed in proliferating preosteoblastic cells 
NM_007388 acid phosphatase 5, tartrate resistant 0.885 ± 0.180 >0.1 enzyme identified in both the ruffled border of the osteoclast membrane 
NM_011519 syndecan 1 0.890 ± 0.047 >0.1 binds to type 1 collagen, fibronectin, tenascin-C 
NM_007557 bone morphogenetic protein 7 0.905 ± 0.063 >0.1 growth factor and cytokine activity 
NM_009926 procollagen, type XI, alpha 2 0.913 ± 0.121 >0.1 present in cartilage 
NM_011347 platelet selectin 0.920 ± 0.075 >0.1 cell adhesion molecule activity 
NM_007542 Biglycan 0.920 ± 0.024 >0.1 may bind to collagen, a genetic determinant of peak bone mass 
M28621 interferon-γ 0.945 ± 0.161 >0.1 inhibit bone resorption 
NM_031163 procollagen, type II, alpha 1 0.947 ± 0.171 >0.1 the major constituent of cartilage 
NM_008318 integrin binding sialoprotein 0.953 ± 0.151 >0.1 noncollagenous protein in bone 
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Table 4.3-Continued 
Accession # Gene Name Fold ∆ SEM 
p-
value. Molecular Function 
 
 
NM_013712 integrin β1 binding protein 2 0.956 ± 0.062 >0.1 muscle-specific integrin beta1-interacting protein 
NM_031168 interleukin 6 0.964 ± 0.065 >0.1 act as stimulators of an early stage of osteoclast formation 
NM_008355 interleukin 13 0.966 ± 0.345 >0.1 inhibit bone resorption 
NM_020273 glucocorticoid modulatory element binding protein 1 0.979 ± 0.077 >0.1 transcription factor activity 
NM_007412 adrenomedullin receptor 0.981 ± 0.125 >0.1 rhodopsin-like, G-protein coupled receptor activity 
NM_011346 lymphocyte selectin 0.982 ± 0.075 >0.1 cell adhesion molecule activity 
NM_009367 transforming growth factor, beta 2 1.000 ± 0.127 >0.1 growth factor and cytokine activity 
NM_009758 bone morphogenetic protein receptor 1A 1.011 ± 0.176 >0.1 TGF-β and BMP receptor 
NM_007560 bone morphogenetic protein receptor 1B 1.024 ± 0.144 >0.1 TGF-β and BMP receptor 
NM_008713 nitric oxide synthase 3 1.026 ± 0.151 >0.1 nitric oxide synthase activity 
NM_007424 aggrecan 1 1.026 ± 0.077 >0.1 glycosaminoglycan binding activity 
NM_007554 bone morphogenetic protein 4 1.027 ± 0.017 >0.1 growth factor and cytokine activity 
NM_007558 bone morphogenetic protein 8A 1.049 ± 0.186 >0.1 growth factor and cytokine activity 
NM_007993 fibrillin 1 1.049 ± 0.045 >0.1 may regulate elastic fiber formation 
NM_011809 ETS 2 1.078 ± 0.176 >0.1 transcription factor expressed in differentiating and mature osteoblasts 
NM_010927 nitric oxide synthase 2 1.086 ± 0.195 >0.1 nitric oxide synthase activity 
NM_011196 prostaglandin E receptor 3 1.102 ± 0.397 >0.1 rhodopsin-like, G-protein coupled receptor activity 
NM_007643 CD36 antigen 1.102 ± 0.461 >0.1 cell adhesion molecule activity 
NM_008216 hyaluronan synthase 2 1.116 ± 0.240 >0.1 with versican-like protein works to captures space destined to become bone 
NM_008764 osteoprotegerin 1.127 ± 0.260 >0.1 signal transducer activity 
NM_008319 intracellular adhesion molecule 5 1.136 ± 0.082 >0.1 cell adhesion molecule activity 
X97991 calcitonin 1.149 ± 0.096 >0.1 signal transducer activity 
NM_010735 lymphotoxin A 1.149 ± 0.129 >0.1 tumor necrosis factor receptor ligand activity 
NM_052994 osteonectin (SPOCK2) 1.164 ± 0.105 >0.1 may mediate deposition of hydroxyapatite, binds to growth factors 
NM_019511 RAMP3 1.172 ± 0.042 >0.1 calcitonin signal transducer activity 
NM_008215 hyaluronan synthase 1 1.177 ± 0.258 >0.1 with versican-like protein works to captures space destined to become bone 
NM_013693 tumor necrosis factor 1.256 ± 0.334 >0.1 growth factor and cytokine activity 
NM_010577 integrin α5 1.304 ± 0.251 >0.1 cell adhesion molecule 
NM_008350 interleukin 11 1.312 ± 0.379 >0.1 act as stimulators of an early stage of osteoclast formation 
NM_008518 lymphotoxin B 1.330 ± 0.031 <0.025 tumor necrosis factor receptor ligand activity 
NM_007761 calcitonin gene-related peptide-receptor 1.345 ± 0.102 <0.1 calcitonin receptor activity 
NM_007588 calcitonin receptor 1.345 ± 0.225 >0.1 calcitonin G-protein coupled receptor activity 
NM_008217 hyaluronan synthase 3 1.357 ± 0.198 >0.1 with versican-like protein works to captures space destined to become bone 
NM_010494 intracellular adhesion molecule 2 1.362 ± 0.550 >0.1 cell adhesion molecule activity 
NM_010576 integrin α4 1.413 ± 0.448 >0.1 cell adhesion molecule 
NM_018782 calcitonin receptor-like 1.413 ± 0.242 >0.1 calcitonin G-protein coupled receptor activity 
NM_011580 thrombospondin 1 1.418 ± 0.278 >0.1 cell attachment 
NM_009627 adrenomedullin 1.426 ± 0.176 <0.1 neuropeptide hormone activity 
NM_008965 prostaglandin E receptor 4 1.445 ± 0.581 >0.1 G-protein coupled receptor_activity 
NM_008396 integrin α2 1.654 ± 0.467 >0.1 cell adhesion molecule 
NM_007802 cathepsin K (Ctsk) 1.661 ± 0.076 <0.01 in the papain family of cysteine proteases 
NM_010554 Interleukin 1α 1.875 ± 0.224 <0.1 potent stimulators of bone resorption 
NM_007556 bone morphogenetic protein 6 1.877 ± 0.161 <0.1 growth factor and cytokine activity 
NM_008361 Interleukin 1β 2.099 ± 0.176 <0.025 potent stimulators of bone resorption 
NM_011361 serum/glucocorticoid regulated kinase 2.169 ± 0.014 <0.001 transferase activity, transferring phosphorus-containing groups 
NM_054084 calcitonin-related polypeptide β 9.548 ± 8.524 >0.1 signal transducer activity 
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The gene microarray was verified by quantitative real time RTPCR for select 
osteogenic genes. 
To verify the microarray studies by real time RTPCR, we selected genes that 
have been shown to be involved in osteoblast differentiation and bone mass regulation.  
The same samples used for the CodeLink bioarray assays were used for the real time 
RTPCR.  All real time RTPCR data shown in Figure 4.6 (A–E) was normalized to the 
internal control, 18S rRNA, and fold changes were determined by dividing the amount of 
a gene exposed to the RPM by the static 1g control (Figure 4.6F).  As evaluated by the 
Codelink microarray, 2T3 cells exposed to the RPM had decreased expression of ALP, 
runx2, PTHR1, and OMD gene expression by a fold change of 0.21, 0.53, 0.20 and 0.18, 
respectively. In addition, 2T3 cells showed an increase in ctsk by a fold change of 1.66.  
To verify these results, real time RTPCR was performed.  The gene expression fold 
changes by real time RTPCR for ALP, runx2, PTHR1, and OMD were 0.21, 0.68, 0.25 
and 0.17, respectively.  The fold change for ctsk from RTPCR was 1.67.  Additionally, 
we confirmed the expression of non-mechanosensitive genes such as BMP4 and 
cystatin C protein levels by immunoblotting.  We show that the fold changes for BMP4 
and cystatin C by Western were 1.12 and 1.13 and by Codelink were 1.03 and 0.71, 
respectively (Figure 4.6G).  The different methodologies used, the microarray assay, real 
time RTPCR, and immunoblotting, produced highly consistent results, providing a level 
of assurance regarding the validity of the microarray data.     
 
Discussion  
The novel and most significant finding of the current study is that exposure of 
preosteoblasts to simulated microgravity or disuse using the RPM partially recapitulates 
the expected changes associated with the bone loss response observed in spaceflight.   
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Figure 4.6 Verification of microarray results by real time RTPCR and 
immunoblot. Aliquots of total RNA were purified, reverse transcribed, and probed by 
real time RTPCR for ALP (A), runx2 (B), pthr1 (C), omd (D), and ctsk (E) using 18s 
rRNA as an internal control, and fold changes were compared to the microarray data 
(F).  Cell lysate from additional experiments was obtained for immunoblotting and 
probed for BMP4 and cystatin C (G) using actin as an internal control.  Data are 




The RPM induced a loss of ALP mRNA and activity, a marker of differentiation, and we 
found that this change occurred without altering cell proliferation or gross morphology of 
2T3 cells.  More importantly, the RPM inhibited mineralization, a long term marker of 
bone formation in vitro despite treatment with an osteogenic factor such as BMP2 or 
BMP4.  Furthermore, using this in vitro system, the current study generated a list of 
genes that were upregulated, downregulated, or unchanged by the RPM.  Several genes 
that are suspected to be involved in bone formation and bone resorption were found to 
change in the expected manner.  We selected 7 genes (ALP, runx2, PTHR1, OMD, ctsk, 
BMP4, and cystatin C) from the list and verified the microarray results by real time 
RTPCR or immunoblot.   
Disuse- and microgravity-induced bone loss in humans and animals has been 
shown to be mediated at least in part by osteoblast differentiation, and ALP and 
mineralization are well-known markers for it (3, 7, 22).  Our current data showing a 
decrease in ALP activity and mRNA levels as well as mineralization is consistent with 
this notion (11).  In addition, the decrease in runx2 is also indicative of a disuse-
response as runx2 mRNA levels have been previously shown to decrease in both 
spaceflight and ground-based studies (3, 27).  The current finding that 2T3 cell exposure 
to the RPM decreases ALP and runx2 expression is consistent with the spaceflight data 
obtained with osteoblasts as well as other bioreactor data using MC3T3-E1 
preosteoblast cells exposed to the Rotating Wall Vessel (RWV) (6, 8, 27).  Runx2, a 
member of the runt homology domain transcription factor family and regulator of matrix 
protein osteocalcin, is an essential transcription factor for osteoblast differentiation and 
bone formation.  We found that runx2 was downregulated by almost two-fold below the 
static 1g control.   Osteocalcin protein levels in the conditioned medium were too low to 
be detected in our studies due to a relatively short experimental duration of 9 days, and 
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this is consistent with previous findings (12).  In other studies, osteocalcin level was 
shown to be decreased in MC3T3-E1 cells by exposure to the RWV (27).  
Additionally, OMD  belongs to the small leucine-rich proteoglycan (SLRP) family 
and is thought to be involved in bone matrix formation (5).  Our current study showing 
the downregulation of OMD by the RPM supports the current hypothesis.  A decrease in 
parathyroid hormone related protein, which plays a role in calcium mobilization, has 
been linked to the decrease in bone density and bone loss in space-flown rats (34).  In 
this light, our result demonstrating that PTHR1 mRNA level was decreased by the RPM 
is also consistent with the space-flown data. In addition to the downregulated genes, 
there were several genes that were upregulated.  Ctsk, which is a member of the papain 
family of cysteine proteases, is mostly expressed in osteoclasts and plays a critical role 
in bone resorption (24, 42).  More recently, however, ctsk has been found in non-
osteoclastic cells such as thyroid epithelial cells (42).  As far as we are aware, this is the 
first time that ctsk expression has been found in osteoblasts.  At present, the biological 
and pathological implications of ctsk expression in osteoblasts are not clear.  Ctsk 
induced by the RPM could be responsible for bone loss by either directly increasing 
osteoclastic activity or through an indirect osteoblast-dependent mechanism.   
We also examined genes that were not unchanged in response to the RPM 
according to the microarray data.  For example, BMP4 and cystatin C mRNA levels in 
the RPM-exposed group showed 1.0- and 0.7-fold changes over the controls, 
respectively.  We performed immunoblot analyses to examine their protein expression 
levels with specific antibodies to BMP4, cystatin C, and actin (as a control) using lysate 
obtained from 2T3 cells exposed to three days of RPM or static 1g control conditions.  
As expected, we did not find any significant difference in their protein expression levels 
as shown in Figure 4.6F.  
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In addition to simulated microgravity or disuse conditions, cells in this in vitro 
system experienced a low level of shear stress and subsequent strain based on 
computational modeling studies.  The model predicted that a minor portion of the cells 
close to the edge of the long frame of the Opticell disk experienced significantly less 
than 1.0 dyn/cm2 of shear stress for a brief moment (less than 4.0 sec/min) and less than 
200 microstrains of mechanical strain for a fraction of the RPM exposure time.   
However, the levels of these forces are significantly lower than the reported stress or 
strain magnitudes (as low as 2 dyn/cm2 shear stress and 500 microstrains) needed to 
stimulate signaling in osteoblasts (18, 19, 23, 30).  It should be noted that it has been 
shown that 0.14 dyn/cm2 of continuous shear exposure for four hours increased 
cyclooxygenase 2 (cox-2) expression (37). Therefore, these results should be taken with 
caution that the observed RPM effects may be partially attributed to mechanical forces 
other than simulated microgravity or disuse conditions.   
In summary, we have developed a novel in vitro system using the RPM, Opticell 
disks, and 2T3 preosteoblast cells, which seems to recapitulate the bone loss-like 
response due to microgravity or disuse conditions.   The data reported here show that 
exposure to the RPM alters gene expression profiles and inhibits differentiation of 
preosteoblasts to osteoblasts, eventually leading to reduced bone formation.  At this 
point, it is not clear whether these two events, differentiation or gene expression 
changes, occur in sequence or concurrently.  However, it is likely that these two events 
are closely interrelated. In addition to having tabulated a list of known and expected 
genes altered by disuse (e.g. ALP, runx2, OMD, PTHR1, and ctsk), we have a list of 
unknown and uncharacterized genes that have dramatically changed in 2T3 cells 
exposed to the RPM.  The functional characterization of these expected and unexpected 
genes could provide critical insight into understanding the mechanisms driving disuse-
induced bone loss.  Moreover, these studies may also lead to the identification of novel 
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targets of therapeutic interventions to prevent bone loss not only in astronauts but also in 
the general population afflicted with metabolic bone diseases. 
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A Confined List of Mechanosensitive Genes in 
Osteoblasts by Comparative Microarray Studies* 
 
Summary 
With a list of gene expression changes due to simulated microgravity or disuse 
from specific aim 1, it is the goal of specific aim 2 to confine this list to those genes that 
may be most important in regulating bone formation in disuse conditions.  Specific aim 1 
resulted in a relatively large list of 140 genes with potential roles in bone loss due to 
disuse.  As such, to achieve this aim, we exposed 2T3 cells to a distinct simulator of 
microgravity or disuse called the Rotating Wall Vessel (RWV) and performed 
comparative microarray analyses.   
Bone loss due to disuse, microgravity, or osteoporosis is caused in part by 
decreased bone formation by osteoblasts.  There are simulators of microgravity or 
disuse used to study the mechanisms regulating bone loss in these environments at the 
in vitro level.  Thus, this research has the potential to elucidate the role of certain 
mechanosensitive genes in bone loss.  The RWV and RPM are the two most commonly 
used simulators of microgravity, but these simulators have not been systematically 
compared to each other or to mechanical stimulating models.  These comparisons are 
vital to validate their use in modeling the disuse phenotype.  Here, we hypothesized that 
exposure to the RWV inhibits differentiation and alters gene expression profiles of 2T3 
cells, and a subset of these mechanosensitive genes behaves in a manner consistent to 
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Exposure of 2T3 preosteoblast cells to the RWV for three days inhibited alkaline 
phosphatase (ALP) activity, a marker of differentiation, and downregulated 61 and 
upregulated 45 genes by more than two-fold compared to static 1g controls as shown by 
microarray analysis.  The microarray results were confirmed by real time RTPCR and/or 
immunoblots for seven distinct genes and proteins including osteomodulin (OMD), runt 
homology domain transcription factor 2 (runx2), and osteoglycin (OGN).  Comparison of 
the RWV data to the RPM microarray study that we previously published showed 17 
mechanosensitive genes that changed in the same direction.  Further comparison of the 
RWV and RPM results to independently published microarray data from mechanically 
loaded mouse tibiae revealed three genes including OGN that were upregulated by 
mechanical loading and downregulated by disuse.  These mechanosensitive genes may 
provide novel insight into understanding the mechanisms regulating bone formation and 
potential targets for countermeasures against decreased bone formation during 
spaceflight, disuse, and osteoporosis.     
Introduction 
Bone loss occurs due to a number of stimuli, including disuse due to illness or 
paralysis, microgravity in spaceflight, or ageing.  Bone loss can lead to fractures, 
causing hospitalization and potentially invasive replacement surgery.  Exposure to 
microgravity conditions induces several adaptive and pathological changes to the human 
body, posing health risks to astronauts during spaceflight.  These pathological changes 
include decreased bone mass (12, 23) at 1%-2% per month during spaceflight, and this 
bone loss may be due to either decreased bone formation by osteoblasts or increased 
osteolytic functions of osteoclasts (3, 23).  Bone loss in space may be regulated by 
similar mechanisms as bone loss due to disuse, and research in this area has the 
potential to benefit the general public.  However, the underlying molecular mechanisms 
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driving bone loss in various environments remain unknown, making it difficult to develop 
adequate countermeasures to mitigate it.   
Bioreactors such as the RPM and RWV provide unique environments to model 
disuse or microgravity for in vitro experiments.  However, it has become increasingly 
important to have validated in vitro ground-based models.  Whenever possible, 
comparisons of data from these systems should be made to spaceflight, in vivo models 
of disuse, and in vivo mechanical loading models to evaluate consistency of results.  The 
RWV and the RPM are the two most commonly used in vitro simulators of microgravity 
or disuse.  While the RWV models microgravity conditions by maintaining continuous 
free-fall, the RPM exposes cells and tissues to random speeds and orientation such that 
the gravity vector is randomly moved relative to the specimen (4, 22).   The RWV (Figure 
1A) is designed such that the particles within it are subjected to solid body rotation, 
which is achieved as the vessel rotates and the liquid accelerates such that the entire 
body of fluid is rotating at the same angular velocity as the vessel wall.  The RWV 
generates minimum shear forces since there is no internal mixer, and thus, the cells in 
the RWV are subjected to solid body rotation and are constantly suspended (22).  In 
contrast, the RPM (Figure 5.1B) is a three dimensional (3D) clinostat that rotates about 
two orthogonal axes.  There are two frames, an inner and an outer frame, which rotate 
about distinct axes, and the platform where the cells rest is the inner frame.  The RPM 
operates in a random mode, where rotation speeds and directions are randomized using 
software developed by the Dutch Space Agency (Leiden, the Netherlands).  The 
continuous movement of the gravity vector averages the vector to zero over time, a 
method called gravity-vector averaging (6). 
Both the RWV (18, 30) and the RPM (16, 19) have been previously used by 
various groups to assess the effects of microgravity or disuse on bone cells.  However, it 
has not been reported whether these simulators induce similar changes with regard to 
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bone loss or bone formation.  Since the RPM and RWV operate in distinct modes, it is 
imperative to compare the data produced by each simulator.  Recently, we have 
characterized gene transcript expression profiles of 10,000 genes using Codelink gene 
chips in 2T3 murine preosteoblasts exposed to the RPM (19).  We compiled a list of 140 
genes (mechanosensitive genes) that changed in response the RPM, and a subset of 
these genes may be involved in regulation of bone formation.  In contrast, a study by 
Xing et al., has characterized gene transcript profile changes induced by exposing 
mouse tibiae to mechanical stimulation, an apparent opposite of microgravity or disuse 
conditions, using a four-point bending method (29).  Therefore, we hypothesized that 
exposure to the RWV inhibits differentiation and alters gene expression profiles of 2T3 
cells, and a subset of these mechanosensitive genes behaves in a manner consistent to 
the RPM and opposite to the trends incurred by mechanical stimulation of mouse tibiae.   
To test this hypothesis, we carried out an additional gene transcript profiling 
study with 2T3 cells exposed to the NASA-developed RWV bioreactor and compared the 
results to our previous transcript database obtained with the Japanese-designed and 
European-manufactured RPM.  In addition, we compared both the RWV and RPM 
transcript databases to a database obtained from mechanically loaded mouse tibiae 
(29).  From these comparisons, we produced a confined subset of genes that was 
affected in all three studies, suggesting that these genes may be implicated in disuse-
induced decrease in bone formation.   
Materials and Methods 
Cell culture—2T3 murine osteoblast precursor cells were cultured in growth medium (α-
minimal essential medium) containing 10% fetal bovine serum (Atlanta Biologicals) with 
100 U/ml penicillin and 100 µg/ml streptomycin in a standard humidified incubator (37°C, 
5% CO2) as previously described by us (19).  For RWV experiments, trypsinized cells 
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were seeded on microcarriers (#P102-1521, Solohill, Ann Arbor, MI), which have 
polystyrene cores and no extracellular matrix coating.  The cells were allowed to grow in 
low adhesion 100 mm plates (Corning, Inc. #3262) for three days to confluency and then 
were exposed to simulated microgravity using the RWV or static 1g control conditions.   
 
Rotating Wall Vessel (RWV)–Rotation of the RWV (Figure 5.1A) maintains microbeads 
coated with attached 2T3 preosteoblasts in a continuous free-fall state, simulating a 
microgravity environment (22).  This RWV system has been shown to be an effective 
simulator of real microgravity conditions as demonstrated in comparative studies using 
blood mononuclear cells in space flight missions STS-54 and STS-56 (20).  In the 
current study, 2T3 cells were exposed to the RWV for three days so that the data could 
be directly compared to data obtained with the RPM for the same time period (19). 
 
Whole cell lysate and alkaline phosphatase (ALP) enzyme activity—Following the RWV 
or static 1g exposure, cells and beads were washed with ice-cold phosphate buffered 
saline (PBS) two times and lysed in 500 µl of a lysis buffer containing 0.1% Triton X-100 
in 1mM MgCl2, 20mM Tris-HCl, and 0.1 mM ZnCl2.  The lysate and bead mixture was 
centrifuged for three minutes at 1,500 rpm to separate the beads from the lysate.  The 
lysate was pipetted out of the mixture and stored at –20°C until needed.  A Bio-Rad DC 
protein assay and ALP activity assay (Sigma) were carried out as described previously 
(19).  
 
Immunoblotting—Aliquots of cell lysate were resolved on a SDS-PAGE gel and 
transferred to a polyvinylidene difluoride membrane (Millipore) (1).  The membrane was 
incubated with a primary antibody overnight at 4°C and then incubated with a secondary 





Figure 5.1 Simulated microgravity or disuse using the RWV and the RPM.  The 
arrows indicate movement about the respective axis of rotation. 
 
Expression was detected by a chemiluminescence method, and the intensities of 
immunoreactive bands were determined by densitometry (1).  Antibodies specific for 
BMP4 (Santa Cruz Biotechnologies), OGN (R&D Biosciences), and peroxiredoxin I and 
peroxiredoxin IV (Lab Frontier, Seoul, Korea) were used.  
 
RNA isolation—Total RNA was prepared by using the RNeasy Mini kit (Qiagen).  Briefly, 
after two ice-cold PBS washes, 500 µl of RLT lysis buffer containing β-mercaptoethanol 
was added to the bead and cell mixture to isolate total RNA.  The bead and lysate 
mixture was centrifuged for three minutes at 1,500 RPM to separate the beads from the 
RNA, and the RNA was pipetted to the homogenizing column in the RNeasy kit.  The 
RNA was purified with the kit and stored at –80°C until needed.   
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Affymetrix Gene Microarrays— All RNA samples passed the Affymetrix test for RNA 
quality and concentration before proceeding to the gene chip study carried out in the 
Microarray Core Facility at the Baylor College of Medicine (Houston, TX).  The samples 
used for these studies were obtained from three independent biological experiments as 
follows:  We pooled cells from 3 independent RWV experiments carried out at the same 
time to obtain a single sample (total RNA) that was used for a single microarray.  This 
process minimized inter-experimental variations and provided a sufficient amount of 
RNA for each microarray.  We repeated this process three different times to obtain a 
final sample size of three microarray chips for the static control samples and three 
microarray chips for the RWV samples.  The array used was Affymetrix GeneChip® 
Mouse 430 2.0, and the data were background adjusted and normalized to median 
intensity.  The data were transformed so that fold changes were obtained by dividing the 
averaged normalized intensities of the RWV samples by the averaged normalized 
intensities of the static samples.  Thus, a fold change above 1.0 indicates a gene 
upregulated by the RWV and below 1.0 indicates a gene downregulated by the RWV.   
The data were statistically analyzed by DNA chip analyzer (dChip) as described below in 
the statistical analysis section and filtered for fold change threshold, and the genes that 
changed in response to the RWV by more than two-fold above or below the static 1g 
controls with p-values of less than 0.05 were deemed considerable and statistically 
significant.  The number of differentially expressed genes and false discovery rate (FDR) 
were calculated for each of 500 permutations, and 1,934 genes had p-values less than 
0.05 at median FDR.  Roughly, half of these genes were false positives.  GoMiner 
software (http://www.miblab.gatech.edu/gominer) was used to sort the genes by 
biological processes and to assign some of the molecular functions of each known gene 
(31).   
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Reverse Transcriptase and Real-Time Polymerase Chain Reaction (RTPCR)—Total 
RNA was reverse transcribed by using random primers and a Superscript-II kit (Life 
Technology) (24).  The synthesized and purified cDNA was amplified using a LightCycler 
(Roche Applied Science), and the size of each PCR product was verified by agarose gel 
electrophoresis as described by us (24).  The mRNA copy numbers were determined 
based on standard curves generated with the genes of interest and 18S rRNA 
templates. The 18S gene (50 nM at 61ºC annealing temperature; Ambion) was used as 
an internal control for real time RTPCR carried out with capillaries (Roche Applied 
Science), recombinant Taq polymerase (Invitrogen), and Taq start antibody (Clontech).  
The primer pairs for the quantitative real time RTPCR are listed in Table 5.1 along with 
Light Cycler conditions.  Real time RTPCR for the listed genes were carried out in 
RTPCR buffer (20mM Tris-Cl, pH 8.4 at 25°C, 4mM MgCl2, 250 µg/ml bovine serum 
albumin, and 200 µM deoxynucleotides) containing SYBR green (1:84,000 dilution), 
0.05unit/µl Taq DNA polymerase, and Taq Start antibody (1:100 dilution) as described 
previously (24).  
 
Table 5.1 Primer pairs and Lightcycler conditions for Real Time RTPCR 
Accession # Gene Primers (5’-3’) bp LightCycler Conditions 
NM_009820 Runx2 Fw GACAGAAGCTTGATGACTCTAAACC 171 7 sec;  62ºC 
  Rv TCTGTAATCTGACTCTGTCCTTGT  9 sec; 72ºC 
NM_007554 BMP4 Fw CTGCGGGACTTCGAGGCGACACTTCT 150 7 sec; 65ºC 
  Rv TCTTCCTCCTCCTCCTCCCCAGACTG  7 sec; 72ºC 
NM_011199 PTHR1 Fw GCACACAGCAGCCAACATAA 531 7 sec at 63ºC 
  Rv CGCAGCCTAAACGACAGGAA  22 sec at 72ºC 
NM_012050 OMD Fw GACGGGCTGGTGAATGTGACTATGCTTGA 147 7 sec; 63ºC 
  Rv CCAAGGGGCATTGATTCTAATCTGTTATT  10 sec; 72ºC 
 
 
Statistical analysis—Data are expressed as mean + SEM with n numbers representing 
biological replicates from independently repeated experiments.  Statistical analysis was 
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performed using the Student's t-test for ALP enzyme activity experiments. A significance 
level of p<0.05 was considered statistically significant.  The microarray data was 
analyzed with dChip, a program based on the Model-Based Expression Index (MBEI) 
method (14, 15).  The raw data were normalized using the invariant set normalization, 
and the average expression values were represented as model-based expression 
indices. We used the ‘PM only model’, and the expression values were expressed in 
log2 scale. Differential gene expression between two groups of samples was analyzed 
by the t-test built in dChip.  
Results 
 
The RWV inhibited ALP activity. 
Expression of ALP increases as osteoblasts mature and differentiate, and its 
enzyme activity is often used as a marker for bone formation.  Thus, we examined the 
effects of the RWV on ALP enzyme activity in 2T3 preosteoblasts.  Exposure of 2T3 
cells to the RWV for three days significantly decreased ALP activity (Figure 5.2A) and 
mRNA (Figure 5.2B) in comparison to static 1g controls.  This finding, which is 
consistent to our previously reported data with the RPM (19), suggests that the 
simulated microgravity or disuse conditions induced by either the RWV or the RPM 
result in a similar inhibitory effect on osteoblast differentiation.   
 
The RWV altered gene expression profiles of 2T3 cells.     
DNA microarray studies were performed on samples obtained from 2T3 cells 














































































































Figure 5.2 RWV exposure inhibited alkaline phosphatase activity and mRNA 
expression in 2T3 cells.  Confluent 2T3 cells grown on microcarriers were placed in 
the RWV or exposed to static 1g conditions for three days.  ALP activity (A) was 
determined by a colorimetric assay and normalized to total protein, and ALP mRNA 
level (B) was determined by real time RTPCR with 18S as an internal control.  Data 








































Upregulated = 45 genes





































Figure 5.3 The effects of the RWV on gene expression profiles of 2T3 cells.
Total RNA was isolated from 2T3 cells exposed to RWV or static 1g control conditions
for three days. The samples were reverse transcribed and analyzed by Affymetrix 
microarrays corresponding to 40,000 mouse genes.  The scatter plot shows mean 
intensities of each gene probe using the data obtained from all microarrays. 
Statistical analysis identified 61 genes upregulated (red dots) and 45 genes 
downregulated (green dots) by more than two-fold compared to static 1g control 
(p<0.05, n=3 each static 1g and RWV).  Unchanged genes are shown in black along 
the diagonal line in the scatter plot.    99
tested by the Affymetrix array, 61 were downregulated while 45 were upregulated 
statistically significantly (p<0.05) by more than two-fold above the static 1g control as 
shown in a scatter plot of the genes (Figure 5.3).  In Figure 5.3, dots aligned with the 
diagonal line represent unchanged genes while genes further from the line were either 
upregulated (above line) or downregulated (below line) by the RWV.  Additionally, Table 
5.2 provides a list of significantly changed genes from the microarray that may be 
implicated in bone formation or mineralization as determined by literature survey, and 
these genes are organized by fold change with molecular function as defined by 
GoMiner.  Table A.1 shows a larger subset of mechanosensitive genes organized by 
biological process.  Table A.2 lists genes that may be involved in osteoblast function with 
relaxed p-value stringency.  The entire RWV array data can be accessed from Gene 
Expression Omnibus (GEO) with accession number GSE4658.  The RPM microarray 
data that we previously published can be accessed with numbers GDS928 or GSE1367 
(19).   
 
Quantitative real time RTPCR and immunoblotting validated the microarray data 
for select osteogenic genes. 
To confirm our microarray data, we performed real time RTPCR and immunoblot 
analyses for a select subset of genes that may be implicated in bone formation.  The 
same samples that were used for the microarrays were used for the real time RTPCR, 
and additional RWV experiments were performed to obtain protein samples for the 
Western blots.  The 2T3 cells exposed to the RWV had decreased expression of runx2, 
bone morphogenic protein 4 (BMP4), parathyroid hormone receptor 1 (PTHR1), and 
OMD genes by a fold change of 0.69, 0.40, 0.54, and 0.10, respectively, as evaluated by 
the Affymetrix microarray.  The gene expression fold changes by real time PCR for 
runx2, BMP4, PTHR1, and OMD, were 0.38, 0.26, 0.59, and 0.10, respectively (Figure  
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Table 5.2 The effect of the RWV on selected genes that may be involved in 
osteoblast differentiation and matrix mineralization. Genes are sorted based on 
fold changes.   
Accession 
# Gene Name *Fold ∆ p-value Molecular Function 
NM_012050 osteomodulin 0.10 <0.05 also called osteoadherin, may mediate cell attachment 
NM_008760 osteoglycin 0.23 <0.05 
binds to TGF-beta, no GAG in 
bone, keratan sulfate in other 
tissues 
NM_025711 asporin 0.28 <0.05 porin activity; cartilage extracellular protein 
BC002065 serine (or cysteine) proteinase inhibitor, clade A, member 3G 0.35 <0.05 
may be involved in osteoclast 
function with MMPs and 
cathepsins 
NM_007729 procollagen, type XI, alpha 1 0.37 <0.05 present in cartilage 
NM_011581 thrombospondin 2 0.39 <0.025 involved in cell attachment 
NM_016873 WNT1 inducible signaling pathway protein 2 0.39 <0.05 
involved in WNT pathway, WNT 
stimulated by BMPs 
BB781435 nidogen 2 0.39 <0.005 calcium binding 
NM_007554 bone morphogenetic protein 4 0.40 <0.0025 growth factor and cytokine activity 
NM_011693 vascular cell adhesion molecule 1 0.41 <0.025 cell adhesion molecule activity 
NM_012043 
immunoglobulin superfamily 
containing leucine rich repeat  
(ISLR) 
0.42 <0.05 involved in cell attachment 
NM_009144 secreted frizzled-related sequence protein 2 0.43 <0.05 
WNT signaling pathway 
antagonist 
BB431535 matrix metalloproteinase 16 0.47 <0.05 involved in osteoclast function and bone resorption 
BC014690 transforming growth factor, beta 3 0.59 <0.05 
growth factor and cytokine 
activity 
AF053954** cbfa1/runx2 (osf2) 0.69 >0.05 
essential transcription factor for 
osteoblast differentiation and 
bone formation 
NM_008216 hyaluronan synthase 2 0.74 <0.05 
with versican-like protein works 
to captures space destined to 
become bone 
NM_007833 decorin 0.76 <0.025 binds to collagen and may regulate fibril diameter 
NM_007431 alkaline phosphatase 2, liver 0.82 <0.05 
essential for hydroxyapatite 
formation and matrix 
mineralization 
BG092290 insulin-like growth factor 2 receptor 1.43 <0.025 
signal transduction and hormone 
activity 
NM_020275 tumor necrosis factor receptor superfamily, member 10b 1.43 <0.05 
growth factor and cytokine 
activity 
NM_010554 interleukin 1α 1.58 <0.05 potent stimulators of bone resorption 
BM935811 integrin α6 2.47 <0.05 cell adhesion molecule 




































































































































































































































































































































































































































Figure 5.4  Verification of microarray results by real time PCR and immunoblot. 
Aliquots of total RNA used for the microarray studies (n=3) were used for real time 
RTPCR for runx2 (A), BMP4 (B), PTHR1 (C), and OMD (D) using 18S rRNA as an 
internal control.  Additional experiments were performed to obtain cell lysate for 
immunoblots for BMP4 (F), PRXIV (G), OGN (H), and PRXI (I) using actin as an 
internal control.   Also shown is the comparison of the microarray fold changes to the 
real time RTPCR (E) or immunoblot results (J). Data are shown as mean±SEM (n≥3, 
* p< 0.05). 
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5.4 A-E).  Additionally, we confirmed the expression of downregulated genes BMP4, 
peroxiredoxin IV (PRXIV), and osteoglycin (OGN) and upregulated gene peroxiredoxin I 
(PRXI) by immunoblotting.  The Affymetrix fold changes for BMP4, PRXIV, OGN, and 
PRXI were 0.40, 0.66, 0.23, and 1.23.  We showed that the fold changes for the proteins 
by Western blot were 0.59, 0.68, 0.32, and 1.58, respectively (Figure 5.4 F-J).  The 
different methodologies used, the microarray assay, real time RTPCR, and 
immunoblotting, produced highly consistent results, providing a level of assurance 
regarding the validity of the microarray data.     
 
Comparison of the RPM and RWV microarrays revealed 17 genes that changed in 
the same direction. 
There was a subset of genes that demonstrated similar expression changes 
when exposed to simulated microgravity or disuse using either the RPM or RWV.  Table 
5.3 displays the genes that changed statistically significantly with p<0.05, showing 16 
downregulated genes and 1 upregulated gene in this group.  Table 5.3 organizes the 
significant genes by biological process as defined by GoMiner and associates each gene 
with a molecular function, if known.   
 
Comparison of the RWV and RPM microarrays to a mechanical loading microarray 
showed that three genes changed in opposite directions between disuse and 
mechanical loading. 
Recently, Xing, et al. published microarray data on mouse tibiae that were 
mechanically loaded (29).  Briefly, they loaded mice in a four point bending mechanical 
loading device for four days, and total RNA was obtained from the region of the 
mechanically stimulated tibia.  The untreated tibiae of the same mice were used as 
unloaded controls, and a 22,000 gene Agilent Technologies microarray was utilized for  
 103
Table 5.3 A list of statistically significant common genes sensitive to disuse in 2T3 
cells using both the RWV and the RPM.  Genes are sorted based on typical 
biological process (p<0.05).   
Accession # Gene Name *Fold ∆ RWV 
#Fold ∆ 
RPM Molecular Function 
Cell Adhesion     
NM_012050 osteomodulin  0.10 0.18 aka osteoadherin, may mediate cell attachment 
NM_007729 procollagen, type XI, alpha 1 0.37 0.29 extracellular matrix structural constituent 
NM_012043 
immunoglobulin superfamily 
containing leucine rich 
repeat  
0.18 0.42 involved in cell attachment 
AK004179 platelet-derived growth factor receptor-like  0.45 0.52 
involved in cell attachment and 
possibly cell proliferation 
Cell Cycle     
NM_011817 growth arrest and DNA damage inducible, gamma  0.40 0.49 
structural constituent of 
ribosome 
Development     
NM_009144 secreted frizzled-related sequence protein 2  0.43 0.41 
transmembrane receptor and 
signal transduction activity 
Regulation of 
Cell Growth     
NM_030127 serine protease  0.74 0.22 serine-type endopeptidase activity 
NM_008760 osteoglycin  0.23 0.38 growth factor activity 
Protein 
Biosynthesis     
NM_026631 nucleolar protein family A, member 2  1.69 2.04 
RNA binding; structural 
constituent of ribosome 




family 2  
0.27 0.43 protein binding 
Cell 
Differentiation     
NM_025711 asporin  0.15 0.28 porin activity; cartilage extracellular protein 
Metabolism     
NM_007934 glutamyl aminopeptidase  0.40 0.35 aminopeptidase activity 
%NM_007431 alkaline phosphatase 2, liver 0.82 0.21 
essential for hydroxyapatite 
formation and matrix 
mineralization 
Skeletal 
Development     
NM_054077 proline arginine rich end leucine rich repeat  0.43 0.45 
extracellular matrix structural 
constituent 
%AF053954 cbfa1/runx2 (osf2) 0.69 0.53 
essential transcription factor for 
osteoblast differentiation and 
bone formation 
%NM_011199 parathyroid hormone 
receptor 1 0.54 0.20 
transmembrane receptor activity 
Unknown     
NM_021355 fibromodulin 0.45 0.45 unknown 
*Fold= RWV/static 1g 
#Fold=RPM/static 1g 
%p<0.05 and/or fold change>2.0 as shown by RTPCR  
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the gene expression studies.  We compared the RPM and RWV microarrays to their 
published data and found that three genes changed in opposite directions with p<0.05.  
Table 5.4 lists the three genes that were upregulated in mouse tibiae by mechanical 
loading and were downregulated in cells exposed to disuse.  Since the experimental 
sample sizes (n=3 each) were relatively small, we also evaluated which genes changed 
commonly in both simulators and opposite to mechanical loading with less stringent p-
value cutoffs (p<0.1).  Under this non-stringent condition, we found that there were an 




Table 5.4 Comparison of gene expression changes among RWV, RPM, and 
mechanical load microarrays.  Sorted by biological process.   















 in vivo 
Molecular 
Function 
Cell Growth & 
Differentiation         
AK014259 osteoglycin 0.22 p<0.05 0.38 p<0.005 2.47 p<0.005 binds to TGF-Beta 














0.45 p<0.005 0.52 p<0.05 2.18 p<0.005 receptor activity 
#RPM data previously published (19) 
*in vivo refers to mechanical loading data previously published (29) 
 
Discussion 
We have previously shown that exposure of 2T3 cells grown in Opticell disks to 
the RPM inhibits ALP activity while gene transcript studies scanning 10,000 mouse 
genes produced a list of 52 upregulated and 88 downregulated genes altered by more 
than two-fold compared to the static 1g control (19).  Here, we used a distinct approach 
to expose 2T3 cells to simulated microgravity using the RWV, which maintains the cells 
in continuous free-fall in culture medium, mimicking a disuse condition.  The RWV is a 
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bioreactor developed by NASA and most commonly used in the United States (17, 21, 
22).  In contrast, the RPM has been developed by the Japanese and the European 
Space Agency and is used mostly by scientists outside of the United States, with the 
exception of our group (4, 6, 19).  Unlike the RPM system where the cells were attached 
to OptiCell membranes and exposed to disuse conditions, the RWV does not have a 
similar platform and adherent cells have to be grown on microcarriers for exposure to the 
RWV.  Given the need for validated ground-based microgravity simulators, it is 
imperative that these simulators be compared not only to each other but also to other in 
vivo mechanical loading and unloading systems. 
To compare the results of the RWV to those published with the RPM, we aimed 
to feasibly match the conditions between the two experiments.  Most importantly, we 
found that exposure of 2T3 cells to either the RPM or RWV produced a similar inhibitory 
effect on ALP enzyme activity.   These results suggest that the RPM and RWV inhibit 
cell differentiation of preosteoblasts, a finding that is consistent with the expected 
disuse- or microgravity-induced decrease in bone mass.  
Previously, it has been controversial whether the RWV decreased or increased 
ALP activity, but this may be due to a difference of whether the cells were grown as 
attached or suspended cultures.  In one study, Rucci, et al. found that ALP activity and 
mRNA expression increased when exposed to the RWV for two days using a rat 
osteoblast-like cell line that was grown as aggregate suspension (21).  In contrast, 
Klement, et al. showed that exposure to the RWV for up to 14 days blunted ALP activity 
and bone matrix mineralization of mouse embryonic pre-metatarsal tissue explants (10).   
It should be noted that in the Klement et al. study, the cells comprising the bone explants 
were still attached to the extracellular matrix within the embryonic bone tissues.  
Similarly, in our current RWV and the previous RPM study, preosteoblasts were grown 
as adherent cells either on microcarriers or on the OptiCell membranes before and 
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during exposure to the simulators.  These results suggest that the inhibitory effect of the 
RWV and RPM on the osteoblast function requires bone cells grown in adherent 
conditions during exposure to simulated microgravity or disuse conditions.  Additionally, 
our finding partially validates and supports the use of ground-based simulators to study 
disuse- or microgravity-induced changes in bone cell biology and pathology. 
We also performed gene microarray analysis to determine changes in gene 
expression profiles of the preosteoblasts and compared the results to our published 
findings with the RPM.  We found that 17 genes changed in the same manner, and 
many of these genes are involved in skeletal remodeling.  For example, we confirmed 
expression levels of runx2, which was downregulated by approximately 1.5-fold, and is 
believed to be a “master gene” that plays a critical role in the formation of the skeleton.  
When runx2 is genetically knocked out in a mouse model, there is a complete lack of 
skeleton formation (8, 11).  Additionally, we confirmed the downregulation of PTHR1 
levels by the RWV.  A decrease in parathyroid hormone related protein, which plays a 
role in calcium mobilization, has been linked to decreases in bone density and 
subsequent bone loss in space-flown rats (26).  OMD belongs to the SLRP family and 
may be involved in bone matrix formation (2), and simulated microgravity- or disuse-
induced decrease in OMD is consistent with our hypothesis.   
Furthermore, we confirmed the downregulated expression levels of BMP4, which 
is involved in skeleton development, including cartilage formation and various joint 
developments (27, 28).   Moreover, oxidative stress is involved in the etiology of various 
pathologies, and oxidants are produced under physiological conditions during 
phagocytosis by macrophages, mitochondrial electron transport, and bone resorption by 
osteoclasts (13).   Bone resorption is known to increase beyond normal physiological 
levels in spaceflight (23), potentially increasing the levels of oxidative stress in the 
human body.  Peroxiredoxins are a family of antioxidants that are often made by cells in 
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response to oxidant production.  It has been found that PRXI is upregulated during bone 
cell differentiation (9, 13).  We found that PRXI protein level was upregulated while 
PRXIV protein was downregulated by the RWV, corroborating with gene expression data 
from the microarray.  These peroxiredoxins may play a differential role in the cells 
attempting to compensate for changes in oxidative state.   
To further investigate the functional significance of the disuse-associated 
changes in gene expression, we compared our microarray results to independently 
published data from mechanically loaded tibiae in a mouse model (29).  When we 
compared their gene expression results to those of the RPM and RWV microarrays, we 
found three genes that were upregulated by mechanical loading and were contrastingly 
downregulated by disuse conditions.  Also, when less stringent statistical p-values were 
applied, we found 13 additional genes displaying the same trends.  For example, OGN 
was downregulated by the RPM and RWV but upregulated by mechanical loading.  OGN 
is a small leucine-rich proteoglycan found in the extracellular matrix of bone, and 
knockout mice for this gene display collagen fibril diameter abnormalities (25).  These 
comparisons suggest that a subset of the genes in 2T3 cells are mechanosensitive and 
may be implicated in microgravity- or disuse-induced decreased bone mass.  
Microgravity occurring during spaceflight is characterized as an environment in which the 
human body is no longer loaded as on Earth, and disuse due to long term illness or 
paraplegia dramatically reduces the normal loading on the body.  Therefore, it is 
interesting that many genes that are changed by increased mechanical loading are also 
changed in the opposite direction by “unloading”.   
The widely accepted model of animal-based simulated microgravity or disuse is 
the rodent hindlimb unloading (HLU) experiment.  To date, there has not been a large 
scale gene expression study performed from bones of animals exposed to HLU.  
However, there have been a few small scale studies investigating specific gene 
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expression.  After four days of HLU using BALB mice, two independent studies found 
decreases in type I collagen, osteonectin, osterix, and matrix metalloproteinase 2 
(MMP2) (7, 32).  However, in both the RWV and RPM, the expression levels of these 
genes did not reach statistical significance but did show a trend towards decreased 
expression.     Additionally, Judex et al. found no change in cathepsin K (ctsk) due to 
HLU exposure while the RPM increased it and the RWV did not alter it.  As well, Judex 
et al. showed no change in runx2, which was decreased by both the RWV and RPM (7).  
Moreover, Zhong, et al. showed that ALP expression decreased with HLU exposure, 
corroborating with the RWV and RPM results (32).  Recently, Hughes-Fulford, et al. 
examined the effects of spaceflight microgravity with or without a centrifugal 1g field 
intervention on the expression of 24 genes in MC3T3-E1 preosteoblasts (5).  In this 
study, there was a significant reduction in expression of genes such as cyclooxygenase 
2 (cox-2), transforming growth factor beta 1 (TGFβ1), fibroblast growth factor 2 (fgf-2), 
and osteocalcin (OCN) with exposure to spaceflight microgravity (5).  In comparison, 
TGFβ1 expression was downregulated by the RWV, comparable to spaceflight, but it 
was upregulated by the RPM.  Additionally, prostaglandin E1 (EP1) was not altered in 
spaceflight, corroborating with the RPM data, but the RWV upregulated its expression.  
Furthermore, spaceflight did not alter cyclin A, cyclin E, actin, or fibronectin, which 
correlates to both the RWV and RPM microarray data.   Our detailed large scale gene 
expression studies and comparisons may allow investigators the information needed to 
select specific genes on which to focus, potentially narrowing the pool of therapeutic 
targets for bone loss.   
In conclusion, we have shown that the two different simulators of microgravity or 
disuse conditions produce similar results with regard to bone cell differentiation and 
osteoblast function.  We have shown that both simulators reproduce a decreased bone 
formation response as also seen in spaceflight.  Furthermore, we have compiled a short 
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list of genes that change in response to the two different types of disuse conditions and 
to mechanical loading, which may serve as specific targets for interventions to prevent 
decreased bone mass in spaceflight, disuse, or osteoporosis.   
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Bone Adaptation to the Mechanical Environment:       
High vs. Low Impact Loading 
 
“Every change in the form and function of bone or of their function alone is followed 
by certain definite changes in their internal architecture and equally definite alteration 
in their external conformation, in accordance with mathematical laws.” 
—J. Wolff, 1892 (38) 
 
Summary 
From specific aims 1 and 2, we showed that mechanical unloading altered 
cellular and molecular responses in osteoblasts.  We established an in vitro model 
system to study disuse and provided a relatively short list of genes that may be 
significant in bone loss pathologies.  In specific aim 3, it is our goal to both to 
expound the mechanism driving in vivo bone adaptation to extremely low magnitude 
and high frequency (LMHF) mechanical loading and explore its use as a novel 
countermeasure device for bone loss in spaceflight.  In the next two chapters, we 
provide background on bone adaptation at the macroscopic and microscopic levels 
to support specific aim 3, which will be discussed in Chapter 8.   
High impact mechanical stimulation such as exercise is often classically 
regarded as an anabolic signal to instigate bone remodeling.  The theory that normal 
bone adapts to its mechanical environment dates back to Julius Wolff (1892), who 
was the first to suggest that stress imparted to bone impacted its architecture (38).  
Harold Frost (1987) elucidated the role of a mechanical stimulus to bone (8, 10) by 
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defining a minimum effective strain that was required from the stimulus in order to 
stimulate bone adaptation.  Frost defined the mechanostat as the biological 
machinery that determines bone strength (7).  In this chapter, we review bone 
adaptation to alterations in mechanical loading at the macroscopic level, focusing on 
the impact of exercise versus externally applied LMHF loading.   
General Bone Adaptation 
 One of the primary functions of bone is providing mechanical integrity for both 
protection and locomotion.  Bone adaptation is the inherent change in bone mass 
and architecture in response to strain induced by mechanical loads.  Three rules 
govern bone adaptation as follows: 1) adaptation is driven by a dynamic stimulus, 2) 
adaptation requires only a relatively short duration of loading, and 3) bone cells 
become accustomed to routine mechanical loading (35).  The response of bone to 
loading or unloading is dependent on both genetic and epigenetic factors.  While 
genetics outlines the general shape, length, and architecture, changes in mechanical 
environment elicit adaptive responses.  According to Wolff’s law, bone architecture is 
defined by mathematical laws, which state that thickness, number, and distribution of 
trabeculae must correspond to distribution of mechanical stresses, and the 
trabeculae should be loaded axially in compression and tension (35, 38).  It was later 
elucidated that strain resulting from mechanical stress itself could cause adaptive 
responses, and Frost defined a minimum effective strain that had be induced to 
instigate such a response (9).  Additionally, it was shown that bone responded to 
dynamic and not static strain (29).  These findings regarding bone adaptation have 
been formed into mathematical laws, calculating that a strain stimulus is a function of 
both strain magnitude and frequency.  Since strain loading is dynamic, the strain 
stimulus can be defined using the Fourier method as shown in equation 6.1: 
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where E=strain stimulus, k=proportionality constant, ε=peak to peak strain magn
and f=frequency.  This equation is critical in bone adaptation because it dictates
a static load would not cause a response since f = 0 and that adaptatio
proportional to strain magnitude.  However, it should be noted that this m
predicts a linear relationship between strain magnitude and frequency, and it is
known that biology seldom encompasses precise linearity.   
Strain is defined as a change in length relative to the object’s original le
and it is widely accepted that strain is a means by which a mechanical for
translated into a signal that can be recognized by the mechanotransdu
machinery of the body (22).  Both the intensity and duration of the load play c
roles in defining adaptation to mechanical deformation.  To avoid failure, the ap
load must not induce strain beyond the bone tissue yield, and this level has 
measured to be over 0.7% or 7000 microstrain (µε) (22).  To determine funct
strain levels in bone, strain gauges have been inserted in vivo in a host of anim
including dog, pig, turkey, sheep, and horse, and strain was measured d
physical activity such as galloping or trotting.  Remarkably, regardless of size
maximum peak strain was measured to be within the range of 2000-3000 µε f
animals, and this species-independent uniform peak strain is a concept c
dynamic strain similarity (DSS) (29).  DSS states that peak functional stra





















of 2-3 between functional and yield strain such that activity elicits a specific strain 
level to bone tissue for homeostatic skeletal response (29).  It is possible that the 
peak strain magnitude is similar in animals of disparate size because larger animals 
have evolved such that weight-related axial stress in the bone is decreased during 
movement at the expense of decreased agility.  For example, a fish can rapidly swim 
and immediately change course of direction more simply than an elephant (29).  For 
humans, a strain of 3000 µε for a femur of approximate length of 45 cm (17.7 in) 
elicits a change in length on the order of magnitude of 1 mm (~0.039 in).  If bone 
cells are responsible for sensing and responding to this strain, which would only be 
on the order of angstroms relative to the length of a cell, the mechansensory system 
must be extremely sensitive to generate an adequate adaptive reaction.   
 In mechanical testing of bone, diverse loading conditions have been used to 
assess bone properties.  Previous studies have shown that in cortical bone tissue, 
application of 2000 µε at a frequency of 0.5 Hz maintained bone mass (31, 33).  
According to equation 1, a similar response should be observed if the frequency was 
increased to 10 Hz and strain decreased to 100 µε.  This trend bound by equation 
6.1 was observed experimentally when the frequency was increased to 1 Hz and 
only a strain of 1000 µε was needed to maintain bone mass.  Further, at a frequency 
of 30 Hz, only 70 µε was needed to inhibit bone resorption (32, 33).   Thus, bone 
response to mechanical signals seems to correlate to increased frequency, meaning 
smaller strains induced by a lower force applied more frequently is ample to 
stimulate bone formation and maintain bone mass.     
 Bone adaptation occurs at both the macroscopic and microscopic levels, 
altering bone mass and architecture to maintain mechanical integrity for posture 
control and movement.  It has been well accepted that high impact activity improves 
skeletal mass while disuse impedes it.  It is also well known that muscle strength 
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greatly impacts bone health as muscles constantly strain bone, causing adaptive 
responses within them.  In the following sections, we review the accumulating 
evidence that exercise and muscle contraction both benefit the musculoskeletal 
system, despite delivering disparate signals to bone.   
Exercise: High Magnitude and Low Frequency 
Osteopenia is a condition of decreased bone mass, and when bone mass 
has reduced to the point of fracture risk, the condition is called osteoporosis.  It is 
clear that there is an abundance of data suggesting that exercise promotes skeletal 
benefits, and the variation among studies is partially due to the type of exercise 
tested, patient population, and data analysis.  However, there remains a common 
conclusion in the vast majority of studies that exercise provides skeletal benefit, 
albeit sometimes site-specific.     
Exercise or physical activity beyond normal, daily routine exists in copious 
forms and induces distinct loads on the body.  For instance, walking imposes a load 
of 1g (1 times body weight) while running increases the load to 3-4g, and jumping 
hurdles further augments the loading to 5g (21).  Exercise can be regarded as a high 
magnitude (greater than 1g) and low frequency (1-2 Hz) impact.  The benefits of 
exercise have been inexorably tested, documented, and relayed to the general public, 
and it has been shown to increase bone and muscle mass (11, 34, 36).  The last two 
decades have provided insight into exercise intervention trials in the normal 
population, beyond that of comparing elite athletes to sedentary controls.  The 
exercise regimes in these experiments ranged from aerobic versus stretching control 
to high weight and low repetition resistance weight training versus low weight and 
high repetition weight training.  Subjects varied within a gamut of ages from a young 
10 years to post-menopausal women over 50 years old.  Studies continued for at 
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least eight months and used bone mineral density (BMD) as a marker of skeletal 
improvement.   
In one study involving young women ages 20-35, researchers investigated 
the use of exercise and calcium supplementation on peak bone mass.  These 
women were divided into an exercise group consisting of weight training combined 
with aerobic activity or a stretching control group.  After two years of exercise or 
control, there was a significant increase in BMD in the spine, femoral neck and 
trochanter, and calcaneus due to exercise, but calcium supplementation did not 
improve BMD in any tested location (5).  In another study with post-menopausal 
women, researchers explored the effects of resistance training (high load, low 
repetitions) versus endurance training (low load, high repetitions) on bone mass in 
the forearm and hip.  After one year of exercise intercession, there were significant 
increases in BMD at the femoral trochanter in the hip and the distal radius of the arm 
with resistance training while endurance training only improved mid-radius BMD.   
Using the one repeat maximum (1-RM) method, the researchers also found that 
muscle strength increased in both groups.  The study concluded that the peak load 
was more important than the number of repetition cycles to increase bone mass in 
early post-menopausal women (18).  In another study of pre-menopausal women 
(age range of 28-39 years), subjects were assigned to exercise or non-exercise 
control groups and monitored for 1.5 years.  The exercise group showed an increase 
in femur trochanter BMD by one year but no change in total, arm, or leg BMD 
compared to control.  In addition, they used the 1-RM method to evaluate muscle 
strength and found a 58% increase in the exercise group when compared to baseline 
and no increase in the control group (20).    
However, not all studies have reported increases in BMD at the femur, a site 
at which many fractures occur in osteoporotic patients.  One study explored whether 
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aerobic or weight training benefited the skeletal system in young college-aged 
women (mean age 19.9 years) over an eight month period.  They found increases in 
spine lumbar BMD in both running and weight training groups compared to a non-
exercise control group but no significant changes at the hip (34).    In another study 
evaluating the effects of jumping in pre- and post-menopausal women, the subjects 
were assigned to perform 50 vertical jumps for six times per week.  Mechanical loads 
induced to the joints were measured by ground reaction forces, amounting to 
3g/jump for pre-menopausal women and 4g/jump for post-menopausal subjects.  
After five months, there was a 2.8% increase in BMD at the femur in the pre-
menopausal group but no change in the post-menopausal women after one year or 
1.5 years (2).  Thus, there was a clear benefit for younger women but not older, post-
menopausal subjects.   
It is clear that there is an abundance of data suggesting that exercise 
promotes skeletal benefits, and the variation among the studies is probably partially 
due to the type of exercise tested.  These discrepancies allow for appreciation of the 
complex nature of mechanical loading and subsequent bone adaptation.  For 
example, during jumping, there is loading due to absorption of the impact as well as 
muscle-generated forces applied to the bone.  In gymnasts, dismounting from the 
parallel bars stimulates an immense load amounting to approximately 11g, which 
partially expounds why gymnasts encompass a hip BMD greater than other athletes 
(21, 23).  However, in the Bassey study, jumping applied no more than 4g reaction 
forces to the joints of the subjects, equivalent to forces from running (2).  Running 
has been generally shown to not improve femur BMD, and thus, in this study, the 
pre-menopausal women probably achieved increased femoral BMD because of 
strain induced by muscle-derived tension to the bone rather than impact (21).     
However, with the complexity of mechanical loading and bone adaptation, there is 
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most likely a host of other reasons as to why lower impact did not improve BMD in 
older women but did in younger women.  We can only surmise conclusions from the 
clinical data available and continue to investigate other treatment options for bone 
loss.  
It is generally well accepted that the growing skeleton is most likely to benefit 
from exercise as bone modeling and remodeling ensure optimal mechanical 
properties of bone, removing old, aged bone and replacing it with new, stronger bone.  
Exercise during childhood assists in the acquisition of bone as well as remodeling its 
architecture.  It has been shown that tennis players who began training during 
childhood had increased BMD, bone mineral content, and cortical wall thickness 
compared to players who began playing during adulthood (15).  Furthermore, a study 
investigating the effects of exercise on pre-pubertal young boys (mean age 10.4 
years) found that not only did the BMD of all boys increase over the course of the 
study as expected but also physical education intervention for eight months 
increased BMD twice that of controls in the exercise group.  The researchers 
concluded based on all parameters measured that exercise before puberty may 
increase femur volumetric BMD by increasing cortical thickness (3).     
Mounting data as summarized in Table 6.1 makes it quite lucid that exercise 
provides benefit to the musculoskeletal system, despite the variation among clinical 
trials.  There is currently no defined exercise regime that seems to be best suited for 
improving bone mass, and if the field of research can adequately compare premium 
exercise routines for various age groups, this would be beneficial to the general 
public.   
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Table 6.1 Summary of exercise studies  
uscle Contraction: Low Magnitude and High Frequency 
As humans age, the harsh effects of high impact exercise becomes a burden 
that the ailing mature skeleton can no longer efficiently tolerate.  While several 
factors dictate osteoporosis, the pathology is exacerbated by increased age, 
coinciding with decreased muscle strength and posture stability.  As ageing 
continues, there is a drastic degeneration in muscle strength (sarcopenia), leading to 
decreases in muscle-bone movement.  Thus, the elderly population is prone to 
accidental falls and subsequent injury, leading to bone fractures.  At each joint in the 
body, muscles apply forces to attached bones such that these signals are fired 
rapidly at low level movements that are imperceptible at the macroscopic level.  
Muscle contractions are constantly applied to the bone in everyday tasks such as 
maintaining posture while standing or sitting (25).  As muscle atrophies with age, 
LohmanIncrease in femur trochanter BMD in 1 yr 
but no change in total, arm, or leg BMD;
Increased muscle strength by 1-RM method





KerrIncrease in BMD at femoral trochanter and 
distal radius with resistance;
Increase in radius BMD in endurance;
Peak load more important than frequency
1 yr.Resistance (high load, 
low reps) and endurance 









Bassey2% increase in BMD at femur in pre-
menopausal but not post-menopausal 
group; Gymnasts 11g and have high hip 
BMD; Perhaps muscle-derived tension 
played larger role than impact 
50 vertical jumps 6X/week





Snow-HarterIncrease in spine lumbar BMD in both 
groups; no changes in femur at hip
Aerobic vs resistance 
training
Women, 20 yr, 
pre-menopausal
FriendlanderIncrease in BMD in spine, femoral neck and 
trochanter, calcaneus;







BradneyIncrease in BMD in all subjects;
2-fold further increase in exercise group
Regular P.E. class with 
various exercises






these signals to the skeleton also diminish.  The notion of stimulating bone formation 
or inhibiting bone resorption in patients with musculoskeletal diseases such as 
cerebral palsy (14, 37), osteopenia (33), and post-menopausal osteoporosis (24) 
with a low magnitude (0.1-0.4g) and high frequency (30-90Hz) mechanical load is a 
new, non-invasive treatment ideal for elderly patients or those with a disability that 
would inhibit them from high impact exercise.  It has been shown through animal and 
clinical trials that a LMHF mechanical stimulation is anabolic to bone (17, 24, 26-28, 
37).  Although not yet experimented in space, this potential osteoporosis 
countermeasure may provide benefit to the musculoskeletal system in a microgravity 
environment.   
While impact from exercise induces strain levels of 2000-3000 µε, muscle 
contractions inflict strains much lower in magnitude on the order of 10 µε.  With 
conventional thought, these strains would not be hypothesized to play a role in 
regulating bone adaptation, growth, or remodeling.  However, as discussed earlier, 
equation 6.1 demonstrates that a lower peak-to-peak strain fired more frequently 
could provide a strain stimulus capable of inducing an adaptive response.  Previous 
studies have been performed to log the strain history of bone in various animals, 
defining specific features such as peak magnitudes and frequencies over a specified 
time range (6).  It is classically thought that the peak strain magnitudes during high 
impact activities have the largest effect on bone response, leading to many strain 
gage analyses of bone centered on maximum strains (4, 19, 30).  These peak strains 
have been shown to be non-uniformly located over the cortex of the bone (30), 
meaning not all bone cells sense the same strain.  Moreover, these peak strains are 
only experienced for short periods of the day, leaving the majority of the strain history 
to be defined by other strain magnitudes.  In fact, in a turkey model, the maximum 
peak strain movements lasted for a total of 2 minutes/day, consisting of wing flaps or 
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body shakes.  However, turkey bones are still well adapted and strong enough to 
support flight, suggesting that other portions of the strain history must be involved in 
bone adaptation (1).    
The vast majority of the strain history of various animals encompasses low 
level st
nt contributor to the strain history 
recordi
rains from long periods of standing or sitting.  In fact, standing intervention for 
3 hours/day during bed rest prevented bone loss, suggesting that the effect of 
muscle contractions needed for postural stability aided in preventing bone loss (16).  
Studies performed in sheep showed that low magnitude strains were experienced 
frequently (Figure 6.1, left) in the range of 40 Hz (Figure 6.1, middle).  In another 
study examining the strain history in three distinct species, in vivo bone strains were 
recorded from the weight-bearing tibia of an adult dog, turkey, and sheep and non-
weight bearing ulna of turkey.    They found that over the course of 12-24 hours, the 
turkey ulnae had strains of 1000 µε once per day, 100 µε about 100 times/day, and 5 
µε thousands of times per day as seen in Figure 6.1 (right).  In the tibia, all three 
animals had one event of 1000 µε, more events at 100µε than the ulnae, and 
thousands of events at <10µε as depicted in Figure 6.1 (right).  Animals were 
videotaped to correlate the type of movement to points in the strain history, and 
walking induced the maximum strain from -1500 to 1000 µε in the turkey tibia at a 
frequency of 0.6 Hz but a continued strain history through 40 Hz.  Standing caused 
strains of ±10 µε at a frequency of 40 Hz (6).   
These studies show that a domina
ngs is non-vigorous activity, where muscle contraction is required during 
activities such as standing.  As such, the question is whether these low magnitude 
strains impact bone remodeling and adaptation.  Subsequent investigations have 
shown the utility of these low level signals in bone adaptation in a host of subjects, 
preventing or normalizing bone loss.  In growing BALB mice, 0.3g mechanical 
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Two minute clip of strain measurements 
in sheep showing frequent low 
magnitude strain signals
Strain measurements in the ulnae of turkey 
and the tibia of sheep, turkey, and dog 
showing large strain events occur less 
frequently than small strain events 
Five second clip of strain 
measurements converted and 
graphed to frequency of occurrence 
showing smaller strains occur at a 
rate on the order of 40Hz
Figure 6.1 Strain history recordings of various animals during normal daily 
activities.  These data show that low strain movements occur (left) in the frequency 
range of 40Hz (middle) more frequently than peak strain movements (right) (6).   
(Figure printed with permission from Journal of Biomechanics) 
  
loading at 45Hz induced strain oscillations of 10 µε on the periosteal surface of the 
tibia as measured by in vivo strain gages.  After treatment for three weeks for 15 
minutes/day, there was a decrease in osteoclast activity compared to age-matched 
controls while bone formation rates (BFR) in the trabecular bone and mid-diaphyseal 
cortical bone were unchanged (39).  However, BFR in the endocortical surface of the 
metaphysis was increased in this study (39) while cortical bone has also been shown 
to not respond to these signals in other studies (26) .  Total body mass, bone length, 
and matrix composition were not negatively altered by the LMHF load (39).  In 
another study, the left tibias of wildtype C57BL/6J mice were exposed to 0.3g or 0.6g 
loading at 45 Hz for 10 minutes/day while the right tibia acted as an internal control.  
Strain levels were as low as 3 µε, and after three weeks of 0.3g or 0.6g loading, 
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there was an increase in trabecular BFR in the metaphysis.  Bone morphology in the 
epiphysis was altered by increased cortical area and thickness (12).  Furthermore, 
the effects of LMHF loading on bone adaptation caused by disuse were investigated 
using the hindlimb unloading (HLU) model.  Adult BALB mice were exposed to 0.3g 
load at 45 Hz for 10 minutes/day for a total of four or 21 days.  There was a decrease 
in BFR due to HLU and an increase due to LMHF loading after 21 days treatment in 
both trabecular and cortical surfaces.  After four days, there were decreases in gene 
expression for several genes, including type 1 collagen, osterix, matrix 
metalloproteinase protein 2 (MMP2), and osteonectin due to HLU.  There was no 
change in expression at four days due to LMHF loading; however, after 21 days, 
there were increases in inducible nitric oxide synthase (iNOS), MMP2, receptor 
activator of the nuclear factor κB (RANKL), and type I collagen.  There were no 
changes due to HLU or LMHF loading in cathepsin K (ctsk), runt homology domain 
transcription factor 2 (cbfa1/runx2), or MMP9 gene expression after  four or 21 days 
(17).    
Studies involving LMHF loading then advanced to rat models, and in one 
study, adult rats were subjected to control, LMHF mechanical stimulation, disuse by 
HLU, HLU intervened by LMHF loading for 10 minutes/day, or HLU intervened with 
normal weight bearing for 10 minutes/day.  After 28 days, there was an increase in 
BFR in the proximal tibia with exposure to LMHF loading.  HLU inhibited BFR while 
intervention with normal weight bearing slightly increased BFR.  However, LMHF 
loading normalized BFR in the HLU group compared to age-matched controls (28).  
There have also been investigations in larger animal models such as turkey and 
sheep.  In one study, the hindlimbs of adult sheep were exposed to approximately 5 
µε induced by 0.3g loading for 20 minutes/day.  After one year of treatment, 
trabecular bone were evaluated with micro-computed tomography (µ-CT) and 
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mechanically tested.  Mechanical loading increased mineral content and trabecular 
number while trabecular spacing decreased, displaying increased trabecular quantity 
and thickening.  There was an increase in stiffness and mechanical strength in the 
longitudinal direction of weight bearing.  This study was critical because it showed 
that not only does LMHF loading increase bone mass but also the quality of the 
trabecular bone, and these effects were observed in a larger animal at a 
considerably longer time point than previous findings (27).   
While animal studies were imperative in moving toward testing this device in 
human
muscular signals were replaced by the LMHF loading device.   
s, the most critical information supporting the hypothesis that such low 
magnitude mechanical signals can induce bone mass and adaptation were obtained 
as studies advanced to humans.  LMHF mechanical loading has been shown to 
benefit various groups, including children with disabilities, young women with low 
bone mineral density (BMD), and post-menopausal women with osteoporosis.  In a 
pilot clinical trial, children with disabilities affecting muscular strength such as 
cerebral palsy and muscular dystrophy were treated with mechanical loading at 0.3g 
at 90 Hz for 10 minutes/day for 5 days/week for a total of six months.  There was a 
6.3% increase in tibia volumetric trabecular bone mineral density (vTBMD) with 
treatment compared to placebo control after brief exposure to LMHF loading, which 
was remarkable since compliance in this study was fairly low at 44% or about 4.4 
minutes/day of treatment.  However, there was no effect on vTBMD in the spine (37).  
The disabilities endured by these children results in poor muscular strength and 
limited mobility.  Therefore, it is possible that these physiological signals of muscle 
contraction to the bone are also diminished in these patients.  Since LMHF loading 
mimics the signals outputted by the musculature to the bone, it is possible that the 
children had increased BMD, at least in specific sites, because the diminished 
 128
There have also been clinical trials investigating the effects of LMHF loading 





There is overwhelming evidence that exercise creates large magnitude strain 
e tissue and bone cells, leading to increased bone mass and bone 
adapta
nd a history of at least one skeletal fracture were exposed to either control or 
treatment conditions for 10 minutes/day at 0.3g and 30 Hz for one year.  There was 
an increase in trabecular bone in the lumbar vertebrae and cortical bone of the femur 
midshaft compared to controls.  Moreover, there was an increase in muscle cross 
section area, and these beneficial results were dependent on compliance level (13).  
Furthermore, clinical trials in post-menopausal women have been performed, and in 
one study, treatment at 0.2g at 30 Hz for two 10 minutes/day treatments for one year 
increased BMD in the femur compared to placebo control.  The women in the 
placebo control group lost 2% BMD over the experimental time frame.  There was 
less bone loss in the spine in the treated group compared to controls, and these 
effects were dependent on compliance.  As such, those who complied with the 
treatment protocol most stringently had the greatest beneficial effects (24).   
Thus, LMHF mechanical loading as summarized in Table 6.2 has been 
shown to benefit the musculoskeletal system despite some variation among 
vice has recently been approved for treatment of osteoporosis, but long term 
studies will provide the most beneficial information as to its safety and efficacy in 
preventing or normalizing bone loss.   
sensed by bon
tion.  These large strains are on the order of 1000 µε and only represent a 
small part of the strain history of normal daily activities, such as when humans 
exercise or horses trot.  The larger portion of strain history is encompassed by  
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Table 6.2 Summary of LMHF studies 
 
 
GarmanBoth loads increased trabecular BFR in 
metaphysis; increase in cortical area and 
thickness of epiphysis




Ward6.3% increase in tibia volumetric BMD; no 
change in spine BMD
6 mos.0.3g, 90Hz, 10min/dayChildren with 
disabilities
RubinIncrease in mineral content and trabecular 
number, decrease in spacing, and 
increase in stiffness and strength
1 year0.3g, 20min/dayAdult sheep
GilsanzIncrease in trabecular bone BMD at 
lumbar spine, cortical bone of femur 
midshaft, and in muscle area





RubinIncrease in BMD in femur; less bone loss 
in spine
0.2g, 10Hz, two 10min/dayWomen, 
post-
Menopausal
JudexIncrease in trabecular and cortical bone 
surface area; after 4 days, decrease in 
genes due to disuse; after 21 days of 





extremely low signals on the order of 10 µε, and it has been shown that these signals 
hen applied at a high frequency induce an adaptive response.  However, while 
Length
XieDecrease in osteoclast activity; No 
change in BFR in trabecular bone and 
mid-diaphysis; Increase in BFR at 
microstrain
RefResultStimulationSubjects
3 weeks0.3g, 45Hz, 15 min/day, 10 BALB mice
w
systemic loading of an entire animal has shown beneficial effects of low magnitude 
mechanical loading, it is unknown whether bone cells can actually sense and 
respond in an anabolic manner.  Previous evidence suggests that bone cells would 
not be able to sense such low level strains.  In fact, stretch-activated channels, one 
potential mechanosensory molecule, have been shown to detect strains only as low 
as 30 µε (6).  Another potential path of mechanotransduction from the tissue to the 
cellular level is through fluid flow produced when bone is mechanically loaded in vivo 
during movement.  In some studies, it has been shown that shear stresses similar to 
in vivo levels can be produced when 1000-2000 µε is applied at 1-2 Hz or if 100-200 
µε is applied at 20-30Hz.  Thus, a 10 µε signal applied at 30 Hz would only amount 
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to stresses on the order of 0.1 dyn/cm2, still below the range of 6-30 dyn/cm2 known 
to induce intracellular calcium in vitro.  However, the modeled shear stress depends 
on many factors, such as the assumed canalicular annular space, which if reduced 
would increase the shear stress prediction (6).  Mechanical loading induces many 
changes and deformation to the tissue and cells that it is possible to construe the 
hypothesis that low level signals can be sensed by the skeletal system through the 
cellular network.  If this is true, it would be of further interest to determine how these 
signals, as low as they may be, are sensed and used to elicit a bone formation 
promoting or bone resorption inhibiting response.  Thus, it was our goal to expound 
this question by applying LMHF loading to an isolated osteoblast system as 
discussed in Chapter 8.   
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Bone Adaptation to the Mechanical Environment: 
Cell Signaling in Osteoblasts 
 
Summary 
The various bones of the skeleton are surrounded by a microenvironment 
controlled by local signals and systemic hormones, and the cells present in bone 
regulate homeostasis by maintaining the tightly regulated process of bone remodeling.  
In the previous chapter, we reviewed the macroscopic level of bone adaptation to 
changes in the mechanical environment, focusing on high and low impact loading.  Here, 
we delve into the microscopic level of cellular adaptation to alterations in mechanical 
loading conditions.  The human body is exposed to a multitude of forces and their 
resulting effects on the tissue and cellular structure, including mechanical strain 
magnitude and rate, pressure, fluid shear stress, compression, tension, and electric 
streaming currents.  The process by which the body senses these signals at various 
levels, either the whole body, organ, tissue, or cell, is still largely not understood.   
Bone adaptation occurs at the cellular level, where cells secrete a multitude of 
growth factors and cytokines, instigating cell signaling cascades leading to cell 
differentiation, osteoid formation, and mineralization in response to alterations in the 
mechanical environment.  In this chapter, we partially review bone cell adaptation by 
covering mechanotransduction and gravity, fluid flow-induced shear stress, and the bone 
morphogenic protein (BMP) signaling pathway.  It is known that the human body has 
adapted to the gravitational field of Earth, as observed in the vast number of changes 
instigated in the body by spaceflight.  Among these changes, bone loss remains one of 
the most critical pathologies hindering the expansion of human-based, long term 
missions.  In developing countermeasures for bone loss in astronauts, few studies have 
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elucidated the cellular and molecular changes impressed upon the skeletal 
microenvironment.  These changes could be essential in understanding general 
principles such as how cells sense mechanical signals, including gravity, and perhaps 
can lead to the development of more efficient methods to mitigate bone loss both in 
spaceflight and other bone pathologies.  Additionally, the cellular environment consists 
of various mechanical loads, including the resultant shear stress from interstitial fluid 
flow.  Mature osteoblasts that are responsible for maintaining the mineralized matrix are 
called osteocytes, which occupy spaces within the bone and are exposed to interstitial 
fluid flow and subsequent shear stress.  It is widely hypothesized that this shear stress 
acts as a signal to osteocytes, which stimulates inactive bone lining cells and 
preosteoblasts to begin the bone formation cascade (15, 20, 37).  With these various 
micro-signals, bone remodeling sustains a healthy balance between bone formation and 
bone resorption through a gamut of cellular control, including local feedback 
mechanisms, intracellular signaling cascades, and growth factor binding.  Perturbations 
to the bone remodeling cycle lead to an imbalance between bone formation and bone 
resorption, ultimately triggering skeletal pathologies.  Thus, bone loss occurs when bone 
resorption outweighs bone formation, as observed in osteoporosis, disuse, and 
spaceflight (6, 63, 67, 85).  Lastly, the bone morphogenic proteins (BMPs) comprise a 
portion of the factors cultivated by osteoblasts, directly influencing cell differentiation and 
proliferation as well as regulating osteoclastogenesis (9). In this chapter, we partially 
review osteoblast cell signaling as relevant to the broad picture of this research.  We 
include mechanotransduction and gravity, fluid shear-induced responses in osteoblasts, 
and the BMP signaling cascade as it relates to bone formation, including the 
downstream canonical smad pathway and the mitogen-activated protein kinase (MAPK) 
pathway. 
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General Mechanotransduction  
 Mechanotransduction is the intricate way in which individual cells comprising 
whole tissues and organs sense mechanical loads and convert the signals into useful 
biochemical information.  This biochemical information is required for seemingly simple 
commands such as wiggling a toe or daunting tasks such as preventing cancer.  
Mechanotransduction is still not completely understood, although many critical 
components have been implicated for their roles in sensing a signal and instigating 
subsequent pathways to induce a physiological response.  Among these identified 
mechansensory components are stretch-activated ion channels, integrins, cadherins, 
caveolae, growth factor receptors, cytoskeletal filaments, and the extracellular matrix 
(Figure 7.1) (31).  Figure 7.2 shows mechanisms by which some of these 
mechanosensors work such as stretch activated ion channels (A) altering their 
conformation and changing their opening and closing rate when the membrane is 
distorted or a channel that experiences tension from the cytoskeleton (B).  Also, Figure 
7.2 shows mechanotransduction through tension applied to enzymes (C) or other 
proteins (D) and the chemical potential of these proteins when under either compression 
or tension (E).  These mechanically sensitive cellular components can be activated by a 
host of signals, including external forces such as gravity, fluid flow-induced shear stress, 
and impact from exercise.  Many organs and tissues in the human body are 
mechanosensitive, including bone, cartilage, muscle, heart, and the gastrointestinal tract 
(32).  Mechanical signals play an essential role in maintaining homeostasis as observed 
in tissue degradation and atrophy due to disuse or microgravity.  For example, 
immobilization during bed rest or paralysis results in a large absence of mechanical 
stimulation such as walking, leading to acute and rapid bone and muscle loss (5, 68, 85).   
There have been common signaling molecules established to play roles in 
mechanotransduction by various cell types.  In general, integrins are one class of 
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Figure 7.1 Mediators of cellular mechanotransduction (31) 




Figure 7.2 Molecular mechanism of conversion from mechanical signal to
chemical information (31) 
(Figure printed with permission from FASEB Journal) 139
universal mechanoreceptors, and the interaction of integrins with the extracellular matrix 
mediates an increase in intracellular calcium (Ca2+) and subsequent activation of the 
MAPK pathway.  The MAPK cascade involves the activation of extracellular signaling-
regulated kinases 1/2 (ERK1/2) by phosphorylation and an ensuing activation of the 
activator protein 1 (AP-1) family of transcription factors.  This signaling cascade leads to 
pro-growth responses in a variety of cells (32).  In particular, the osteocyte, which is the 
mature bone cell responsible for bone maintenance and hypothesized bone 
mechanosensor, responds to mechanical signals by extracellular Ca2+ influx through 
stretch-activated ion channels, leading to increases in intracellular Ca2+ (32).    
Additionally, osteocytes are unique cells because they create long processes, which are 
believed to be their means of communication to other bone cells such as bone lining 
cells and osteoblasts.  As such, osteocytes use these cell-cell connections to transmit 
signals through gap junctions leading to biological responses.   
There have been detailed investigations performed to elucidate the pathways 
ensuing after a mechanical signal is detected, revealing individual molecules responsible 
for mediating specific responses.  Because of the breadth of detailed knowledge 
available, it is not the goal of this chapter to provide a comprehensive review of signaling 
pathways involved in skeletal maintenance.  However, we provide insight into key cell 
signaling pathways, including mechanotransduction and gravity, fluid flow-induced shear 
stress on bone formation, and the role of the BMP family in bone formation.   
 
Mechanotransduction and Gravity 
The structure-function relationship of bone has evolved over the course of human 
life, and it is well known since the time of Julius Wolff (1892) that bone adapts to its 
mechanical environment.  As such, it is no surprise that the skeleton has adapted to the 
gravitational field on Earth, and the launch of the space program in the 1960s confirmed 
 140
that the human body, when exposed to long term, near-zero gravitational impact, 
endures harsh biomedical alterations such as cardiovascular deconditioning and 
musculoskeletal atrophy (67, 76).  The unique environment of spaceflight most likely 
alters the skeleton at the whole organ, tissue, and cellular levels.  However, the details 
of such changes are only partially understood.  In particular, the mechanosensory 
machinery cells use to sense mechanical loading, such as gravity, is still largely 
unidentified.  Bone adaptation to changes in the mechanical environment depends at 
least partially on the transduction of mechanical signals to chemical information.  
It is fairly well understood how the human body perceives gravity to maintain 
orientation, and in most invertebrates and vertebrates, there is some type of specialized 
organ that allows maintenance of equilibrium with respect to gravity and movement.  In 
humans, the otolith organs called the utricle and saccule, which are located in the inner 
ear, are responsible for the perception of gravity and maintenance of balance.  Hair cells 
in the inner ear are activated by movement and transmit signals through nerve fibers to 
the brain, signifying changes in position, acceleration, and gravity.  As observed in 
spaceflight, there is an abrupt loss of constant linear acceleration due to gravity, and the 
otolith stimulus responsible for maintaining vertical orientation is removed, leading to 
abnormal spatial orientation and movement control.  These effects are diminished over 
time as the neurovestibular system adapts to microgravity, which results in the need for 
readaptation when astronauts return to Earth (8, 55).   
However, the question at hand is whether individual cells of various organs and 
tissues in the human body themselves sense gravity, leading to the pathologies induced 
by spaceflight such as site-specific rather than systemic loss of bone. For instance, it is 
reasonable to conjecture that without gravity, the body no longer walks as on Earth.  As 
such, there is no cyclic motion, which regulates the fluid movement in the skeletal 
system.  Without this ensuing oscillatory flow, there could be a lack of a bone formation 
 141
signal to the mechanosensing cell, leading to decreased bone formation and inevitable 
bone loss.  Likewise, it is reasonable to surmise that without a mechanical load as 
essential as gravity, there is a change in mechanotransduction, impeding the expression 
of signals imperative for genes regulating bone formation.  However, to test these 
hypotheses, we must have ways to study isolated cell systems in a microgravity system, 
and as spaceflight has become more sporadic, scientists have turned to simulators of 
microgravity.   
Much of what is known regarding how cells sense gravity has been studied in the 
plant cell.   Weight causes differential mass displacement, due to differences in masses 
among different organelles.  The cytoskeleton has traditionally been regarded as a 
mediator in the perception of gravity both in animals and plants (11, 29, 30, 62, 77).  In 
plants, the mechanism used to sense gravity is most likely through the movement of 
statoliths.  A statolith is a specialized form of an amyloplast, which are plant organelles 
responsible for storing and converting sugar into energy, found in the root tip cells called 
statocytes of higher order plants.  Statoliths are more dense than the cell cytoplasm and 
sediment with exposure to gravity, and they are entangled with the cytoskeleton actin 
filaments.  It is widely hypothesized that sedimentation of statoliths emanates a 
mechanosensory pathway leading to reorientation of the cytoskeleton and a cellular 
response such as turning of the root in response to a change in motion (27).   
Additionally, there has been research performed to understand whether there are 
temporal effects of plant responses to gravity.  The concept of perception time is the 
minimum duration of the stimulation interval necessary to induce gravitropic bending of 
the root.  Hejnowicz, et al. stated that the shortest stimulation time was one second, and, 
therefore, they assumed that the perception time is shorter than one second (27).  The 
notion of perception time is important because it implies that the sensitivity to gravity 
involves not only exposure to the magnitude of the gravity vector but also constant 
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alignment of the vector to the subject for some minimal time.  In spaceflight, cell 
signaling by gravitropic organelles is altered because there is no force displacing them to 
a specific gravity-dependent target for gravity-sensing signaling.  Thus, a method of 
continually changing the direction of the gravity vector more rapidly than the cell’s 
perception time may inhibit gravitropic responses.  Consequently, simulating 
microgravity under normal ground conditions by using devices such as the Random 
Positioning Machine (RPM) or the Rotating Wall Vessel (RWV) bioreactor, which 
continuously rotate and move the gravity vector relative to the subject, are based on the 
hypothesis that sensing no weight would have similar effects as being weightless.  
These gravity vector-averaging systems have enabled scientists to advance knowledge 
in both microgravity-based science and general mechanotransduction.   
 There has been some research performed on the effects of spaceflight and 
simulated microgravity on mammalian cells, namely changes in gene expression as 
covered previously in Chapters 3, 4, and 5.  However, how cells sense gravity is a 
continually evolving field because statoliths do not account for how all mechanosensitive 
cells in the body perceive gravity as there is no evidence of statoliths in bone cells, 
muscle cells, or other tissue cells of the human body.  It is well accepted that individual 
cells must be able to detect changes in mechanical load as evidenced by bone 
remodeling by osteoblasts and osteoclasts.  It is hypothesized that mammalian cells 
sense gravity through the cytoskeleton, whereby movement distorts the cell surface and 
its connections to the cytoskeleton (30).  Cells are attached to their extracellular matrix 
(ECM) through special proteins called integrins, whose receptors form clusters called 
focal adhesions.  The focal adhesions are physically connected to the actin cytoskeleton 
by interactions between the cytoplasmic tail of integrin receptors and actin-associated 
molecules in the cytoplasm like vinculin (30).  Thus, it has been shown that activation of 
many of the signaling molecules with exposure to a mechanical load is mediated through 
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integrins and subsequent mitogenic receptors, and moreover, these molecules are not 
floating about in the cell but rather are connected to the cytoskeleton in the focal 
adhesion complex.  As such, it seems that cells are “hardwired” such that the 
cytoskeletal filaments form the physical connections between the cell surface, which is 
exposed to mechanical loads, and the nucleus, where gene programming takes place.  
This theory is called the tensegrity model, a bridged word describing tensional integrity, 
depicting that the cell is pre-stressed to gives cells mechanical stiffness.  Thus, with its 
physical connections, perturbations to the cell environment alters the cell surface, 
modifies its connection to the ECM, and causes resultant changes to the nucleus (30).   
 Although it is well understood how the whole body senses gravity and how plant 
cells respond to changes in gravity, it is only partially understood how mammalian cells 
react to microgravity.  Future studies may elucidate this mechanosensory pathway, 
which would not only lead to advanced spaceflight but also general improved 
understanding of mechanotransduction.   
 
Fluid Shear Signaling* 
 Bone cells are among the most mechanically sensitive cells in the body, and their 
response to mechanical loading is an important factor in bone formation.  Mechanical 
loading, as shown through in vitro studies using fluid flow (44), results in highly adaptive 
responses of bone-forming and bone-resorbing cells that together maintain homeostasis 
in bone tissue (64). Mechanical unloading of bone causes disruptions to these 
mechanisms, resulting in pathological changes that lead to increased bone resorption 
and subsequent bone loss (5).  For example, studies have previously suggested that  
 
*Adapted from Vadoothker, SV and Patel, MJ, et al., Fluid Shear Stress Induces Differential 
Responses of Bone Formation Proteins in Preosteoblast Cells, 2007, In preparation 
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astronauts and bed-ridden patients experience unloading due to a decrease in 
osteoblast function (33, 56).  It is widely hypothesized that fluid flow in bone may signal 
osteoblast differentiation (15, 20, 37) and induce osteoblasts to secrete key bone 
formation markers and matrix proteins (66).  Mechanical loading as a result of fluid flow 
is known to result in a dynamic and oscillatory flow profile in bone tissue, and, thus, 
oscillatory fluid flow is hypothesized to be the most likely flow profile present in bone 
during physical activity (61, 64, 79). When bone is loaded (foot strike to ground), a 
hydrostatic pressure gradient is created, and interstitial fluid is forced into the canalicular 
network of bone. Unloading (time in between foot strikes) induces an adverse pressure 
gradient causing reversal of fluid flow.  Together, loading and unloading create the 
bidirectional and oscillatory fluid flow inside bone tissue (41, 48, 79).  Because 
microgravity or bed rest results in the lack of a loading and unloading cycle, it is possible 
that the detrimental effects to the musculoskeletal system are due to an absence of 
signals normally induced by cyclic fluid flow.   
 
Shear Sensitive Proteins in Osteoblasts 
Several studies have linked changes in osteoblast morphology and protein 
expression to fluid flow exposure.  Oscillatory fluid flow upregulates various proteins 
involved in bone formation, including prostaglandin E2 (PGE2), cyclooxegenase-2 (cox-
2), osteopontin (OPN), alkaline phosphatase (ALP), and osteocalcin (OCN) (44, 48, 61).  
Ponik, et al. and Malone, et al. determined that both osteoblasts and osteocytes 
elongated and actin stress fibers increased in response to a unidirectional fluid flow 
stimulus, similar to how endothelial cells lining the blood vessel wall react to constant 
blood flow (69).   ALP is found in bone cells prior to cell differentiation and matrix 
mineralization (17), and fluid flow and the resulting shear stress have been found to 
increase levels of ALP (19, 28, 57, 60).  Fluid shear has also been shown to temporally 
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activate signal transduction pathways involving cox-2 and OPN, both proteins necessary 
for bone mechanotransduction (61, 83). Specifically, primary bone cells with no 
mechanical stimulation experienced great decreases in OPN production, suggesting that 
inactivity may decrease the emergence of an osteoblastic phenotype (40). Other 
proteins of interest studied through fluid flow exposure include nitric oxide (NO), PGE2, 
receptor activator of nuclear factor kappa B ligand (RANKL), and osteoprotegerin (OPG). 
Signaling molecules NO and PGE2 were upregulated by fluid flow in osteoblasts and 
were found to be active in actin cytoskeleton disruption (50). Furthermore, bone cells 
have been shown to release prostaglandins in response to fluid flow and have 
contributed to either bone growth or bone resorption depending on G-protein coupled 
receptors (GPCR) activated by fluid flow (13). An increase in NO production has also 
been shown to decrease osteoclastogenesis and bone resorption (45), allowing for the 
continued maintenance of bone tissue. Similarly, RANKL, a marker for bone resorption 
and osteoclastogenesis, is competitively blocked by OPG in response to oscillatory fluid 
flow (39), and a decrease in RANKL production as a result of a mechanical stimulus has 
been shown to increase levels of NO in bone tissue, reducing bone resorption (45). 
Correspondingly, when bone cells were subjected to tensile mechanical stress, the cells 
increased OPN expression, suggesting that OPN may also play a role in mediating bone 
cell mechanotransduction (51). Studies of these and other proteins involved in bone 
formation as a result of fluid flow allow a greater understanding of how bone cells 
respond to mechanical stimuli to maintain skeletal homeostasis.   
 
Two Novel Shear Sensitive Proteins in Osteoblasts 
While the previously mentioned markers have been studied greatly in depth, 
many more markers exist that have never been studied in response to shear stress.  
These proteins could enhance the knowledge regarding bone mechanotransduction in 
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response to fluid flow and ultimately how bone formation occurs.  New insight into the 
cellular and molecular events leading to bone formation provides the necessary 
information for expanding the development of pharmaceutical treatments targeting 
formation since most drugs target bone resorption (www.nof.org).  An increase in the 
expression of bone morphogenic protein 4 (BMP4), an osteogenic marker of bone 
formation present since skeletogenesis (74), has been found in vitro in endothelial cells 
as a result of shear stress from oscillating fluid flow (69).  BMP4, when studied in bone, 
has also been shown to be an osteoinductive growth factor that regulates signaling in 
osteoblasts (54).  Studies have also determined that if BMP4 is delivered through gene 
therapy, ectopic endochondral bone formation occurred in skeletal muscle (43).  
Similarly, an increase in exposure to BMP4 improved bone healing in vivo when BMP4 
was delivered to the appropriate osteoprogenitor cells (46, 58). Thus, various reports 
have established BMP4 as an important bone formation marker with a key role in 
osteoblast differentiation and proliferation; however, to date, no studies have examined 
the effects of fluid flow on BMP4 in bone cells.  Additionally, osteoglycin (OGN), another 
osteogenic marker, is understudied in bone formation but has been shown to regulate 
collagen fibrillogenesis (24). Patel et al. and Xing et al. have both also found through 
microarray studies that mechanical unloading or loading regulates OGN.  However, its 
response to fluid shear stress has never been reported.     
Most bone cell mechanotransduction studies have exposed cells from 
approximately 5 dyn/cm2 to 20 dyn/cm2 (39, 42, 48, 50, 73), although models have 
predicted that osteocytes experience anywhere from 8 to 30 dyn/cm2 of shear stress in 
vivo depending on the activity performed (79).  While both unidirectional (laminar) and 
bidirectional (oscillatory) fluid flow profiles have been employed through in vitro studies 
to gain a better understanding of mechanotransduction in bone cells, few studies have 
directly compared the response of osteoblasts to both fluid flow profiles (28, 35, 61).  
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Thus, we have shown that oscillatory shear stress induces the expression of alkaline 
phosphatase (ALP) activity, BMP4, and OGN while laminar shear stress inhibits these 
same markers.  In our studies, 2T3 cells were exposed to laminar shear stress at 15 
dyn/cm2 and oscillatory shear stress at ±5 dyn/cm2.  The cells responded to mechanical 
stress by aligning in the direction of unidirectional, laminar fluid flow but not in response 
to oscillatory fluid flow (Figure 7.3). Additionally, laminar shear stress blunted ALP 
activity in comparison to static and oscillatory shear stress conditions (Figure 7.4).  This 
phenomenon has been shown by others, but more importantly, we report that this effect 
is independent of the shear magnitude and rather depends on the direction of the flow.  
As shown in Figure 7.5, ALP activity was decreased by laminar shear at varying 
magnitudes of shear stress between 5-15 dyn/cm2 compared to both static and 
oscillatory shear stress conditions.   
Both BMP4 and OGN have not been studied under shear stress, but our studies 
show they may be highly shear-sensitive bone formation proteins.  Laminar shear stress 
at 15 dyn/cm2 decreased BMP4 and OGN expression compared to oscillatory shear 
stress at ±5dyn/cm2 (Figure 7.6).  Since both the magnitude and direction of the shear 
stress differed in this experiment, we sought to evaluate whether this effect remained 
when the magnitude of the shear stress was held constant.  As a result, we found that 
the direction of the flow was indeed the key player in regulating both BMP4 and OGN 
since the decreased expression of both proteins was exhibited at all magnitudes of 
shear stress (Figure 7.7).  Furthermore, we show the effects of shear stress on BMP4 
and OGN expression are dose-dependent (Figure 7.8) where at least 10 dyn/cm2 of 
laminar shear stress is required to decrease BMP4 expression.  For OGN, laminar shear 
stress at 5 or 10 dyn/cm2 is sufficient to induce decreased expression.  In this figure, the 
laminar sample at 15 dyn/cm2 was mistakenly left out of the gel for the Western blot; 
however, previous data (Figure 7.7) shows that laminar shear stress at 15 dyn/cm2 also  
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A. Static B. Laminar    C. Oscillatory 
 
Figure 7.3 2T3 cells aligned in the direction of unidirectional laminar fluid flow. 
Confluent 2T3 cells were exposed to static (A), laminar (15 dyn/cm2) shear stress (B), 
or oscillatory (± 5 dyn/cm2) shear stress (C) for 24 hours.  Cells were 
photomicrographed with a phase contrast microscope at the end of the experiement. 






























































Figure 7.4 Oscillatory shear stress increased ALP activity in 2T3 cells. Cells 
were exposed to static, laminar (Lam), or oscillatory (Osc) shear stress conditions as 
in Figure 7.1.  Cell lysate was obtained after 24 hours, and ALP activity was 
measured using a colormetric assay and normalized to total protein.  Data are 
represented as mean ± SEM and graphed as a % of control (* p < 0.05, n ≥ 13). 149






































































Figure 7.5 Oscillatory shear stress increased ALP in a dose-dependent manner 
compared to laminar shear stress.  Cells were exposed to static, laminar (Lam), or 
oscillatory (Osc) shear stress conditions at varying magnitudes.  Cell lysate was 
obtained after 24 hours, and ALP activity was measured using a colormetric assay 
and normalized to total protein.  Data are represented as mean ± SEM and graphed 















































































































Figure 7.6 Oscillatory shear stress increased expression of BMP4 and OGN 
compared to laminar shear stress. Cells were exposed to static, laminar (Lam), or 
oscillatory (Osc) shear stress conditions as in Figure 7.1.  Cell lysate was obtained 
after 24 hours, and specific antibodies against BMP4 (A) and OGN (B) were used to 
detect protein expression by Western blot.    Data are represented as mean ± SEM 



































































































Figure 7.7 Oscillatory shear stress increased BMP4 and OGN compared to 
laminar shear stress at identical magnitudes.  Cells were exposed to static, 
laminar (Lam), or oscillatory (Osc) shear stress conditions at a constant magnitude of 
15 dyn/cm2.  Cell lysate was obtained after 24 hours, and specific antibodies against 
BMP4 (A) and OGN (B) were used to detect protein expression by Western blot. 

































































































Figure 7.8 Oscillatory shear stress increased BMP4 and OGN in a dose-
dependent manner compared to laminar shear stress.  Cells were exposed to 
static, laminar (Lam), or oscillatory (Osc) shear stress conditions at varying 
magnitudes.  Cell lysate was obtained after 24 hours, and specific antibodies against 
BMP4 (A) and OGN (B) were used to detect protein expression by Western blot. 
Data are represented as mean ± SEM and graphed as a % of control (*p<0.05, n=3-
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decreased OGN expression compared to the appropriate oscillatory shear conditions.            
OGN has been shown to play a role in collagen fibril regulation and is a member of the 
small leucine-rich proteoglycan (SLRP) family, whose members are hypothesized to play 
roles in bone matrix mineralization (72).  In our studies, both BMP4 and OGN expression 
were regulated by shear stress exposure, suggesting that the expression of both 
proteins is controlled by a mechanically sensitive pathway.  Changes in shear magnitude 
did not affect the increased expression of BMP4.  When laminar and oscillatory shear 
stress magnitude were held constant, oscillatory flow still increased expression of both 
proteins compared to laminar flow, suggesting that the flow direction plays a role in 
regulating BMP4 and OGN expression.   These findings are consistent with previous 
work showing that oscillatory fluid flow is the physiological flow naturally present in bone 
(79), and it suggests that oscillatory shear stress may cause an osteogenic response 
while distinctly differing flow profiles such as laminar flow inhibit bone formation.   
Fluid flow inevitably induces signaling cascades, regulating diverse sets of 
proteins, cytokines, and growth factors responsible for maintaining appropriate cellular 
function and ultimately bone remodeling.  Fluid-induced shear stress is one of the many 
mechanical signals to which bone cells must respond, and the reviewed molecules are 
only a small fraction of the numerous factors involved in maintaining the highly complex 
process of skeletal homeostasis.   
  
Bone Morphogenic Protein (BMP) Signal Transduction  
There are a number of cell signaling pathways altered by mechanical loading, 
leading to a multitude of anabolic responses.  Here, we aim to review the signaling 
cascades induced by the BMPs, which are members of the Transforming Growth Factor 
Beta (TGF-β) superfamily and have been shown in numerous studies to instigate potent 
osteogenic effects such as stimulating the differentiation of mesenchymal stem cells to 
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osteoblast lineage (7, 38, 59, 82).  While BMPs were first identified in the context of 
bone and cartilage formation (75), they have since been implicated in various processes 
including neural development (47, 65) and cardiovascular pathogenesis (12, 14).  They 
are multi-functional growth factors whose cellular and molecular mechanisms of action 
have recently been ascertained and utilized in the development of clinical applications 
for bone and cartilage regeneration (16, 21, 53).     
 
BMP Structure and Function 
To date, there have been approximately 15-20 BMPs identified (7, 26, 81), and 
each BMP has a precursor and a cleaved, secreted mature form (81).  There is a 
conserved seven cysteine-rich region, where six of these cysteines form a knot while the 
seventh is involved in dimerization.   The large precursor protein, at an approximate 
weight of 50 kDa, contains a signal peptide, a pro-domain, and a mature domain.  Once 
the signal peptide is cleaved, the precursor protein undergoes glycosylation and 
dimerization.  To secrete the active BMP, the cell proteolytically cleaves the pro-domain 
at a dibasic site, rendering the C-terminal active domain available for release (81).  
BMPs can form active homodimers and heterodimers, both composed of polypeptide 
chains connected by disulfide bonds (26).   
As the name suggests, BMPs are morphogenes, those regulating the shape of 
the organism, whereas the TGFβ proteins are classified as cytokines, which are small 
biological factors that have specific effects on cell-cell interactions and communication.  
While BMPs are members of the TGFβ superfamily and share 40-50% structural 
similarity with TGFβ, they can have drastically disparate effects on osteoblast 
differentiation markers (26).  BMP-2 has been shown to enhance ALP activity and OCN 
expression, but TGFβ has also been shown to inhibit these same markers (70).    One of 
the most critical functions of the BMPs for clinical applications is their ability to induce 
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ectopic bone and cartilage, rendering them useful for joint defects and injuries.  Among 
the many BMPs, the ones with the immense osteogenic capabilities are BMP2, BMP4, 
and BMP7 (9, 81).  Currently, only BMP2 and BMP7 have been shown clinically to 
provide an in vivo induction of bone for fracture healing, spinal fusion, and other skeletal 
deformations (16, 36).   
 
SMAD Pathway 
The canonical BMP pathway begins with a BMP binding to its cell surface 
receptor (Figure 7.9) (9).  It has been shown that when BMP2 binds to a pre-formed 
heteromeric receptor complex, it activates the smad pathway.  If, however, BMP2 binds 
to a receptor complex induced by BMP2 itself, the MAPK pathway is instigated, as 
discussed later (52).  The BMP receptors are serine/threonine kinase receptors, and 
there are two groups of BMP receptors distinguished as type I and type II.  There are 
two subclasses of type I receptors called type IA or activin receptor-like kinase (ALK)-3 
and type IB or ALK-6.  The first receptor to which a BMP binds is BMP receptor II 
(BMPRII), and this ligand-receptor complex initiates a cascade of events starting with the 
recruitment of and dimerization to BMP receptor I (BMPRI).  Once BMPRII binds to 
BMPRI, the constitutive kinase activity of type II activates type I and commences the 
smad cascade.  It begins with the phosphorylation of smads 1, 5, 8 by the 
BMPRII/BMPRI heterodimer.  Once phosphorylated, smads 1, 5, 8 can induce many 
different responses, including signaling to smad 4 and its translocation to the nucleus to 
act as a transcription factor for downstream BMP signaling targets (9).  Osteoblast 
differentiation depends on interactions of smads with runt homology domain transcription 
factor 2 (runx2), as shown in the differentiation of mesenchymal cells.  If runx2 is 
mutated yielding a truncated runx2 protein, there is no interaction with smads 1, 2, 3, 





Figure 7.9 BMP signaling pathway showing smad phosphorylation and 
translocation of smad 4 to nucleus for transcriptional regulation and alternative 
MAPK pathway  
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(84).  Thus, smad proteins play an essential role in relaying signals from the cell surface 
to the nucleus for gene transcription, some of which are critical to bone formation.   
 
Mitogen Activated Protein Kinase (MAPK) Pathway  
 Both BMP and TGFβ activate smad-independent pathways, namely the 
Ras/MAPK pathway (Figure 7.10).  There have been three major subclasses of MAPKs 
identified in mammalian cells including the extracellular signaling-regulated kinases 
(ERK), the c-Jun N-terminal kinases (JNK), and the p38 family (71).  In osteoblast cell 
culture, there have been reports of ERK activation in response to growth factors that act 
through receptor tyrosine kinases (RTKs).  These RTKs include platelet-derived growth 
factor (PDGF), insulin-like growth factor-1 (IGF-1), basic fibroblast growth factor (bFGF), 
and GPCRs such as prostaglandin F2α (71).  ERK activation has been linked to collagen 
cross-linking with integrins and interleukin-6 as well as increased cell proliferation and 
bone cell differentiation (71).  It has been shown that BMP2 stimulates Ras activity and 
downstream ERK and p38 (3, 80).  This signaling cascade results in downstream 
effects, including increased expression of Fos/Jun family members and activating 
transcription factors 2 (ATF2).  Activation of p38 MAPK is essential for BMP2-induced 
increases in type I collagen, ALP, and OCN while induction of fibronectin and OPN 
requires both p38 and ERK (9).  It has additionally been shown that p38 incites ALP 
activity, marking the role of MAPKs in cell differentiation and bone formation (71).  Many 
signaling cascades regulate various bone cell responses, and MAPKs are only one 
group that controls bone remodeling.  However, it is established that MAPKs play an 




Figure 7.10 Summary of general MAPK pathway showing activation by growth 
factor such as a BMP and subsequent activation of a MAPKKK (first MAP 
activated) to MAPK (last MAPK activated) and eventual transcriptional 
regulation  157
BMP Antagonists 
 Cellular control of the BMP pathway is performed by both intracellular and 
extracellular antagonists.  These control systems that inhibit BMP activity include 
blocking the smad pathway by inhibitory smads 6/7, smad degradation or intracellular 
blocking, and blocking of BMPs by extracellular binding proteins such as noggin, 
chordin, and DAN.  Smad 6 and 7 interfere with smad 1 and 5 phosphorylation and 
subsequent dimerization with smad 4.  They are activated by phosphorylation by type I 
BMP or TGFβ receptors, and smad 6 is a more specific BMP inhibitor than smad 7 (9).  
It has been shown that BMP2, TGFβ, and activin can induce the expression of smad 6 in 
stromal and muscle cells (34).   Since smads are modulated by BMPs, it is possible that 
osteoblast cells exposed to rBMPs may increase smad 1, 5, 8 complex in the short term 
but also increase smad 6 and 7 over longer periods of exposure for endogenous BMP 
signaling control by negative feedback (9).  Smads themselves are regulated by various 
factors, including intracellular binding proteins such as ski, an oncogene that blocks 
BMP, activin, and TFGβ signaling by corepressor activity.  Ski mutations result in failure 
to bind to signaling smads and to inhibit the BMP pathway (78).  Additionally, there are 
smad ubiquitination regulatory factors (smurf) 1 and 2 that are specific to activated 
smads and consequently regulate their degradation (9).  There are many extracellular 
antagonists that are secreted polypeptides tempering BMP signaling by prohibiting 
binding to cell surface receptors.  Table 7.1 shows the various antagonists and whether 
they are expressed and/or induced by BMPs.   
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*Table 7.1 Selected extracellular BMP antagonists  
Antagonist Expressed Induced by BMPs 
Noggin Yes Yes 
Chordin Yes No 
Dan Yes No 
Twisted Gastrulation (Tsg) Yes No 
Follistatin Yes No 
Gremlin Yes Yes 
  (*Modified from Canalis, et al., 2003) (9) 
 
In our studies, noggin was used to inhibit BMP activity, and we focus on it in this 
section.  Noggin was originally identified for its actions in the development of the 
Spemann Organizer, a region of the central nervous system which blocks BMP4 to allow 
neural folding and eventual formation of the spinal cord and brain.  Noggin, like the other 
extracellular antagonists, binds BMPs and prevents them from binding to their cell 
surface receptors.  It binds to BMP2, 4, 5, 6, and 7 and does not seem to have any 
effects independent of BMP signaling (9).  In cell culture, osteoblasts express noggin, 
and expression of it is enhanced by treatment with rBMP 2, 4, and 6.  Noggin blocks 
BMPs in differentiated and undifferentiated osteoblast cells, preventing BMP effects 
such as collagenous and non-collagenous protein expression, ALP activity, and 
mineralization (23, 59).  It has been shown that stromal cells from noggin overexpresser 
mice do not undergo osteoblastic differentiation (18, 22), which in turn also prevents 
osteoclastogenesis since osteoblasts express necessary signals such as RANKL, the 
ligand for receptor activator of NF-κB (RANK) essential for osteoclast differentiation (1).  
In vivo, noggin prevents chondrogenesis, membranous ossification, and development of 
limbs (2, 10).  Noggin overexpresser mice develop osteopenia and suffer fractures (18), 
and human heterozygous mutations in the noggin gene results in joint lesions  (25).  
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Chordin is also secreted by the Spemann Organizer and blocks BMP activity similarly to 
noggin.  It is specific to BMPs, and double noggin/chordin mutations lead to diverse 
abnormalities, including disrupted mesoderm development and patterning (4).  Follistatin 
was identified as a binding protein to activin but also binds to BMP4, repressing BMP 
signaling (9).  Follistatin knockouts endure neonatal death, a result of varying 
deficiencies including those to the skeleton (49).  The Dan family of secreted 
glycoproteins has the capability to bind BMPs, in particular BMP2 and 4 with varying 
affinity.  However, dan knockout mice display modest phenotypic changes compared to 
other BMP antagonist knockout models (9).   
BMPs play a critical role in a sundry of processes, including development and 
skeletal maintenance.  There are inherent feedback mechanisms in play to balance BMP 
signaling by intracellular and extracellular antagonists.  Skeletal homeostasis depends 
on this control to maintain osteoblast function and bone remodeling.   
 
Conclusion 
Bone adaptation occurs at the cellular level where cells such as osteoblasts and 
osteocytes sense deformation due to mechanical loading or unloading, instigating a cell 
signaling cascade leading to changes in cell proliferation, death, or differentiation.  Bone 
cells are among the most mechanically sensitive in the body, and there are many 
different ways in which mechanical loads, including gravity, are sensed.  The means by 
which gravity is sensed by cells still evades science, but there is continuing research in 
this field.  There have been many studies using simulated microgravity to study changes 
in cellular architecture and gene expression, illuminating some insight into downstream 
effects due to alterations in the gravitational field.  Additionally, other bone pathologies 
such as osteoporosis, depend on our knowledge on how the skeletal system adapts to 
changes in hormones, decreased exercise and subsequent fluid flow, and muscle 
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atrophy.  Fluid flow-induced cell signaling plays a critical role in instigating bone 
remodeling, which is regulated by a multitude of factors.  Among the many proteins that 
play roles in cell signaling leading to bone formation, osteoblasts secrete BMPs, which 
cause signaling cascades mediated by either smad proteins or MAPKs.  Through 
numerous means, bone adaptation to changes in mechanical environment occurs not 
only at the macroscopic level but also at the cellular level.   
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The Effects of Disuse and Low Magnitude Mechanical 




From specific aims 1 and 2, we developed an in vitro disuse system to study 
cellular alterations in osteoblasts caused by disuse.  We evaluated system gene 
expression, providing insight into how osteoblasts respond through molecular 
transformations to unloading.  In specific aim 3, it is our goal to explore a 
countermeasure device and its cellular and molecular effects in osteoblasts.   
Bone loss due to osteoporosis or disuse such as in paraplegia or microgravity is 
a significant health problem.  As a treatment for osteoporosis, brief exposure of intact 
animals or humans to low magnitude and high frequency (LMHF) mechanical loading 
has been shown to normalize and prevent bone loss.  However, the underlying 
mechanisms and the target cells by which LMHF mechanical loading alleviate bone loss 
are not known.  Here, we hypothesized that direct application of LMHF mechanical 
loading to osteoblasts alters their cell responses, preventing decreased bone formation 
induced by disuse or microgravity conditions.  To test our hypothesis, preosteoblast 2T3 
cells were exposed to a disuse condition using the Random Positioning Machine (RPM) 
and intervened with a LMHF mechanical load (0.1-0.4g at 30Hz for 10-60 min/day).  
Exposure of 2T3 cells to the RPM decreased bone formation responses as determined 




*Adapted and printed with permission from Patel, MJ, et al., Low Magnitude Mechanical Loading 
Prevents Decreased Bone Formation Responses of Osteoblasts by a Bone Morphogenic Protein-
Dependent Mechanism, American Journal of Physiology Cell Physiology, 2008, In Review 
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submaximal dose of bone morphogenic protein 4 (BMP4, 20ng/ml). However, LMHF 
mechanical loading prevented the RPM-induced decrease in ALP activity and 
mineralization. Mineralization induced by LMHF mechanical loading was enhanced by 
treatment with BMP4 and blocked by the BMP antagonist noggin, suggesting a role for 
BMPs in this response.  In addition, LMHF mechanical loading rescued the RPM- 
induced decrease in gene expression of ALP, runt homology domain transcription factor 
2 (runx2), osteomodulin (OMD), parathyroid hormone receptor 1 (PTHR1), and 
osteoglycin (OGN).  These findings show that osteoblasts directly respond to LMHF 
mechanical loading to induce bone formation responses, potentially leading to 
normalization or prevention of bone loss caused by disuse or microgravity conditions. 
The mechanosensitive genes identified here provide potential targets for pharmaceutical 
treatments that may be used in combination with LMHF mechanical loading to better 
treat osteoporosis, disuse-induced bone loss, or microgravity-induced bone loss.   
 
Introduction 
Musculoskeletal pathologies associated with decreased bone mass, including 
osteopenia, osteoporosis, disuse-induced bone loss, and microgravity-induced bone 
loss, affect millions of Americans annually.  Bone loss is particularly dangerous since it is 
at first asymptomatic and leads to severe fractures of bones, typically those in the hip, 
spine, and wrist (3).   While osteoporosis usually affects the elderly, it can afflict both 
men and women of any age.  Additionally, bone loss occurs in spaceflight, rendering 
astronauts at-risk for fractures during long term space travel.  On average, astronauts 
lose 1-2% of bone mass per month during space missions (14), and there are no known 
countermeasures that can effectively mitigate this bone loss.   
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It has long been regarded that mechanical stimuli are anabolic to bone.  High 
magnitude, low frequency impact such as running has been recognized to increase bone 
and muscle mass (2, 31, 34).  However, the opposite stimulus, a low magnitude and 
high frequency (LMHF) mechanical load experienced in activities as low impact as 
standing, has also been shown to be anabolic to bone (24).  This type of signal is 
transmitted by the musculature to the skeleton during the majority of each day, assisting 
in maintenance of posture and other non-strenuous activities.  If it is true that muscle 
atrophy (sarcopenia) parallels ageing (15, 16, 22), then these intrinsic, LMHF 
mechanical signals would diminish with it, leaving the musculoskeletal system without 
potentially key signals critical to the regulation and retention of skeletal mass and 
morphology.   
Recently, a LMHF mechanical loading device has been developed to treat bone 
loss by applying a low magnitude mechanical signal at a high frequency to the whole 
animal or human. The LMHF mechanical load has been shown to be effective in treating 
musculoskeletal pathologies in a number of subjects during research and clinical trials, 
including animals (26), children with musculoskeletal diseases such as cerebral palsy or 
muscular dystrophy (7, 35), young women with low bone mass (6), and post-
menopausal osteoporotic women (23).  While several pre-clinical and clinical trials have 
demonstrated that the LMHF mechanical loading affects bone formation in vivo, the 
target tissues of the mechanical load and underlying mechanisms mediating the 
responses are not known.   Here, we hypothesized that a LMHF mechanical loading 
applied directly to osteoblasts would prevent decreased bone formation responses in 
osteoblasts by altering gene expression and cell function. 
To test our hypothesis, pre-osteoblast 2T3 cells were exposed to the RPM to 
model a decreased bone formation response (20) and intervened with the LMHF 
mechanical signals (0.1-0.4g acceleration at 30Hz frequency) for 10-60 min per day.  We 
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developed an in vitro method to apply LMHF mechanical loading to osteoblast cells, 
examined various bone formation markers, and performed BMP inhibitor studies.  We 
found that vibration stimulated an osteogenic response in a BMP-dependent manner, 
inducing alkaline phosphatase (ALP) activity, enhancing subsequent mineralization, and 
increasing osteogenic gene expression.   
Materials and Methods 
Cell culture – 2T3 murine osteoblast precursor cells were kindly provided to us by Dr. 
Steve Harris, University of Texas Health Science Center at San Antonio.  The cells were 
cultured in a growth medium (α-minimal essential medium) containing 10% fetal bovine 
serum (Atlanta Biologicals) with 100 units/ml of penicillin and 100µg/ml of streptomycin 
and grown in a standard humidified incubator (37°C, 5% CO2) as previously described 
by us (20, 21).   For mineralization experiments, the growth medium was supplemented 
with ascorbic acid (50 µg/ml) and β-glycerolphosphate (5 mM) with or without BMP2 or 
BMP4 (0-50 ng/ml) and/or noggin (100 ng/ml).   
 
Random Positioning Machine (RPM) – A desktop RPM manufactured by the Dutch 
Space Agency was used to simulate disuse or microgravity conditions as previously 
described by us (20).  Briefly, OptiCell disks seeded with cells were mounted on the 
center of the platform located on the inner frame, and the RPM was operated in random 
modes of speed and direction via a computer user interface with dedicated control 
software inside a humidified incubator (5% CO2 at 37oC).   
 
Low Magnitude and High Frequency (LMHF) Mechanical Loading Platform—LMHF 
mechanical loading was delivered to the cells using a vertically oscillating platform 
custom manufactured by Juvent, Inc (Figure 8.1A). The magnitude of mechanical 
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loading is defined as a peak-to-peak load (Figure 8.1B), and cells were exposed to 0.1-
0.4g acceleration (where 1g is Earth’s gravitational field) at 30 Hz frequency for 10-60 
minutes per day for 3-21 days (Figure 8.1C).  The loading platform dimensions are 
17”X17”, and the loading conditions were controlled through a program installed on a 
laptop.  
 
xperimental Design— Confluent 2T3 cells grown in OptiCells were exposed to static 


















































































































































Figure 8.1 LMHF mechanical loading using a custom built platform.  Confluent 
2T3 cells grown in OptiCell chambers were exposed to LMHF loading using a 
platform (A) designed to produce dynamic, vertical oscillations, where the peak to 
peak acceleration is the magnitude of the load (B).  Cells were exposed to five 
different experimental conditions (C) with varying g-loads as shown on the y-axis 
using the LMHF platform and/or the RPM.   
 
E
(1g) or RPM conditions with or without a brief, daily LMHF mechanical load inside a 
humidified incubator (5% CO2 at 37oC).  As shown in Figure 1C, 2T3 cells were exposed 
to five different conditions: 1) Static: cells were exposed to control 1g conditions 
continuously throughout the experimental duration, 2) Static+LMHF:  cells were exposed 
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to static 1g conditions and treated once with LMHF mechanical loading for 10-60 
minutes/day,  3) RPM: cells were continuously rotated on the RPM, simulating a disuse 
or microgravity environment,  4) RPM+LMHF: cells were exposed to the RPM and 
removed once from the RPM and mechanically loaded daily as in the Static+LMHF 
group, and  5) RPM+Static:  Since the RPM+LMHF group not only was treated with the 
LMHF mechanical loading but also was returned to static 1g conditions briefly, we 
employed the RPM+Static group as a control.  This group of cells was exposed to the 
RPM and intervened with the static 1g conditions daily (10-60 min/day).  
 
Whole cell lysate and alkaline phosphatase (ALP) enzyme activity—Following the 
lizarin Red Stain—Following the experiment, cells were washed with ice-cold PBS two 
ourier Transform Infrared (FTIR) Spectroscopy— After 15-21 days of exposure to 
experiment, cells were washed with ice-cold phosphate buffered saline (PBS) two times 
and lysed in 500 µl of a lysis buffer containing 0.5% Triton X-100, 1 mM MgCl2, and 10 
mM Tris-HCl.  Samples were stored at -80ºC until needed. Alkaline phosphatase (ALP) 
activity was determined using a Diagnostics ALP assay kit (Sigma) as previously 
described by us (20, 21). 
 
A
times and fixed in 70% ethanol for 15 minutes.  Cultures were stained for two minutes 
with a 1% Alizarin red solution for calcium detection.  Following the stain, cultures were 
rinsed with a 0.01%HCl-ethanol solution and dH20.  The plates were dried overnight 
before being scored for percent mineralization using ImageJ analysis software.  
Quantification graphs express mineralization as a percent of the experimental control.   
 
F
stimulus, cells were scraped in 100% ethanol and dried at 50°C overnight. Samples 
were mixed with potassium bromide (Sigma), pressed into pellets, and analyzed with a 
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Nexus 470 FTIR spectrometer (ThermoNicolet, Madison, WI), which was equipped with 
a deuterated triglycine sulfate (DTGS) detector. A nitrogen purge was performed, and 
sixty four scans were acquired (4).     
 
Reverse Transcriptase and Real Time Polymerase Chain Reaction (RTPCR)–Total RNA 
tatistical analysis—Data are expressed as mean ±  SEM with n numbers representing 
Results 
 
MHF mechanical loading did not alter cell morphology or cell number of 2T3 
xposed to Static, Static+LMHF, RPM, or RPM+LMHF conditions for 
three days showed no apparent change in cell morphology after stimulus exposure as 
was prepared and amplified as previously described by us (20, 21).  Briefly, total RNA 
was prepared using the RNeasy Mini Kit (Qiagen) and reverse transcribed by using 
random primers and a Superscript-II kit (Life Technology).  The synthesized and purified 
cDNA was amplified using a LightCycler (Roche Applied Science), and mRNA copy 
numbers were determined based on standard curves generated with the genes of 
interest and normalized against 18S ribosomal RNA. The primer pairs for quantitative 
real time RTPCR for ALP, runx2, BMP4, OMD, and PTHR1 were previously published 
by us (20, 21) and for OGN by others (37).  Real time RTPCR for the listed genes were 
carried out in RTPCR buffer as described previously by us (20, 21). 
 
S
biological replicates pooled from independent experiments.  Statistical analysis was 
performed using the Student's t-test. A significance level of p<0.05 was considered 
statistically significant. 
L

















































Figure 8.2 LMHF mechanical loading did not alter morphology or cell number of 
2T3 cells.  Confluent 2T3 cells were exposed to Static, Static+LMHF, RPM, or 
RPM+LMHF conditions for 3 days.  LMHF loading was applied to the appropriate 
groups at 0.3g for 10 min/day.  Cultured cells were photomicrographed with a phase 
Static StatA
in Figure 8.2A.  Additionally, cell number did not change between static and 
experimental groups with exposure to LMHF mechanical loading or RPM (Figure 8.2B).  
These results suggest that the RPM or LMHF mechanical loading did not significantly 

































LMHF mechanical loading increased ALP activity in a magnitude- and time-
ependent manner. 







microscope at the end of the experiment (A), and cell proliferation was assessed by 
counting cells using a Coulter counter and graphed as % of static control.   Data are 




Here, we examined whether LMHF mechanical loading regulated ALP activity, an 
early bone formation 
 applied to 2T3 cells for 10 min/day for three days induced an increase in ALP 
activity in a magnitude-dependent manner, where 0.3g and 0.4g induced significant 
changes compared to static control (Figure 8.3A).  Next, we investigated the time-
























































































































































































Figure 8.3 LMHF loading increased alkaline phosphatase (ALP) activity in a 
magnitude- and time-dependent manner.  2T3 cells were exposed to Static or 
Static+LMHF conditions at varying loading magnitudes (A) or varying treatment-
time/day (B), and cell lysates were obtained.  After 3 days exposure, ALP activity was 
determined using a colorimetric assay, normalized to total protein, and graphed as a 
% of static control.  Data are expressed as mean ± SEM (n=6,  *p<0.05).   
 
loading for as few as 10 minutes/day for three days was sufficient to increase ALP 
activity in 2T3 cells.  Exposure for 30 minutes or one hour per day did not further 
increase ALP activity compared to 10 minutes/day (Figure 8.3B).   These results suggest 
that LMHF mechanical loading increases ALP activity in a magnitude- and time-
dependent manner. 
 
LMHF mechanical loading prevented inhibition of ALP activity induced by RPM.  
Previously, we have shown that exposure of 2T3 cells to either the RPM or RWV 
e 
examin
induces bone loss responses as determined by ALP activity (20, 21).  Here, w
ed whether LMHF mechanical loading prevents ALP activity inhibition induced by 
exposing 2T3 cells to RPM.  As expected, RPM exposure (three days) decreased ALP 
activity by 30% of static control (Figure 8.4).  This RPM-induced decrease was 
completely normalized to the static level by exposing cells to LMHF mechanical loading 
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(RPM+LMHF) at either 0.3g (Figure 8.4A) or 0.4g (Figure 8.4B) for 10 min/day. In 
contrast, exposure to static conditions for 10 min/day (RPM+Static) was not able to 
prevent RPM-inhibition of ALP activity (Figure 8.4B), suggesting a specific effect of the 
mechanical loading and not the static 1g conditions.  In addition, LMHF mechanical 
loading (Static+LMHF) for 10 min/day at both 0.3g and 0.4g increased ALP activity by 
30% above static control as shown in Figure 8.4.  These results are consistent with the 
following mineralization studies. 
 
Figure 8.4 LMHF mechanical loading prevented inhibition of alkaline 
phosphatase activity caused by RPM. 2T3 cells were exposed to Static, 
Static+LMHF, RPM, RPM+LMHF, and RPM+Static conditions for 3 days.  LMHF was 
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A. 0.3g B. 0.4g
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was measured using a colormetric assay, normalized to total protein, and graphed as 
a % of static control.  Data are expressed as mean ± SEM (n=6-9  *p<0.01, **p<0.05).
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LMHF mechanical loading stimulated mineralization in a magnitude-dependent 
manner.  
2T3 cells show no apparent mineralization in an experimental time frame of 15-
21 days unless osteogenic factors such as BMP2 or BMP4 are added to the culture 
medium (5).  Here, we examined whether LMHF mechanical loading stimulates 
mineralization of 2T3 cells without supplementing the culture medium with exogenous 
BMPs.   As expected, the static cells cultured for 21 days in the absence of added BMPs 
(Static) did not show any significant calcium deposits as identified by Alizarin Red 
staining (Figure 8.5A and B). Also as expected, supplementing the media with 20 ng/ml 
of BMP4 (Static+BMP4) induced a dramatic increase in calcium deposits (Figure 8.5A 
and B). Exposure of 2T3 cells to LMHF mechanical loading alone (without exogenously 
added BMP4) significantly increased calcium deposits by 10 to 40-fold over the static 
conditions (Static+LMHF).  Additionally, the effect of LMHF signals was magnitude-
dependent, as calcium deposition significantly increased when cells were loaded at 
levels as low as 0.1g up to 0.4g.  To further demonstrate whether LMHF loading induced 
physiologically relevant mineralization in 2T3 cells, FTIR analysis was performed. Figure 
8.5C is a representative FTIR analysis showing adsorption bands at 1650 cm−1 (Amide I, 
C=O) and 1530 cm−1 (Amide II, N-H and C-N), which represent bonds in the extracellular 
matrix and lipid content (4).  Additionally, mineral samples had peaks at 1030 cm−1 (P-
O), at 870 cm−1 (C-O), and a split peak at 600 cm−1 (P-O).  These bands are 
characteristic of  carbonate-containing, poorly crystalline hydroxyapatite (4).  These 
results suggest that LMHF loading alone can stimulate mineralization of 2T3 cells 

















































































































Figure 8.5 LMHF mechanical loading induced mineralization in a magnitude-
dependent manner.  Confluent 2T3 cells were exposed to Static, Static+BMP4, or 
Static+LMHF conditions at varying loading magnitudes (0.1-0.4g for 10 min/day) for 
21 days and stained for calcium deposition using Alizarin Red and analyzed with 
FTIR for chemical composition (C).  The Opticell membrane was scanned (A), and 
quantification (B) was determined using imaging software and graphed as a % of 
static control.  Data are expressed as mean ± SEM (n=6-10, *p<0.01, **p<0.05).     
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LMHF mechanical loading stimulated and RPM inhibited mineralization in 2T3 
cells in a BMP4 concentration-dependent manner. 
We next investigated the effects of LMHF loading and the RPM on 2T3 cell 
mineralization in a BMP4 concentration-dependent manner.  We carried out experiments 
for a shorter duration of 15 days (rather than the 21 day experiments in Figure 8.5) to 
detect differences among BMP4-treated groups.  2T3 cells were exposed to Static, 
Static+LMHF, or RPM conditions and treated with or without recombinant BMP4 in 
concentrations varying from 0-50 ng/ml (Figure 8.6).  BMP4 alone induced mineralization 
in static cultures at 20 or 50 ng/ml treatment, while 10 ng/ml showed a moderate but not 
statistically significant increase.  The LMHF loading significantly augmented the BMP4 
effect (Static+LMHF) at 20 ng/ml of BMP4 by more than two-fold above the 
corresponding static group.  We also found that the LMHF loading tended to enhance 
the effect of 10 ng/ml BMP4 above that of the corresponding static group, although it did 
not reach statistical significance.  The RPM prevented mineralization at submaximal 
concentrations of BMP4 (1 to 20ng/ml) compared to those of both the Static and 
Static+LMHF groups.  This anti-osteogenic effect of RPM in the presence of submaximal 
BMP4 concentrations was also observed when cells were treated with 20 ng/ml BMP2 
(data not shown).  However, when treated with a higher concentration of BMP4 (50 
ng/ml), 2T3 cells showed maximal mineralization in all three groups (Static, 
Static+LMHF, and RPM), and no differences were observed among them.  These results 
suggest that BMP4 and LMHF provide pro-mineralization effects in an additive manner, 
and the RPM completely prevents the pro-mineralization effect of submaximal 
concentration of BMPs (up to 20 ng/ml).  However, treating cells with a supermaximal 
BMP4 concentration (50 ng/ml) saturates the RPM and LMHF effects, suggesting a key 
role for BMPs as a mediator of mineralization in response to either mechanical condition.  
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Figure 8.6  LMHF loading induced and RPM inhibited mineralization in 2T3 cells 
in a BMP4 concentration-dependent manner.  Confluent 2T3 cells were exposed to 
Static, Static+LMHF, or RPM conditions in the presence of varying concentrations of 
BMP4 for 15 days.  LMHF was applied to the appropriate groups at a magnitude of 
0.4g for 10 min/day.  Cell cultures were stained with Alizarin Red (A), and the 
intensity was quantified (B) as in Figure 3.  Data are expressed as mean ± SEM (n=4, 
*p<0.05).   
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LMHF mechanical loading prevented RPM-induced inhibition of 2T3 cell 
mineralization.  
Previously, we have shown that exposure of 2T3 cells to either the RPM or RWV 
induces bone loss responses as determined by ALP activity, mineralization, and 
osteogenic gene expression (20, 21). Here, we examined whether daily LMHF loading of 
2T3 cells could prevent the inhibition of mineralization induced by the RPM.  For this 
study, 2T3 cells were exposed to Static, Static+LMHF, RPM, RPM+LMHF, and 
RPM+Static conditions in the presence of BMP4 (20 ng/ml) for 15 days and stained with 
Alizarin Red.  As shown in Figure 8.7, LMHF loading of static cells (Static+LMHF) 
increased mineralization by 50% above the Static group, while the RPM dramatically 
inhibited mineralization by ~90% of the Static group.  This RPM-induced inhibition was 
completely normalized to the level of the Static+LMHF group by exposing the cells to 
LMHF loading for 10 min/day (RPM+LMHF).  However, exposure of the RPM group to 
static conditions for 10 min/day (RPM+Static) could not rescue the inhibition of 
mineralization by the RPM (Figure 8.7), suggesting a specific effect of LMHF loading and 
not the static 1g conditions.  However, osteocalcin (OCN), a downstream target protein 
of runx2, was not changed with LMHF loading or RPM exposure (Figure 8.7C).  These 
results suggest that RPM inhibits mineralization of 2T3 cells, which can be completely 
rescued by exposure to brief, daily LMHF loading. 
 
LMHF mechanical loading induced mineralization in a BMP-dependent manner.   
The result in Figure 8.6 suggested that the osteogenic effect of LMHF may be 
mediated by a BMP-dependent mechanism.  To further test this hypothesis, we 
examined whether the specific BMP antagonist noggin (8) could block the osteogenic 
response induced by LMHF loading.  As shown in Figure 8.8, LMHF loading, BMP4 (20 




























































































Figure 8.7 LMHF loading prevented inhibition of mineralization caused by RPM.
2T3 cells were exposed to Static, Static+LMHF, RPM, RPM+LMHF, and RPM+Static 
conditions in the presence of BMP4 for 15 days.   LMHF was applied to the 
appropriate groups at 0.3g for 10 min/day.  Alizarin Red staining was quantified and 
data are expressed as mean ± SEM (n=6, *p<0.005, **p<0.05).   
 
Static group. However, treatment with noggin (100 ng/ml) completely blocked 
mineralization in all groups (Static, Static+LMHF, Static+BMP4, and 
Static+BMP4+LMHF). This result suggests an essential role of BMPs in the 
mineralization response induced by LMHF.  
 
LMHF mechanical loading rescued RPM-induced decrease in osteogenic gene 
expression.   
We have previously identified genes in 2T3 cells that change in response to the 
RPM and the RWV (20, 21).  Here, we investigated alterations in a subset of osteogenic 




































































































Figure 8.8  LMHF loading induced mineralization in a BMP-dependent manner. 
2T3 cells were exposed to Static, Static+LMHF, Static+BMP4, and 
Static+LMHF+BMP4 with or without noggin for 18-21 days. LMHF loading was 
applied to the appropriate groups at 0.4g for 10 min/day.  Alizarin Red staining was 
quantified and data are expressed as mean ± SEM (n=6-10, *p<0.005, **p<0.05). 
 
 187
time RTPCR data (Figure 8.9) showed that RPM exposure for three days significantly 
inhibited the expression of ALP, runx2, OMD, PTHR1, and OGN. LMHF loading 
significantly increased the expression of all the tested genes except for osteoglycin in 
the Static+LMHF group (Figure 8.9).  Moreover, LMHF prevented the RPM-induced 
decrease in expression of ALP, runx2, OMD, PTHR1, and OGN (RPM+LMHF). Unlike 
other genes studied here, regulation of BMP4 mRNA level was unique.  RPM exposure 
did not decrease BMP4 mRNA level compared to static control, which is consistent with 
our previous findings (20). However, LMHF loading of static cells (Static+LMHF) 
increased BMP4 level by ~two-fold above Static control and increased BMP4 level by 
~2.5-fold in RPM-exposed cells (RPM+LMHF) compared to the RPM (Figure 8.9).   
These data demonstrate that LMHF regulates expression of osteogenic genes, providing 
a potential molecular mechanism by which LMHF stimulates bone formation responses 
in 2T3 cells.   
Discussion 
One of the most significant findings of the current study is that cultured 
osteoblasts can directly sense and respond to an extremely low magnitude mechanical 
stimulus when applied at a high frequency, leading to osteogenic changes.   The data 
presented here suggest that osteoblasts are partially responsible for the anabolic effects 
of LMHF loading observed in vivo in both animals and humans (7, 26, 35).  These 
results are significant because they suggest that low impact loading in intact animals and 
humans may directly stimulate osteoblasts and stimulate bone formation responses.  It is 
widely accepted that bone is responsive to signals that create peak strain magnitudes of 
2,000-3,500 microstrains (µε), such as those created from physical activities like running 
(19, 27, 30).  However, muscle contractions during standing impose strains in the 











































































































































































































































































































































Figure 8.9 LMHF loading rescued RPM-induced decrease in osteogenic gene 
expression.  Confluent 2T3 cells were exposed to Static, Static+LMHF, RPM, and 
RPM+LMHF conditions for 3 days.  LMHF loading was applied to the appropriate 
groups at 0.3g for 10 min/day.  Total RNA was obtained from the cell lysates, purified, 
and reverse transcribed to obtain cDNA.  Quantitative real time PCR was performed 
for ALP (A), runx2 (B), osteomodulin (C),  parathyroid hormone receptor 1 (D), and 
osteoglycin (E) using 18s rRNA as an internal control.  Data are expressed as mean ± 
SEM (n=3-10, *p<0.05). 
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strenuous activities (30) and have recently been shown to normalize bone loss (23, 25, 
26).  Previous studies have shown that in cortical bone tissue, application of 2,000 µε at 
a frequency of 0.5 Hz (high magnitude and low frequency) maintained bone mass (28, 
30).  When the frequency was increased to 1 Hz, only a strain of 1,000 µε was needed to 
maintain bone mass, and at 30 Hz, only 70 µε (low magnitude, high frequency) was 
needed to inhibit bone resorption (29, 30).   Thus, bone response to mechanical loading 
appears to correlate with the product of frequency and load magnitude, meaning small 
strains induced by a low force could stimulate bone formation and maintain bone mass if 
applied at a high frequency.  However, the underlying molecular mechanisms regulating 
how such a low level signal can be anabolic to bone tissue and which cells or tissues 
sense and mediate the response are unknown.  
The current study provides insight into the potential mechanisms regarding how 
such low level mechanical loads can prevent or normalize bone loss.  To examine the 
underlying mechanisms of the observed in vivo anabolic effects in response to LMHF 
loading, we used the RPM to induce a bone loss response in vitro using 2T3 cells. As 
expected, the RPM decreased ALP activity (Figure 8.4) and mineralization (Figure 8.7), 
and LMHF treatment increased both markers in static cells (Static+LMHF) in a 
magnitude-dependent manner (Figures 8.3 and 8.5).  Moreover, LMHF prevented the 
RPM inhibition of ALP activity (Figure 8.4) and mineralization (Figure 8.7), preventing 
bone loss responses induced by the disuse or simulated microgravity conditions.  The 
effects of both the RPM and LMHF loading were much more dramatic on mineralization 
than ALP activity of 2T3 cells.  This may be because ALP activity is an early indicator of 
bone formation and is transient (17), making it a less sensitive marker of osteogenesis, 
especially in response to mechanical stimuli.  These findings show that osteoblasts can 
directly respond to the LMHF signal at least in vitro by induction of osteogenic markers, 
suggesting that bone may respond to LMHF signals in vivo through osteoblast cells.   
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Importantly, we found that LMHF loading alone can induce mineralization of 2T3 
cells (Figure 8.5) in a magnitude-dependent manner, and up to 20 ng/ml of BMP4 or 
BMP2 supplementation further increased this response in an additive manner (Figure 
8.6).  However, a supermaximal concentration (50 ng/ml) of BMP4 added to the cells 
was able to overcome both the RPM inhibition and LMHF increase (Figure 8.6). More 
importantly, treatment with the BMP antagonist noggin completely blocked mineralization 
induced by the LMHF stimuli. One of the limitations of this study was the range of low 
magnitude force due to physical limitations of the LMHF loading platform.  Nevertheless, 
we tested LMHF loading magnitudes of 0.1-0.4g, and observed a 10 to 40-fold increase 
in mineralization in a magnitude-dependent manner with exposure to LMHF loading. 
Together, these results clearly demonstrate a key role of BMPs in the osteogenic 
responses of osteoblasts in response to LMHF mechanical loading.  Moreover, these 
data suggest that while either BMP2/4 treatment or LMHF alone may be used, a 
combination of the mechanical and humoral stimuli may be a better therapeutic modality 
to prevent or normalize bone loss.  However, it is important to point out that chronic 
systemic supplementation of BMP4 has been shown to induce hypertension at least in a 
mouse model (18), suggesting a caution must be raised in its use.   
The current study reveals some of the osteogenic genes that are regulated by 
LMHF and/or RPM.  We have previously shown by DNA microarray analysis that the 
RPM and RWV inhibit expression of a subset of osteogenic genes (20, 21).  Here, we 
investigated ALP, runx2, PTHR1, OMD, OGN, and BMP4.  Runx2 is considered a 
“master gene” that plays a critical role in the formation of the skeleton, and without 
runx2, there is a complete lack of skeleton formation in a mouse model (12, 13).  
Parathyroid hormone related protein plays a role in calcium mobilization and has been 
linked to loss of bone density in space-flown rats (32) while OMD and OGN belong to the 
small leucine rich proteoglycan (SLRP) family, members of which have been 
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hypothesized to play roles in bone matrix formation and mineralization (1).  LMHF 
loading induced the expression of each of these genes (Static+LMHF) and prevented 
the RPM-inhibition of their expression (RPM+LMHF) (Figure 8.9).   
We found that regulation of BMP4 by the RPM and LMHF was unique compared 
to the other genes.  BMP4 is involved in the development of the skeleton, including 
cartilage formation and various joint developments (33, 36).  The RPM did not alter 
BMP4 mRNA levels, which is consistent to our previous report (20).  However, LMHF 
loading induced an increase in BMP4 mRNA in both static (Static+LMHF) and RPM-
exposed cells (RPM+LMHF).  This result suggests that the mechanism of action of the 
RPM and LMHF loading are distinct.  While the bone loss response of osteoblasts in 
response to RPM is not dependent on changes in BMP4 mRNA level, LMHF loading is 
BMP-dependent.  Together, these data suggest that LMHF regulates expression of 
osteogenic genes, providing a potential molecular mechanism by which LMHF 
stimulates bone formation responses in 2T3 cells.  The mechanosensitive genes 
identified here provide potential targets for pharmaceutical treatments that may be used 
in combination with LMHF mechanical loading to more effectively treat bone pathologies.   
In this study, we show that osteoblasts respond directly to a LMHF mechanical 
load.  It has not been reported how the LMHF may be sensed and transmitted in to the 
cells to induce the osteogenic responses. Potential mechanotransduction pathways may 
involve integrins (11), stretch-activated channels and the ensuing influx of extracellular 
calcium (11), or cell deformations and cytoskeleton (9, 10).  Elucidating the 
mechanosensors and mechanotransduction pathways would be interesting future work. 
We have revealed that LMHF mechanical loading, which has been shown to 
prevent bone loss in animals and humans, elicits cellular and molecular changes in 
osteoblasts, which may mediate bone formation responses to extremely low magnitude 
loading.  As summarized in Figure 8.10, the RPM inhibits markers of bone formation 
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such as ALP activity and mineralization as well as critical gene expression such as 
runx2. However, LMHF mechanical loading prevents these effects in a BMP-dependent 
manner.  This research provides critical insight into how such low level mechanical 
loading prevents or normalizes bone loss in animals and humans, and this mechanical 









Figure 8.10 Summary pathway showing mechanistic insight into RPM inhibition 
and mechanical loading induction of bone formation 
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Summary and Conclusions 
Musculoskeletal pathologies associated with decreased bone mass, including 
osteoporosis, disuse-induced bone loss, and microgravity-induced bone loss, affect 
millions of Americans annually. Many pharmaceutical treatments have slowed 
osteoporosis, but there is still no countermeasure for bone loss observed in astronauts.  
Additionally, high magnitude and low frequency impact such as running has been 
recognized to increase bone and muscle mass under normal but not microgravity 
conditions.  However, a low magnitude and high frequency (LMHF) mechanical load 
experienced in activities such as postural control, has also been shown to be anabolic to 
bone.  While several clinical trials have demonstrated that LMHF mechanical loading 
normalizes bone loss in vivo, the target tissues and cells of the mechanical load and 
underlying mechanisms mediating the responses are unknown.    
As such, the objectives of this project were to analyze any cellular and molecular 
changes induced in osteoblasts by LMHF loading and to investigate the utility of a LMHF 
mechanical load in mitigating microgravity-induced bone loss.  The central hypothesis of 
the project was that simulated microgravity or disuse conditions induce bone loss by 
inhibiting expression of genes critical in regulating bone formation, osteoblast 
differentiation, and subsequent mineralization while a LMHF mechanical load prevents 
these effects.  Thus, the central hypothesis of this project was tested with three specific 
aims, as follows:     
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• Specific Aim 1: To determine the effect of simulated microgravity disuse on cell 
differentiation and mineralization of mouse calvarial 2T3 pre-osteoblasts 
• Specific Aim 2:  To compile a confined list of selected genes that change upon 
exposure to simulated microgravity or disuse 
• Specific Aim 3:  To determine whether LMHF mechanical loading prevents 
microgravity- or disuse-induced decrease in bone formation 
 
To achieve these aims, we developed an in vitro disuse system using the 
Random Positioning Machine (RPM).  For the first time, we reported systemic gene 
expression studies in 2T3 preosteoblasts using the RPM disuse system showing that 
140 genes were altered by RPM exposure with over two-fold statistically significant 
changes.  Moreover, we also utilized an independent simulator called the Rotating Wall 
Vessel (RWV) to partially validate the in vitro disuse systems and to confine the list of 
genes to those most critical in regulating bone formation.  After comparative studies, we 
constricted the list to 17 commonly changed genes, three of which were not only 
decreased with disuse but also increased with mechanical loading in vivo.  Furthermore, 
we employed the RPM disuse system to evaluate the mechanism by which a LMHF load 
mitigates bone loss.  Exposure of osteoblasts to the RPM decreased bone formation 
markers such as alkaline phosphatase (ALP) activity and mineralization even in the 
presence of bone morphogenic protein 4 (BMP4), and the LMHF mechanical loading 
prevented the RPM-induced decrease in both markers.  
In conventional thought, high impact exercises instigate large strains, which 
initiate bone adaptation and remodeling.  However, these large strains are only a small 
portion of the strain history recorded over a 24 hour period of various animals.  As such, 
the dominant portion of the strain history is composed of smaller, more frequent strains.  
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The LMHF mechanical loading platform mimics these strains that are characteristic of 
physiological musculature loading on bones during activities such as postural control.   
In this dissertation, we examined the hypothesis that direct application of LMHF 
mechanical loading to osteoblasts alters their cell responses, preventing decreased 
bone formation induced by disuse as marked by ALP activity and gene expression.  
Exposure of 2T3 cells to the RPM decreased bone formation responses as determined 
by ALP activity and mineralization even in the presence of a submaximal dose of BMP4 
(20ng/ml).  However, LMHF mechanical loading prevented the RPM-induced decrease 
in ALP activity and mineralization. Mineralization induced by mechanical loading was 
enhanced by treatment with BMP4 and blocked by the BMP antagonist noggin, 
suggesting a role for BMPs in this response.  In addition, mechanical loading rescued 
the RPM-induced decrease in gene expression of ALP, runx2, osteomodulin (OMD), 
parathyroid hormone receptor 1 (PTHR1), and osteoglycin (OGN).  These genes are 
part of a larger set of mechanosensitive genes identified in this dissertation.  Additionally, 
for the first time, these findings show that osteoblasts respond directly to extremely low 
magnitude mechanical loading to induce bone formation responses, potentially leading 
to normalization or prevention of bone loss caused by disuse or microgravity conditions.  
Therefore, by achieving the three specific aims set forth, this dissertation has 
shown that LMHF mechanical loading promotes anabolic responses at the cellular and 
molecular level, partially providing mechanistic understanding by which such a low 
magnitude load prevents or prolongs bone loss in vivo in animals and humans.  In 
addition, we have shown that LMHF loading prevents simulated microgravity-induced 
decrease in bone formation response at the in vitro level, supporting use of the platform 
in spaceflight to countermeasure bone loss. Furthermore, we provided systemic gene 
expression analyses and confined the list of genes to those that may play critical roles in 
regulating bone formation in normal and disuse conditions.  In conclusion, this research 
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is significant because it sought to evaluate whether the extremely low level mechanical 
loading induced changes in an isolated osteoblast system, and if so, what the underlying 
molecular mechanisms were regulating those changes.  This information not only 
provides further understanding of how osteoblasts sense and respond to various 
mechanical loads but also imparts potential targets for pharmaceutical treatments that 
could be combined with LMHF loading to better treat bone loss due to osteoporosis, 




 There are limitations to the studies performed in this dissertation including, but 
not limited to, the following points: 
1. Simulated environments 
2. Experiments compared in Aim 2 but not performed at same time 
3. Defining “mechanosensitive” when observing gene changes 
4. Molecular effects of LMHF loading beyond BMPs 
5. Experiments performed in cell line 
6. Detailed mechanistic studies in future work 
7. LMHF loading dependent on more factors than strain magnitude and frequency 
 
The environments used for these studies with the RPM and RWV are designed 
to simulate disuse or microgravity conditions and have been shown to recapitulate some 
responses observed in vivo in isolated cells, animals, and humans.  However, it should 
be noted that the both environments are only simulations, and therefore, the results must 
be tested in actual spaceflight or disuse conditions.    
 Additionally, in aim 2, we compare the results from the RPM to the RWV; 
however, these experiments were not performed side-by-side.  This caveat must be 
noted as a limitation to the comparative studies performed.  Furthermore, the effects 
observed from the microarray gene expression analyses after exposure to both 
simulators are dependent on the definition of “mechanosensitive”.  For instance, if a 
gene was upregulated by the RPM but its downstream targets were unaffected, the gene 
could be labeled as not mechanosensitive even though its expression level changed with 
exposure to the stimulus.  An example from both microarrays is the runx2 gene, whose 
expression level was downregulated by both the RPM and RWV and upregulated by 
LMHF.  However, osteocalcin, which is a downstream target of runx2, was unchanged 
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by exposure to each stimulus.  Thus, although the gene expression level was changed, 
the activity of runx2 may not be changed.  Future work would need to perform detailed 
studies using a truncated form of the runx2 gene inserted into cells and exposed to the 
stimulus to determine if the gene is truly mechanosensitive.  However, in this dissertation, 
a gene whose expression level was changed by the stimulus was labeled 
mechanosensitive.   
 Moreover, the goal of this dissertation was to develop a method to study the 
effects of disuse at the cellular and molecular level and to investigate whether LMHF 
loading normalized bone loss in vivo by acting on osteoblasts directly.  As such, the 
project is now developed so that future work can focus on the changes noted in this 
dissertation.  Thus far, we have only partially implicated BMPs in potentially playing a 
role in the LMHF loading effects on osteoblasts, and future work should center about 
investigating the entire pathway.  Additionally, there are many other pathways 
independent of BMPs that may play roles in mediating the effects of both the RPM and 
LMHF loading, including adhesion molecules such as focal adhesion kinases (FAK) and 
integrins.  This conclusions of this dissertation were limited to the data presented here, 
which show that the effects of LMHF requires BMPs and that simulated disuse alters 
many genes, the specific roles of which should be the focus of future studies.  
Additionally, the work performed here was in an immortalized cell line that no longer 
mimics in tact in vivo osteoblasts.  The results would need to be confirmed in a primary 
cell type, which could then be used for future mechanistic work.   
 Lastly, LMHF loading depends not only on magnitude and frequency of the 
applied load, but also it depends on the effects caused at the tissue and cellular level.  
For instance, perhaps there is a role for bone microdamage, which occurs 
physiologically as part of the adaptation and remodeling cycle of bone.  Additionally, we 
showed in this dissertation that the effects of LMHF were magnitude-dependent.  
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However, we did not perform frequency dose curves.  Frequency is most likely the larger 
contributor to the osteogenic effects of LMHF loading as the strain magnitude is much 
lower than the levels needed to induce bone adaptation but is also applied much more 
frequently than the larger strain events.  Additionally, as previously discussed, there are 
most likely many changes induced by LMHF loading, including the activation of various 
mechanical signaling pathways.  This project did not evaluate the effects on specific 
mechanosensitive elements such as ion-gated channels, stretch-activated channels, 
adhesion complexes, or g-protein coupled receptors.  These studies were limited to 
gene expression and the role of BMP4/BMPs in the effects of the RPM and LMHF 
loading.  However, it should be noted that there is most likely a host of other 
downstream factors that may play roles in mediating the effects of disuse and LMHF 
loading on bone loss.   
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Future Directions  
This dissertation has set up a method by which disuse and LMHF mechanical 
loading can be tested in vitro to explore changes at the cellular and molecular level of 
osteoblasts.  To advance these experiments, the ensuing steps could revolve around 
targeting a specific gene or molecular pathway altered by both disuse and LMHF loading 
as identified in this dissertation.  To develop sophisticated cell signaling pathways, the 
next steps should revolve around functional tests by knocking down gene expression 
using pharmacological agents or siRNA and overexpressing gene expression by plasmid 
or adenovirus.  This type of functional knowledge could directly implicate a specific 
mechanosensitive gene in mediating osteoblast responses to disuse or LMHF 
mechanical loading and be specifically used for pharmaceutical treatments.   
We have begun studies involving OGN, which is a gene that is decreased by the 
RPM and RWV and increased by LMHF mechanical loading as shown in Figure 9.1.  
OGN is a small leucine-rich proteoglycan found in the extracellular matrix of bone, and 
knockout mice for this gene display collagen fibril diameter abnormalities.  Most 
investigations of OGN are in the eye extracellular matrix, and there is also an OGN 
knockout mouse available from the Tasheva lab.  An overall x-ray of the skeleton of the 
OGN-/- mouse does not show macroscopic alterations to the bones due to OGN deletion.  
However, there have not been sophisticated studies examining the mechanical 
properties of the bones of these mice.  Future work could image the bones using micro-
computed tomography (µ-CT) to assess morphological changes to the trabecular and 
cortical bone due to the gene deletion by comparing to an appropriate background 
control.  Additionally, the bones could be mechanically tested, evaluating parameters 
such as modulus of elasticity and load to failure.  Lastly, the bones could be sectioned 
and stained by immunohistochemistry for various proteins involved in bone resorption 
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and bone formation.  This type of information is unavailable and would greatly enhance 
the role of OGN in bone remodeling.   
We currently have molecular reagents targeting OGN, including a working 
antibody for Western blots (Figure 9.1A and C),   primers for real time RTPCR (Figure 
9.1B and D), and DNA plasmid for overexpression (Figure 9.2).  The plasmid 
transfection conditions are partially optimized, but cell death during transfection may still 
be too high.  Moreover, preliminary data shown in Figure 9.2 suggest that OGN may be 
linked to the BMP pathway through BMP4.  However, these results shown in two 
independent experiments (Figure 9.2 B and C) were inconsistent.  It may be of interest 
to pursue the link between OGN and BMP4 because we have previously observed that 
treatment of 2T3 cells with recombinant OGN (rOGN) protein combined with rBMP4 
increases mineralization compared to treatment with either rOGN or rBMP4 alone (data 
not shown).   
Additionally, we have tested various siRNA sequences from Dharmacon, 
including their smart pool siRNA available for OGN.  It, however, does not provide 
substantial knockdown of OGN in 2T3 cells at concentrations less than 100uM.  
However, at 100uM, there was knockdown, but this result was inconsistent (Figure 9.3).  
As such, we are currently testing additional siRNA sequences targeting osteoglycin.  
Therefore, there are ample molecular reagents available to pursue the role of OGN not 
only in osteoblast function but also in LMHF mechanical loading-induced prevention of 
decreased bone formation.   
Moreover, we have collaborations available to perform hindlimb unloading (HLU) 
studies using a mouse model.  To elevate the in vitro studies in this dissertation, OGN-/- 
mice could be used in an HLU in vivo experiment intervened with LMHF loading.  We 
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Figure 9.1 RPM decreased while LMHF loading increased expression of OGN
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Figure 9.2 OGN plasmid induced overexpression of OGN protein compared to a 
GFP control plasmid and may be involved in regulation of BMP4.  OGN plasmid 
transfection conditions are shown in A and B.  Inconsistent preliminary results in B 
and C suggest OGN may be related to the BMP pathway through BMP4.  

















































Figure 9.3 OGN siRNA did not knockdown OGN protein.  Cells were treated with 
siOGN or non-silencing control (NS) siRNA.  Transfection of siRNA occurred as noted 









Figure 9.4 MicroCT setup of analysis for HLU studies  
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as shown in Figure 9.4.  Additionally, µ-CT can evaluate the morphology and properties 
of bone architecture as shown in Figures 9.5, 9.6, and 9.7.   
Additionally, although the BMP pathway as shown in Figure 9.8 is well 
established for its role in bone formation, this dissertation is the first to provide insight 
into the direct effects of LMHF loading on osteoblast function.  Thus, it is feasible and 
would be interesting to further establish the effect of LMHF loading on the BMP 
molecular signaling pathway.  We have shown by antagonist studies that the effects of 
LMHF mechanical loading require BMPs.  However, future work may surround studying 
downstream signaling molecules such as smad 1,5,8 phosphorylation and mitogen 
activating protein kinases (MAPK).  We have preliminary data suggesting differential 
regulation of some members of the BMP pathway with MAPKs in Figure 9.9 and smad-
dependent factors in Figure 9.10.  However, most of the preliminary data is inconclusive.  
The preliminary data included here was obtained from samples exposed to three days of 
RPM or LMHF loading.  Since many of the signaling proteins are phosphorylated and 
typically are activated acutely, it may be necessary to perform short time courses to 
accurately determine the molecular mechanisms regulating both responses.  If any of 
these molecules change with LMHF loading or RPM exposure, their functional roles may 
be analyzed easily because of available blocking agents.  Furthermore, there are a 
number of other genes such as OMD, PTHR1, and runx2 that may be further 
investigated for their role in how the LMHF loading prevents bone loss.   
Lastly, the effects of LMHF loading and RPM on osteoblast mineralization may 
be dependent on lots or shelf life of the recombinant BMP4 used.  As shown in Figure 
9.11, a new lot of BMP4 was shown by smad 1,5,8 phosphorylation to be much stronger 
than the lot used in these experiments presented in this dissertation.  However, we 
cannot decipher whether it was the lot or the shelf life of the BMP4 that yielded a 




























Property p-value % Change
Bone Volume 0.004 64.4
BV/TV 0.002 60.3
Connectivity 0.002 79.5
Tb Number 0.02 23.4
Tb Thickness 0.008 22.7
Tb Spacing 0.03 26.9























































































































































































































































































































































Figure 9.5 HLU for 13 days decreased bone volume in the femur metaphysis of 
BALB mice.    
Hindlimb Unloading (HLU)Control
A. Femur Epiphysis
B. Trabecular Bone Architecture Analysis
*
Property p-value % Change
Bone Volume 0.14 28.8
BV/TV 0.08 19.2
Connectivity 0.09 14.3
Tb Number 0.18 7.8
Tb Thickness 0.03 12.1
Tb Spacing 0.21 6.9
















































































































































































































































































































































































Figure 9.6 HLU for 13 days did not alter bone volume in the femur epiphysis of 
BALB mice.    
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Property p-value % Change
Bone Volume 0.28 20.9
BV/TV 0.24 22.5
Connectivity 0.77 8.3
Tb Number 0.41 8.5
Tb Thickness 0.25 8.5
Tb Spacing 0.27 12.5
Mineral Density 0.09 6.1
Hindlimb Unloading (HLU)Control
A. Tibia Metaphysis






































































































































































































































































































































































Figure 9.7 HLU for 13 days did not alter bone volume in the tibia metaphysis of 


























Figure created by M. Patel from manuscript:





BMP/Wnt Signaling Pathway: Alkaline Phosphatase and Mineralization
Mineralization
MAPKs
Figure 9.8 BMP pathway leading to runx2 and ALP expression as well as 



































































































Figure 9.9 Preliminary data showing effects of RPM and LMHF loading on 















































































































































































































































































































































































































































































































































































































Figure 9.10 Preliminary data showing effects of RPM and LMHF loading on 






















































































































































































Figure 9.11 BMP4 lot test at varying concentrations    
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determine if the effects of LMHF loading and RPM are BMP-lot dependent.  If so, then 
future studies will need to repeat the BMP4 concentration-dependent experiments to 
determine the ideal concentration where the effects of the RPM and LMHF loading can 
be observed.   
If it is truly the goal of this project to understand how such low level mechanical 
loads can mediate bone adaptation, then future directions such as those discussed here 
must be considered.  This biological information will further elucidate our knowledge of 
how the skeletal system maintains its integrity to fully provide its protective and 
supportive functions to the body, and as such, it will render opportunities to develop new  
techniques to better treat bone pathologies.  Additionally, the success of clinical trials 
exploring the utility of the LMHF mechanical loading platform in mitigating osteoporotic 
bone loss combined with the research performed in this dissertation strongly support the 
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Table A.1 A list of selected statistically significant RWV-mechanosensitive genes 
in 2T3 cells. Sorted based on typical biological process. 
Accession # Gene Name *Fold ∆ 
p-
value Molecular Function 
Cell Adhesion     
NM_012050 Osteomodulin 0.10 0.04 aka osteoadherin, may mediate cell attachment 
NM_011581 thrombospondin 2 0.39 0.03 structural molecule activity; calcium ion binding 
BB781435 nidogen 2 0.39 0.004 calcium ion binding 
NM_007729 procollagen, type XI, alpha 1 0.40 0.04 extracellular matrix structural constituent 
NM_012043 immunoglobulin superfamily containing leucine rich repeat  (ISLR) 0.42 0.02 involved in cell attachment 
BB250384 
L08431 vascular cell adhesion molecule 1 0.45 0.02 protein binding 
BF225985 discoidin domain receptor family, member 1 0.49 0.04 protein kinase activity; protein serine/threonine kinase activity 
BC013560 procollagen, type IV, alpha 2 2.02 0.03 
structural molecule activity; 
extracellular matrix structural 
constituent 
BG073728 RGM domain family, member B 2.24 0.05 protein self binding 
BM935811 integrin alpha 6 2.47 0.01 receptor activity; protein binding 
BF158638 procollagen, type IV, alpha 1 2.59 0.002 
structural molecule activity; 
extracellular matrix structural 
constituent 
Cell Cycle     
NM_011817 
AK007410 
growth arrest and DNA damage inducible, 
gamma 0.40 0.009 structural constituent of ribosome 
AK004608 heat shock protein 8 2.27 0.04 protein binding; ATP binding 
Cell 
Differentiation     
NM_025711 Asporin 0.15 0.05 porin activity; cartilage extracellular protein 
Development     
NM_031258 chordin-like 1 0.16 0.03 unknown 
NM_009144 secreted frizzled-related sequence protein 2 0.43 0.03 transmembrane receptor and signal transduction activity 
BB549310 olfactomedin 1 2.66 0.02 unknown 
Skeletal 
Development     
NM_007554 bone morphogenetic protein 4 0.40 0.002 cytokine activity 
NM_054077 proline arginine-rich end leucine-rich repeat 0.43 0.05 extracellular matrix structural constituent 
NM_011641 transformation related protein 63 0.47 0.04 DNA binding; transcription factor activity 
Cell Growth     






Accession # Gene Name *Fold ∆ 
p-
value Molecular Function 
NM_016873 WNT1 inducible signaling pathway protein 2 0.39 0.01 phospholipase A2 activity; calcium ion binding 
BC020038 endothelial cell-specific molecule 1 0.46 0.01 insulin-like growth factor binding 
Cytoskeletal 
Regulation     
NM_008857 protein kinase C, iota 0.45 0.04 actin filament organization 
AV297945 myosin X 0.46 0.046 motor activity; actin binding 
AW491660 tubulin, alpha 4 2.42 0.007 microtubule based movement; GTPase activity; structural molecule activity 
Metabolism     
NM_007934 glutamyl aminopeptidase 0.40 0.03 DNA binding; protein binding 
AY057913 brain derived neurotrophic factor 0.46 0.02 mechanoreceptor differentiation; protein binding; growth factor activity 
NM_007436 aldehyde dehydrogenase family 3, subfamily A1 2.56 0.04 aldehyde dehydrogenase activity 
Proteolysis     
NM_011269 Rhesus blood group-associated A glycoprotein 0.36 0.01 cysteine-type endopeptidase activity 
AF282844 matrix metalloproteinase 16 0.47 0.04 metalloendopeptidase activity 
BB658835 
a disintegrin-like and metalloprotease 
(reprolysin type) with thrombospondin 
type 1 motif, 5 (aggrecanase-2) 
0.48 0.03 metalloendopeptidase activity; peptidase activity 
AK011596 transferrin receptor 2.40 0.05 receptor activity; transferrin receptor activity 
Signal 
Transduction     
NM_008046 follistatin 0.39 0.02 BMP signaling pathway 
Protein Folding     
NM_013560 heat shock protein 1 2.03 0.04 unknown 
NM_011020 heat shock 70kDa protein 4 like 2.06 0.02 ATP binding; unfolded protein binding 
Transport     
AK018504 ras association (RalGDS/AF-6) domain family 2 0.43 0.27 protein binding 
AV344473 sorting nexin associated golgi protein 1 0.48 0.008 unknown 
BB280137 RAB guanine nucleotide exchange factor (GEF) 1 0.48 0.02 DNA binding; zinc ion binding 
BB144704 ATP-binding cassette, sub-family A (ABC1), member 1 0.48 0.02 ATP binding; ATPase activity 
Chromosome 
Organization     
BB533903 histone 1, H1c 0.29 0.03 DNA binding; protein binding 
M25487  







Accession # Gene Name *Fold ∆ 
p-
value Molecular Function 
Nitric  Oxide 
Synthesis     
BF166000 high mobility group box 1 0.41 0.04 nitric-oxide synthase regulator activity 
Multidrug 
Transport     
BB291885 ATP-binding cassette, sub-family C (CFTR/MRP), member 4 2.35 0.003 multidrug efflux pump activity 
Endocytosis     




    
NM_007705 cold inducible RNA binding protein 0.21 0.003  
D67017 heat shock protein 105 2.54 0.02 protein binding; ATP binding 
AW763765 heat shock protein 1A 3.18 0.04 ATP binding 
Regulation of 
Cell Growth     




    
NM_009517 wild-type p53-induced gene 1 2.18 0.03 unknown 
Unknown      
BC002065 serine (or cysteine) proteinase inhibitor, clade A, member 3G 0.35 0.02 endopeptidase inhibitor activity 
NM_133859 olfactomedin-like 3 0.40 0.02 unknown 
NM_016753 latexin 0.44 0.01 enzyme inhibitor activity; metalloendopeptidase inhibitor activity 
NM_007984 fascin homolog 1, actin bundling protein 0.47 0.04 actin binding; actin filament binding 
NM_029632 protein phosphatase 1, regulatory (inhibitor) subunit 11 2.17 0.03 unknown 
AI266910 ceroid-lipofuscinosis, neuronal 2 2.07 0.04 serine-type endopeptidase activity 




Table A.2 The effect of the RWV on selected genes that may be involved in 
osteoblast differentiation and matrix mineralization. Genes are sorted based on 
fold changes with relaxed p-value stringency.   
Accession # Gene Name *Fold ∆ 
p-
value Molecular Function 
NM_012050 osteomodulin 0.10 <0.05 aka osteoadherin, may mediate cell attachment 
NM_008760 osteoglycin 0.23 <0.05 binds to TGF-beta, no GAG in bone, keratan sulfate in other tissues 
NM_025711 asporin 0.28 <0.05 porin activity; cartilage extracellular protein 
BC002065 serine (or cysteine) proteinase inhibitor, clade A, member 3G 0.35 <0.05 
may be involved in osteoclast function with 
MMPs and cathepsins 
NM_007729 procollagen, type XI, alpha 1 0.37 <0.05 present in cartilage 
NM_011581 thrombospondin 2 0.39 <0.025 involved in cell attachment 
NM_016873 WNT1 inducible signaling pathway protein 2 0.39 <0.05 
involved in WNT pathway, WNT stimulated by 
BMPs 
BB781435 nidogen 2 0.39 <0.005 calcium binding 
NM_007554 bone morphogenetic protein 4 0.40 <0.0025 growth factor and cytokine activity 
BM218630 protocadherin 18 0.40 0.075 calcium ion binding 
NM_011693 vascular cell adhesion molecule 1 0.41 <0.025 cell adhesion molecule activity 
NM_012043 immunoglobulin superfamily containing leucine rich repeat  (ISLR) 0.42 <0.05 involved in cell attachment 
NM_009144 secreted frizzled-related sequence protein 2 0.43 <0.05 WNT signaling pathway antagonist 
NM_021355 fibromodulin 0.45 0.051 binds to collagen, may regulate fibril formation, binds to TGF-beta 
BB431535 matrix metalloproteinase 16 0.47 <0.05 involved in osteoclast function and bone resorption 
AW412729 procollagen, type XII, alpha 1 0.48 0.072 present in collagen; extracellular matrix structural constituent 
NM_010511 interferon gamma receptor 1 0.52 0.087 inhibit bone resorption 
AF153440 BMP and activin membrane-bound inhibitor, homolog (Xenopus laevis) 0.53 0.065 
antagonist to BMPs; involved in TGF-beta 
signaling pathway 
BC014690 transforming growth factor, beta 3 0.59 <0.05 growth factor and cytokine activity 
AF053954 cbfa1/runx2 (osf2) 0.69 0.086 essential transcription factor for osteoblast differentiation and bone formation 
NM_020273 glucocorticoid modulatory element binding protein 1 0.70 0.059 transcription factor activity 
NM_008216 hyaluronan synthase 2 0.74 <0.05 with versican-like protein works to captures space destined to become bone 
NM_007833 decorin 0.76 <0.025 binds to collagen and may regulate fibril diameter 
NM_007431 alkaline phosphatase 2, liver 0.82 <0.05 essential for hydroxyapatite formation and matrix mineralization 
BB082407 hyaluronan and proteoglycan link protein 4 1.22 0.082 present in articular cartilage 
BM251152 chondroitin sulfate proteoglycan 2 1.23 0.070 present in cartilage 
BG092290 insulin-like growth factor 2 receptor 1.43 <0.025 signal transduction and hormone activity 
NM_020275 tumor necrosis factor receptor superfamily, member 10b 1.43 <0.05 growth factor and cytokine activity 
BG069059 leucine rich repeat (in FLII) interacting protein 1 1.52 0.082 
leucine rich repeats involved in bone 
mineralization 
NM_010554 interleukin 1α 1.58 <0.05 potent stimulators of bone resorption 
NM_011361 serum/glucocorticoid regulated kinase 1.65 0.072 transferase activity, transferring phosphorus-containing groups 
M94967 prostaglandin-endoperoxide synthase 2 2.05 0.062 
prostaglandins important in fluid shear over 
bone cells 
BM935811 integrin α6 2.47 <0.05 cell adhesion molecule 
AK003744 cystatin E/M 3.45 <0.05 antagonist to cathepsin family 
NM_011111 serine (or cysteine) proteinase inhibitor, clade B, member 2 7.14 0.078 
may be involved in osteoclast function with 
MMPs and cathepsins 
X75557 proliferin 14.4 0.059 involved in cell adhesion; may regulate cathepsin L; involved in cell proliferation 




 Table A.3 Comparison of gene expression changes among RWV, RPM, and 
mechanical load microarrays.  Genes are sorted by biological process.   

















 in vivo 
Molecular 
Function 
Cell Growth & 
Differentiation         
AK014259 osteoglycin 0.22  <0.05 0.38  <0.005 2.47  <0.005 binds to TGF-Beta 
NM_008409 integral membrane protein 2A 0.31 0.17 0.53  <0.05 2.85  <0.005 
marker gene of 
osteoblastic 
cells in bone 
formation 
NM_007792 cysteine and glycine-rich protein 2 0.65  <0.05 0.68 0.15 4.12  <0.0025 zinc ion binding 
AK011346 pleiotrophin 0.43 0.17 0.36  <0.05 4.29  <0.0025 




Cell Adhesion         
NM_015734 procollagen, type V, alpha 1 0.56 0.06 0.65 0.11 1.97  <0.0025 
present in 
cartilage ECM 
NM_007739 procollagen, type VIII, alpha 1 0.57 p>0.05 0.68 p>0.1 2.56 p<0.0025 
present in 
cartilage ECM 
Cell Death         
NM_008086 growth arrest specific 1 0.59  0.16 0.53  <0.01 2.26  <0.0025 protein binding 





0.56  <0.01 0.52  <0.05 2.15  <0.005 nucleic acid binding 





Transduction         
NM_008809 
platelet derived growth 
factor receptor, beta 
polypeptide 




NM_009037 reticulocalbin 0.69  <0.05 0.85 0.36 2.31  <0.005 calcium ion binding 
Transcription 
regulation         
NM_010351 goosecoid 0.58 0.20 0.68 0.13 2.3  <0.005 DNA binding 





Movement         




Other         




2.56  <0.0025 iron ion binding 
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